data_1gl8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gl8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.917 HG21 HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' HH2' HG23 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.673 ' HG ' ' CG2' ' A' ' 33' ' ' VAL . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 ' O ' HG21 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.522 ' HB3' ' HE1' ' A' ' 116' ' ' TYR . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.673 ' CG2' ' HG ' ' A' ' 29' ' ' SER . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HG23 ' A' ' 63' ' ' ILE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' HG23 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.692 HG11 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 34' ' ' MET . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.609 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.622 ' HB2' HG11 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.433 ' C ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 70' ' ' THR . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.504 HG12 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.504 ' HE1' HG12 ' A' ' 88' ' ' VAL . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.475 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.454 HD13 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.405 HG21 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.405 ' HD3' HG21 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.692 ' HG3' HG11 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.558 ' HB3' HD13 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.478 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD13 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 34' ' ' MET 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.518 HD13 ' HG2' ' A' ' 62' ' ' LYS . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.716 HG13 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.716 ' HB ' HG13 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.489 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 HG13 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' HG21 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.703 ' HE2' HD11 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.65 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HE2' ' HD3' ' A' ' 106' ' ' LYS . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.788 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.788 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.582 HD23 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.578 HD12 HD12 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.65 HG13 ' HB3' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.575 ' CE2' ' HE3' ' A' ' 34' ' ' MET . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.54 ' HB ' ' HE1' ' A' ' 90' ' ' PHE . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' HE2' ' A' ' 58' ' ' GLU . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' HD13 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.547 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.662 HG23 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HH2' HG22 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HA ' HG13 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.665 HG13 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.919 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.723 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.723 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.799 ' HE2' ' HZ2' ' A' ' 106' ' ' LYS . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.856 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.653 ' HB3' ' HD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.75 HD22 ' NH2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD13 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.75 ' NH2' HD22 ' A' ' 81' ' ' ASN . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 HG23 ' HB1' ' A' ' 39' ' ' ALA . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.623 HG13 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.65 ' HB2' HG21 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.919 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.746 ' HB2' HG11 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.584 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.799 ' HZ2' ' HE2' ' A' ' 58' ' ' GLU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.5 ' HA ' HD11 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 113' ' ' ILE . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.755 HG13 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.4 ' OD2' HG12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG22 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG22 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.774 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 64' ' ' ALA . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.743 ' HE3' ' HE1' ' A' ' 90' ' ' PHE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG22 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.484 ' O ' HG21 ' A' ' 70' ' ' THR . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.267 . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG12 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' PRO 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CD2' HG23 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.755 ' HG2' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.621 HD21 HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.565 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HG12 ' OD2' ' A' ' 19' ' ' ASP . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' A' ' 85' ' ' ILE 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.441 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CD1' HD12 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.615 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.615 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.798 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HA ' HG22 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG12 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.624 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.558 ' HH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.449 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.525 ' HZ3' HG12 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.993 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' HD23 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.634 HG12 ' HZ1' ' A' ' 106' ' ' LYS . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HD2' ' HD2' ' A' ' 67' ' ' LYS . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.609 HD21 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.609 ' OH ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.407 HG12 ' HE2' ' A' ' 34' ' ' MET . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.585 HG21 HG21 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.549 ' HB3' HG13 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.551 ' C ' HG11 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.619 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.494 HG23 HD12 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.627 HD22 ' NH2' ' A' ' 83' ' ' ARG . 47.5 t30 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.627 ' NH2' HD22 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 70' ' ' THR . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.993 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.788 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.634 ' HZ1' HG12 ' A' ' 51' ' ' VAL . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.551 HG22 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' HD23 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.474 HG22 HG13 ' A' ' 17' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD23 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 HG11 ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.788 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.536 ' HZ2' ' ND2' ' A' ' 69' ' ' ASN . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' HG23 ' A' ' 85' ' ' ILE . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 116.698 -1.62 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.568 ' HD2' ' H ' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.788 ' HH ' ' HE3' ' A' ' 34' ' ' MET . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.468 ' HG ' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.536 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.742 ' HD2' HD22 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 32' ' ' PRO . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.586 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.537 ' HA ' HG22 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.615 ' HG2' HG11 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.587 ' O ' HD13 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.945 HG13 HG23 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.945 HG23 HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.802 ' HZ3' HD21 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.69 HG11 HG13 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 HG11 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.568 ' HE2' ' HZ2' ' A' ' 106' ' ' LYS . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.489 ' OH ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.413 ' CD2' HG12 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' C ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.802 HD21 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.457 HG22 ' HB3' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.7 ' HE1' HD11 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.7 HD11 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.461 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HZ2' ' HE2' ' A' ' 58' ' ' GLU . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.481 ' HA ' HD12 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.483 ' HG ' ' HE3' ' A' ' 115' ' ' LYS . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.489 HD12 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' OE2' HG21 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HE3' ' HG ' ' A' ' 112' ' ' SER 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.6 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.743 HG13 HG23 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.649 HG11 HG13 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.779 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.649 HG13 HG11 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.65 ' HE1' ' CE1' ' A' ' 90' ' ' PHE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' HA ' HD13 ' A' ' 55' ' ' LEU . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.941 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 HG12 ' HE2' ' A' ' 34' ' ' MET . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' HB3' HG22 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 71' ' ' ASP . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HD2' ' HB3' ' A' ' 69' ' ' ASN . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.749 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.646 ' HB2' HG11 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.779 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.749 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.511 ' O ' HD11 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HD2' HG12 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 88' ' ' VAL . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.941 HG22 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 HG21 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 14' ' ' VAL . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.478 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG2' HD11 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.519 HD21 ' HA3' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.671 HG13 HG11 ' A' ' 26' ' ' VAL . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.711 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 4.5 Cg_endo . . . . . 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.928 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.715 ' HB3' ' HE2' ' A' ' 58' ' ' GLU . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.719 HD21 ' HH ' ' A' ' 59' ' ' TYR . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.715 ' HE2' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.719 ' HH ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.49 HG22 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.904 ' HG ' HG21 ' A' ' 101' ' ' ILE . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.519 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.529 HD12 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.904 HG21 ' HG ' ' A' ' 84' ' ' SER . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.494 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG3' HG11 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.693 HG22 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.62 HD12 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HE3' ' HG2' ' A' ' 98' ' ' GLU . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.459 ' HH2' HG22 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.714 ' HG2' HD11 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.714 HD11 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 30' ' ' GLU . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' H ' ' HB3' ' A' ' 29' ' ' SER . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.672 HG22 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.672 ' HD3' HG22 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.684 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.698 HD21 ' HH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.698 ' HH ' HD21 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 HD13 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.66 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.66 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.498 HD13 HG23 ' A' ' 70' ' ' THR . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.673 HD22 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' HE2' ' A' ' 34' ' ' MET . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HD3' ' HZ2' ' A' ' 97' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.673 ' HD2' HD22 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HZ2' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.604 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.653 ' HA ' HD11 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.576 HG13 HG21 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.589 ' HD2' ' ND2' ' A' ' 69' ' ' ASN . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.576 HG21 HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.642 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.821 HG11 HG13 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' HA3' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG11 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.462 ' HE1' HG12 ' A' ' 63' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.427 ' CD2' HD21 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.478 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 71' ' ' ASP . 56.6 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG12 ' HZ1' ' A' ' 106' ' ' LYS . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.603 ' HB3' ' HH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' HE2' ' HE3' ' A' ' 106' ' ' LYS . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.612 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.849 ' HD3' HD11 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.553 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.584 ' HB2' HG11 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.589 ' ND2' ' HD2' ' A' ' 16' ' ' ASP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HD2' ' HG3' ' A' ' 40' ' ' PRO . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 HD12 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.654 ' HE1' HG23 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.467 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.654 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.654 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' HG21 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HZ1' HG12 ' A' ' 51' ' ' VAL . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.669 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.612 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 113' ' ' ILE . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.849 HD11 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 66' ' ' TYR . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.801 ' HG2' HD11 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.801 HD11 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.792 ' HE2' ' HH ' ' A' ' 59' ' ' TYR . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.839 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.42 ' O ' HG21 ' A' ' 70' ' ' THR . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.839 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.792 ' HH ' ' HE2' ' A' ' 34' ' ' MET . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.684 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CD1' HG21 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.493 HD13 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.659 HG23 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB2' HG21 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HE1' ' HE3' ' A' ' 34' ' ' MET . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.443 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.596 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.596 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.423 HG23 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.654 ' HA ' HD12 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' HE2' ' HE2' ' A' ' 58' ' ' GLU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.539 HG23 HD12 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HH2' HG23 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 HG13 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.734 ' HG3' ' HZ3' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.808 ' HE2' HG13 ' A' ' 63' ' ' ILE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.6 HG23 ' HH2' ' A' ' 22' ' ' TRP . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HA ' ' HZ1' ' A' ' 57' ' ' LYS . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.664 HD21 ' HH ' ' A' ' 59' ' ' TYR . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' A' ' 54' ' ' GLU . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.881 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.762 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.808 HG13 ' HE2' ' A' ' 34' ' ' MET . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.788 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.775 ' HB3' HG13 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.66 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 87' ' ' THR 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.66 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.737 HD21 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.573 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.734 ' HZ3' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.737 HH11 HD21 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.544 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.881 ' HE2' ' HE2' ' A' ' 58' ' ' GLU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HG ' HG13 ' A' ' 88' ' ' VAL . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.762 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.428 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.841 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.898 ' HD2' ' HG3' ' A' ' 67' ' ' LYS . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG11 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HD2' ' HZ2' ' A' ' 67' ' ' LYS . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.618 HD21 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' OH ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.674 ' HB3' HG13 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.898 ' HG3' ' HD2' ' A' ' 36' ' ' ASP . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.51 HG23 HG23 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.723 HD22 ' NH2' ' A' ' 83' ' ' ARG . 31.7 t30 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.723 ' NH2' HD22 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.759 HG13 HD21 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.841 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.588 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.747 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.737 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.747 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HD3' HG11 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.759 HD21 HG13 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.424 HG21 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.424 ' OE1' HG21 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG23 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HA ' HD11 ' A' ' 27' ' ' LEU . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 23' ' ' LYS . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.639 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.57 HG11 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.913 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CD2' HG23 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.661 ' HD2' HG23 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.433 HG23 HD12 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HH ' ' CZ ' ' A' ' 96' ' ' ARG . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.82 HD22 ' NH1' ' A' ' 83' ' ' ARG . 7.2 t30 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.784 HD12 HD13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.82 ' NH1' HD22 ' A' ' 81' ' ' ASN . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.784 HD13 HD12 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.891 ' HB3' ' HH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.47 ' CZ ' ' HH ' ' A' ' 80' ' ' TYR . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.695 ' HG2' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.504 HG22 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 109' ' ' LEU 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.891 ' HH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HG21 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.954 HG21 HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.604 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG22 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG13 HG11 ' A' ' 26' ' ' VAL . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.829 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.559 HG22 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.829 ' HH ' ' HE3' ' A' ' 34' ' ' MET 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.566 ' H ' ' CD ' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.482 ' C ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.642 HD22 ' NH2' ' A' ' 83' ' ' ARG 0.265 2.9 t30 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.642 ' NH2' HD22 ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.703 HG13 HD21 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.65 ' HE2' HD12 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.742 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.695 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.703 HD21 HG13 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.404 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.632 ' HE3' ' HE2' ' A' ' 98' ' ' GLU 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.695 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.597 HG13 HG23 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HD2' ' CG ' ' A' ' 69' ' ' ASN . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.58 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HB2' HG21 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.755 HG23 ' HB2' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.548 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.847 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.426 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HB3' ' HD2' ' A' ' 71' ' ' ASP . 77.9 Cg_exo . . . . . 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.847 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.601 ' HE2' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.779 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.779 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.755 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.78 HG23 HG22 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 16' ' ' ASP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.451 ' HD2' ' HB3' ' A' ' 40' ' ' PRO . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.679 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 15.8 t30 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.679 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.439 HG23 HG21 ' A' ' 82' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.616 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' HA ' HG22 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' HG11 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.746 ' HA ' HD11 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.616 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.702 HG13 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' HB ' HG13 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.664 ' HH2' HG13 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.677 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.332 . . . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.661 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.605 ' HB3' HD11 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.547 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 HG23 HD12 ' A' ' 68' ' ' LEU . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.457 HG23 HD13 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.677 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HB2' HG11 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.494 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.494 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.498 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.661 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.774 HG23 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.799 ' HE3' ' HE1' ' A' ' 90' ' ' PHE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.715 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.616 ' HG3' ' HD2' ' A' ' 71' ' ' ASP . 58.0 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.347 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.635 HG11 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.715 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 1.0 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 1.0 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.774 ' HB3' HG23 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.604 ' HG3' ' HD2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.616 ' HD2' ' HG3' ' A' ' 40' ' ' PRO . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.479 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 6.6 t30 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.571 HG21 HG23 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB3' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.799 ' HE1' ' HE3' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.663 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.663 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.588 HG22 HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HG2' HG11 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.771 HG22 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 116' ' ' TYR 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.561 ' CG ' ' HE2' ' A' ' 72' ' ' GLU . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.694 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG22 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HG2' HD11 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.741 HD21 ' HA3' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.673 ' HE2' HD13 ' A' ' 113' ' ' ILE . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG22 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.686 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.53 ' HD2' HG21 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.756 ' HD2' ' NZ ' ' A' ' 67' ' ' LYS . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.773 HD21 ' HH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.585 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.773 ' HH ' HD21 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.672 ' HE3' HD11 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HB3' HG23 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' NZ ' ' HD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.426 ' C ' HD11 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HG ' HG22 ' A' ' 101' ' ' ILE . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.449 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 34' ' ' MET . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.741 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.608 HG13 HG22 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HG2' HG11 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.413 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.673 HD13 ' HE2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.672 HD11 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HD2' ' CG ' ' A' ' 69' ' ' ASN . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.614 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.425 ' HD2' HG21 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG21 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.658 HG12 HG11 ' A' ' 26' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.777 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.614 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.735 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG12 HD21 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.735 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.907 ' HB3' HD23 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.567 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' C ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.42 ' CG ' ' HD2' ' A' ' 16' ' ' ASP . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HG1' ' HA ' ' A' ' 39' ' ' ALA . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.446 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.777 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.404 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.649 ' HB2' HD23 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.421 ' HG2' HG11 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.649 HD23 ' HB2' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.418 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.448 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.421 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.542 ' H ' HG23 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HG22 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' HD11 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.478 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG22 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.708 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.256 . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.696 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.696 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.427 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.805 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.442 HG12 ' HE1' ' A' ' 34' ' ' MET . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.775 ' H ' HG22 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.494 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 89' ' ' LEU 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.494 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 82' ' ' ILE . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HG3' HG12 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.805 HG22 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.467 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.623 HD13 ' HH ' ' A' ' 59' ' ' TYR 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.808 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HH2' HG13 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.808 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HA ' HG13 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.594 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.722 ' HE2' HG12 ' A' ' 63' ' ' ILE . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG13 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo . . . . . 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.645 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.823 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.722 HG12 ' HE2' ' A' ' 34' ' ' MET . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.612 HG23 HD13 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.471 HD21 ' NH1' ' A' ' 83' ' ' ARG . 15.2 m120 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' HD21 ' A' ' 81' ' ' ASN . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG21 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.612 HD13 HG23 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.607 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HB2' HG11 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.594 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.607 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.588 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 14' ' ' VAL . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.644 ' HB ' HG13 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HD11 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' VAL . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CE2' HD23 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.6 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 109' ' ' LEU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.532 HD11 HG12 ' A' ' 65' ' ' VAL . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HD23 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.615 ' HZ1' ' HG3' ' A' ' 32' ' ' PRO . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.439 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.658 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HD2' ' HE2' ' A' ' 58' ' ' GLU . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.523 ' O ' HD11 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.573 HG21 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 109' ' ' LEU 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.573 ' OE1' HG21 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.722 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.76 HG11 HG13 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.535 ' O ' HG21 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.76 HG13 HG11 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.714 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.503 ' O ' HG21 ' A' ' 70' ' ' THR . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo . . . . . 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.8 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.637 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.409 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.8 HG22 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.734 HD13 ' HH ' ' A' ' 59' ' ' TYR 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.917 HG21 HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' HH2' HG23 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.673 ' HG ' ' CG2' ' A' ' 33' ' ' VAL . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 ' O ' HG21 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.522 ' HB3' ' HE1' ' A' ' 116' ' ' TYR . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.673 ' CG2' ' HG ' ' A' ' 29' ' ' SER . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HG23 ' A' ' 63' ' ' ILE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.622 HG11 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB2' HG23 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD23 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -55.13 -39.09 92.74 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -67.6 -15.56 63.72 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.3 t -76.92 -17.54 58.86 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.705 0.802 . . . . 0.0 110.413 169.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.42 -150.46 17.01 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.361 1.458 . . . . 0.0 110.333 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.87 45.44 1.78 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.367 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.7 -14.47 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 7.4 ttpt -61.93 -50.91 70.26 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.309 175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.6 mt -83.39 7.06 17.87 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.01 -59.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 25.54 60.0 0.45 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 126.142 1.777 . . . . 0.0 112.275 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.692 HG11 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.617 HG23 ' HE1' ' A' ' 34' ' ' MET . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.462 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.609 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.622 ' HB2' HG11 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.433 ' C ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.636 HD11 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 70' ' ' THR . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.504 HG12 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.504 ' HE1' HG12 ' A' ' 88' ' ' VAL . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.475 ' HD2' HD22 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.454 HD13 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.405 HG21 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.405 ' HD3' HG21 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.692 ' HG3' HG11 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.558 ' HB3' HD13 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.478 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD13 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.61 HD11 ' HE2' ' A' ' 34' ' ' MET 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.518 HD13 ' HG2' ' A' ' 62' ' ' LYS . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.716 HG13 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.716 ' HB ' HG13 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.489 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG11 HG13 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' O ' HG21 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.703 ' HE2' HD11 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' HB2' HG23 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.96 -43.47 51.96 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -61.34 -17.77 55.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.488 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 25.6 p -113.06 3.64 16.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 35.66 -105.29 0.03 OUTLIER Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.01 1.767 . . . . 0.0 113.528 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -73.33 82.37 1.63 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 107.71 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 t -85.03 72.99 10.75 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.616 -2.538 . . . . 0.0 110.222 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.06 -45.31 7.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.717 HD13 ' HG3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -51.97 -33.74 39.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 125.378 1.674 . . . . 0.0 114.009 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.54 HD12 ' HB3' ' A' ' 86' ' ' PRO 0.269 10.7 tp -112.46 79.12 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 123.721 1.724 . . . . 0.0 113.772 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.42 -50.17 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 110.462 -3.063 . . . . 0.0 117.76 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HE2' ' HD3' ' A' ' 106' ' ' LYS . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.788 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.788 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.582 HD23 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.578 HD12 HD12 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.65 HG13 ' HB3' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.717 ' HG3' HD13 ' A' ' 47' ' ' LEU . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 HD13 ' A' ' 48' ' ' ILE . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.575 ' CE2' ' HE3' ' A' ' 34' ' ' MET . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.54 ' HB ' ' HE1' ' A' ' 90' ' ' PHE . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.521 ' O ' HG22 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' HE2' ' A' ' 58' ' ' GLU . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.468 ' HA ' HD13 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.547 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.703 HD11 ' HE2' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.662 HG12 HG23 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.662 HG23 HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' HH2' HG22 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.665 ' HA ' HG13 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.665 HG13 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.919 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.723 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.715 ' HB3' HD13 ' A' ' 48' ' ' ILE . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.65 -31.55 87.71 Favored 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -67.65 -17.19 64.51 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.66 -4.26 55.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.708 0.803 . . . . 0.0 110.897 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 -121.86 5.74 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.25 50.32 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.364 2.043 . . . . 0.0 113.084 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.662 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.86 -10.86 10.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 177.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 15.0 tptm -59.71 -9.19 2.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 mt -48.85 -35.2 14.09 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.715 HD13 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -56.52 -33.05 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 171.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . -57.14 -46.76 99.82 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG11 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.723 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD11 HD13 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.799 ' HE2' ' HZ2' ' A' ' 106' ' ' LYS . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.856 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.856 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' HD2' HG21 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.653 ' HB3' ' HD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.75 HD22 ' NH2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD13 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.75 ' NH2' HD22 ' A' ' 81' ' ' ASN . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.571 HG21 ' SG ' ' A' ' 45' ' ' CYS . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.623 HG13 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.65 ' HB2' HG21 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.919 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.746 ' HB2' HG11 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.584 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.799 ' HZ2' ' HE2' ' A' ' 58' ' ' GLU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.623 ' HG ' HG13 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.5 ' HA ' HD11 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 113' ' ' ILE . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.755 HG13 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.621 HG21 HD21 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' OD2' HG12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG22 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG23 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.713 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG22 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.774 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 64' ' ' ALA . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.743 ' HE3' ' HE1' ' A' ' 90' ' ' PHE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG22 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.84 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.465 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.565 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo -61.79 -40.79 42.53 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.612 ' HE1' ' HD2' ' A' ' 71' ' ' ASP . 12.1 p-90 -59.46 -28.26 66.83 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.8 t -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.017 0.927 . . . . 0.0 113.038 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 44' ' ' PRO . . . 72.1 -111.16 3.48 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 125.225 1.393 . . . . 0.0 110.263 -176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 43' ' ' GLY . 9.0 Cg_exo -78.17 53.07 4.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.475 2.117 . . . . 0.0 114.008 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.84 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.74 -7.36 38.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 174.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 36.5 mmtt -58.54 -19.16 35.34 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 8.0 mt -36.2 -44.37 0.4 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.812 HD13 ' HB3' ' A' ' 38' ' ' TRP . 1.5 pp -58.05 -36.67 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.267 . . -55.33 -50.13 88.47 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -178.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG12 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' PRO 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CD2' HG23 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.755 ' HG2' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.621 HD21 HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.612 ' HD2' ' HE1' ' A' ' 41' ' ' TRP . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HG12 ' OD2' ' A' ' 19' ' ' ASP . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' A' ' 85' ' ' ILE 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.441 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CD1' HD12 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.798 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.615 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.615 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.798 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.467 ' HA ' HG22 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG12 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.471 ' HA ' HD13 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.624 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.558 ' HH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG13 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.449 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.525 ' HZ3' HG12 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.731 HG11 HG13 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.993 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG21 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' HD23 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.674 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.2 -27.52 83.86 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.547 ' HH2' HD11 ' A' ' 85' ' ' ILE . 6.9 p-90 -80.69 8.43 8.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.556 1.542 . . . . 0.0 114.826 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 t -127.27 107.94 10.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.325 1.05 . . . . 0.0 111.863 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.21 -61.74 5.98 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 112.556 -2.111 . . . . 0.0 113.197 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.31 -28.18 70.65 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.615 2.21 . . . . 0.0 115.941 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.725 ' SG ' HG23 ' A' ' 85' ' ' ILE . 83.5 m -63.6 -35.11 79.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -61.47 -37.75 84.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.873 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.76 -36.6 73.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.501 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.571 HG23 ' O ' ' A' ' 103' ' ' ALA 0.333 2.6 pp -69.2 -26.61 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . -57.26 -49.09 95.92 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.634 HG12 ' HZ1' ' A' ' 106' ' ' LYS . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.465 ' HD2' ' HD2' ' A' ' 67' ' ' LYS . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.609 HD21 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.609 ' OH ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.407 HG12 ' HE2' ' A' ' 34' ' ' MET . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.585 HG21 HG21 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.549 ' HB3' HG13 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.551 ' C ' HG11 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.619 HD11 HG12 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.646 HG23 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.494 HG23 HD12 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.627 HD22 ' NH2' ' A' ' 83' ' ' ARG . 47.5 t30 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.627 ' NH2' HD22 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.725 HG23 ' SG ' ' A' ' 45' ' ' CYS . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.993 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.788 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' O ' HG23 ' A' ' 48' ' ' ILE . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.634 ' HZ1' HG12 ' A' ' 51' ' ' VAL . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.593 HD21 HD13 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.551 HG22 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.542 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG13 HG21 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HG2' HD23 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG22 HG13 ' A' ' 17' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD23 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HB3' ' HZ2' ' A' ' 97' ' ' LYS . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG13 HG11 ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.788 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.865 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo -53.4 -44.39 49.37 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.701 ' HE1' ' HD2' ' A' ' 71' ' ' ASP . 6.6 p-90 -63.43 -15.72 58.5 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -65.62 -36.12 82.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.948 0.899 . . . . 0.0 112.133 177.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.69 -100.13 1.65 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 117.642 -1.643 . . . . 0.0 109.577 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' O ' HG12 ' A' ' 48' ' ' ILE . 61.3 Cg_endo -75.8 24.04 0.43 Allowed 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 123.418 2.746 . . . . 0.0 115.615 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.865 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 5.7 m -73.67 154.37 39.72 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.851 0.834 . . . . 0.0 111.878 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 51.4 tttp 75.74 -46.65 0.56 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 111.343 -2.662 . . . . 0.0 110.733 -168.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.89 -30.65 71.28 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.7 0.762 . . . . 0.0 109.606 172.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.687 ' C ' ' HD3' ' A' ' 50' ' ' PRO 0.253 8.1 pt -89.81 55.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.587 1.661 . . . . 0.0 112.761 170.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . -105.64 19.16 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 111.613 -2.54 . . . . 0.0 113.785 161.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' C ' ' A' ' 48' ' ' ILE . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.615 HG11 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.788 ' HH ' ' HE3' ' A' ' 34' ' ' MET . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.468 ' HG ' ' HA ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.625 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.536 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.701 ' HD2' ' HE1' ' A' ' 41' ' ' TRP . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.535 HD13 HD11 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.742 HD22 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.452 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.742 ' HD2' HD22 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' HZ2' ' HB3' ' A' ' 32' ' ' PRO . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.613 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.586 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.537 ' HA ' HG22 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.615 ' HG2' HG11 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.587 ' O ' HD13 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.945 HG13 HG23 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.945 HG23 HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.802 ' HZ3' HD21 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.69 HG11 HG13 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.69 HG13 HG11 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.638 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.524 ' CE2' HD13 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.57 -41.97 64.92 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -75.27 4.96 6.14 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.452 ' O ' HD11 ' A' ' 47' ' ' LEU . 11.5 t -111.06 111.79 23.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.636 0.731 . . . . 0.0 112.642 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.81 -62.96 5.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 113.249 -1.796 . . . . 0.0 112.01 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.61 41.87 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.184 3.256 . . . . 0.0 115.141 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.867 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 77.2 m -121.2 -152.53 0.51 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.77 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' H ' ' HB2' ' A' ' 38' ' ' TRP . 17.8 ttpt -43.58 -42.11 4.92 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.303 1.441 . . . . 0.0 114.408 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 42' ' ' CYS . 3.6 mp -38.33 -36.13 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.024 1.73 . . . . 0.0 114.135 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -129.69 -38.74 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 38.59 36.69 0.12 Allowed Pre-proline 0 N--CA 1.5 2.039 0 C-N-CA 127.257 2.223 . . . . 0.0 116.427 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.568 ' HE2' ' HZ2' ' A' ' 106' ' ' LYS . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.489 ' OH ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.413 ' CD2' HG12 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' C ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.802 HD21 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.457 HG22 ' HB3' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.7 ' HE1' HD11 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.498 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.7 HD11 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.461 HG23 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HZ2' ' HE2' ' A' ' 58' ' ' GLU . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.481 ' HA ' HD12 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.483 ' HG ' ' HE3' ' A' ' 115' ' ' LYS . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.489 HD12 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' OE2' HG21 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' HE3' ' HG ' ' A' ' 112' ' ' SER 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.6 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.743 HG13 HG23 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG23 HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.466 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.649 HG11 HG13 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.779 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.649 HG13 HG11 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.65 ' HE1' ' CE1' ' A' ' 90' ' ' PHE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.823 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.07 -37.19 78.87 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -72.65 -9.81 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.573 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 17.2 p -114.99 73.9 0.85 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -18.81 -64.09 0.01 OUTLIER Glycine 0 CA--C 1.547 2.069 0 CA-C-N 114.065 -1.425 . . . . 0.0 115.309 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.507 ' HA ' HD13 ' A' ' 47' ' ' LEU . 72.1 Cg_exo -60.98 -12.41 22.44 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 123.987 3.124 . . . . 0.0 119.403 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 26.2 m -50.04 -35.86 26.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 46.6 mmtt -57.47 -32.69 67.21 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER -67.2 -33.35 75.2 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 45' ' ' CYS 0.337 0.8 OUTLIER -73.13 -19.21 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.181 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . -62.05 -46.3 91.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' HA ' HD13 ' A' ' 55' ' ' LEU . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.941 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 HG12 ' HE2' ' A' ' 34' ' ' MET . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' HB3' HG22 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.545 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 71' ' ' ASP . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.502 ' HD2' ' HB3' ' A' ' 69' ' ' ASN . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.499 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.749 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.646 ' HB2' HG11 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.779 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.749 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.511 ' O ' HD11 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HD2' HG12 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 88' ' ' VAL . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.941 HG22 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG13 HG21 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG21 HG13 ' A' ' 14' ' ' VAL . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.478 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HG2' HD11 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.671 HG11 HG13 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.519 HD21 ' HA3' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.671 HG13 HG11 ' A' ' 26' ' ' VAL . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.711 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.414 ' CE2' ' HB2' ' A' ' 46' ' ' LYS . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HG3' ' HB3' ' A' ' 71' ' ' ASP . 4.5 Cg_endo -57.5 -37.13 98.22 Favored 'Trans proline' 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -67.34 -19.16 65.4 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 38.4 t -67.94 -27.57 66.72 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 110.989 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.34 -137.8 13.5 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.54 34.32 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.353 2.035 . . . . 0.0 114.66 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.7 m -57.66 -24.05 54.61 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 38' ' ' TRP . 1.6 tmmt? -60.09 -51.09 71.11 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.505 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.57 -16.7 63.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.029 1.731 . . . . 0.0 113.936 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.268 3.1 pt -110.48 -61.76 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB2' ' HD2' ' A' ' 53' ' ' ASP . . . 37.12 51.26 1.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 119.0 0.818 . . . . 0.0 111.928 -172.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG11 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.715 ' HB3' ' HE2' ' A' ' 58' ' ' GLU . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.719 HD21 ' HH ' ' A' ' 59' ' ' TYR . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.715 ' HE2' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.719 ' HH ' HD21 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG3' HG22 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.49 HG22 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 HG23 HD12 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.904 ' HG ' HG21 ' A' ' 101' ' ' ILE . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.522 HG22 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.711 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.655 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.519 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.65 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.529 HD12 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.904 HG21 ' HG ' ' A' ' 84' ' ' SER . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.494 ' HB2' HD11 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.574 ' HG3' HG11 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.693 HG22 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.492 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.62 HD12 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' HE3' ' HG2' ' A' ' 98' ' ' GLU . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.422 ' OD2' ' HB3' ' A' ' 73' ' ' ALA . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.459 ' HH2' HG22 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.714 ' HG2' HD11 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.714 HD11 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.416 ' HB3' ' H ' ' A' ' 30' ' ' GLU . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' H ' ' HB3' ' A' ' 29' ' ' SER . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.672 HG22 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.672 ' HD3' HG22 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.684 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 46' ' ' LYS . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -56.19 -36.88 97.16 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.534 ' HE1' ' HD2' ' A' ' 71' ' ' ASP . 7.6 p-90 -75.58 14.27 0.65 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 35.5 t -95.96 -17.74 20.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.788 1.235 . . . . 0.0 113.357 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.51 -137.83 14.34 Favored Glycine 0 CA--C 1.537 1.447 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.86 50.54 3.6 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.305 2.003 . . . . 0.0 112.544 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.3 m -86.36 154.83 20.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.724 -1.126 . . . . 0.0 107.973 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 50.8 tttp 85.19 -60.12 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 128.169 2.587 . . . . 0.0 108.222 -164.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.88 -45.96 71.21 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.585 1.554 . . . . 0.0 113.329 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.5 pt -63.17 -67.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 33.86 39.92 0.1 Allowed Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD21 ' HH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.543 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.698 ' HH ' HD21 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.513 ' HG2' HD11 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.6 HG21 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.441 ' H ' HD13 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 HG23 HD13 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.534 ' HD2' ' HE1' ' A' ' 41' ' ' TRP . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.66 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.66 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.505 ' OG ' HG22 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.498 HD13 HG23 ' A' ' 70' ' ' THR . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.673 HD22 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' HE2' ' A' ' 34' ' ' MET . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HD3' ' HZ2' ' A' ' 97' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.673 ' HD2' HD22 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HZ2' ' HD3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.658 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.604 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.653 ' HA ' HD11 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.576 HG13 HG21 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.589 ' HD2' ' ND2' ' A' ' 69' ' ' ASN . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.576 HG21 HG13 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.642 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HG2' HD13 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.821 HG11 HG13 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD22 ' HA3' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.821 HG13 HG11 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.462 ' HE1' HG12 ' A' ' 63' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.427 ' CD2' HD21 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.919 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 71' ' ' ASP . 56.6 Cg_endo -57.44 -34.84 98.62 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -71.77 -18.8 62.09 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.458 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 12.2 p -93.62 48.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 124.263 1.982 . . . . 0.0 108.83 169.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.7 42.76 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 111.837 -2.438 . . . . 0.0 110.345 -173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.5 -34.65 19.58 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.388 2.059 . . . . 0.0 113.698 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.919 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER 54.61 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 121.328 3.825 . . . . 0.0 121.328 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -43.33 -24.84 0.11 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.322 2.249 . . . . 0.0 116.904 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.19 -23.86 3.74 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.964 1.706 . . . . 0.0 114.021 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.3 -31.85 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.877 0.471 . . . . 0.0 111.245 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . -54.11 -40.75 84.28 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG12 ' HZ1' ' A' ' 106' ' ' LYS . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.531 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.603 ' HB3' ' HH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' HE2' ' HE3' ' A' ' 106' ' ' LYS . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.612 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.849 ' HD3' HD11 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.553 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.584 ' HB2' HG11 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.589 ' ND2' ' HD2' ' A' ' 16' ' ' ASP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HD2' ' HG3' ' A' ' 40' ' ' PRO . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.514 HG23 HD12 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG23 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.654 ' HE1' HG23 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.467 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.654 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.654 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.498 HG21 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' HD3' HG21 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HZ1' HG12 ' A' ' 51' ' ' VAL . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.402 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.484 ' HA ' HD12 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.669 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.612 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.426 ' HG3' HG12 ' A' ' 113' ' ' ILE . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.849 HD11 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 66' ' ' TYR . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG13 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.801 ' HG2' HD11 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.801 HD11 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.792 ' HE2' ' HH ' ' A' ' 59' ' ' TYR . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.839 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.928 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.23 -35.31 75.01 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -66.48 -13.92 61.52 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 174.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.3 t -91.63 17.89 8.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.198 1.399 . . . . 0.0 110.872 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.5 -109.17 0.64 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.325 1.917 . . . . 0.0 111.979 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.3 48.69 2.54 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 122.16 1.907 . . . . 0.0 114.407 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.928 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -56.57 -23.19 38.68 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 39.1 mmtt -53.26 -20.03 3.77 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 65.8 mt -53.09 -28.04 23.27 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.686 HD13 ' HB3' ' A' ' 38' ' ' TRP . 1.7 pp -59.24 -38.61 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . -54.91 -48.69 95.2 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.839 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.63 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.792 ' HH ' ' HE2' ' A' ' 34' ' ' MET . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.684 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CD1' HG21 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.493 HD13 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.659 HG23 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB2' HG21 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.72 ' HE1' ' HE3' ' A' ' 34' ' ' MET . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.443 ' HA ' HG13 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.596 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.596 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.423 HG23 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.654 ' HA ' HD12 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' HE2' ' HE2' ' A' ' 58' ' ' GLU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.539 HG23 HD12 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.414 HD23 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HH2' HG23 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.536 HG11 HG13 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.734 ' HG3' ' HZ3' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.788 HG23 ' HB2' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.808 ' HE2' HG13 ' A' ' 63' ' ' ILE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.6 HG23 ' HH2' ' A' ' 22' ' ' TRP . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' HB3' HD12 ' A' ' 48' ' ' ILE . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.94 -34.47 48.01 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.438 ' HE1' ' HD2' ' A' ' 71' ' ' ASP . 8.2 p-90 -67.34 -21.04 65.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 173.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 8.7 t -71.95 -24.18 61.57 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.744 1.218 . . . . 0.0 111.359 171.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.43 -157.62 14.86 Favored Glycine 0 CA--C 1.543 1.787 0 C-N-CA 126.684 2.087 . . . . 0.0 108.366 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -78.89 73.88 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.684 1.589 . . . . 0.0 108.885 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -81.29 24.41 0.55 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -64.51 -23.27 67.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.944 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 mt -41.43 -37.8 1.12 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.827 2.051 . . . . 0.0 115.345 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.597 HD12 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -67.64 -29.16 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.33 -46.45 99.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.599 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HA ' ' HZ1' ' A' ' 57' ' ' LYS . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.664 HD21 ' HH ' ' A' ' 59' ' ' TYR . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' A' ' 54' ' ' GLU . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.881 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.724 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.762 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.808 HG13 ' HE2' ' A' ' 34' ' ' MET . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.788 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.775 ' HB3' HG13 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' HD2' ' HE1' ' A' ' 41' ' ' TRP . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' HB2' HG21 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.66 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 87' ' ' THR 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.66 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.737 HD21 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.573 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.734 ' HZ3' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.737 HH11 HD21 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.544 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.881 ' HE2' ' HE2' ' A' ' 58' ' ' GLU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.552 ' HG ' HG13 ' A' ' 88' ' ' VAL . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.48 HG21 HD22 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.762 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.428 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.841 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.898 ' HD2' ' HG3' ' A' ' 67' ' ' LYS . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.487 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.23 -38.17 88.16 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -71.06 -12.55 61.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.8 t -73.28 -21.03 60.69 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.713 1.205 . . . . 0.0 113.149 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.25 -140.4 15.21 Favored Glycine 0 CA--C 1.542 1.768 0 C-N-CA 124.265 0.936 . . . . 0.0 111.104 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.9 34.62 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 123.495 2.797 . . . . 0.0 114.967 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.94 -23.48 65.32 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 tmmt? -69.09 -57.83 4.89 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.72 -33.33 34.0 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.533 1.933 . . . . 0.0 115.632 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -105.42 -51.55 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.423 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . . . 33.81 55.41 1.57 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG11 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.447 ' HD2' ' HZ2' ' A' ' 67' ' ' LYS . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.618 HD21 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' OH ' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.674 ' HB3' HG13 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.898 ' HG3' ' HD2' ' A' ' 36' ' ' ASP . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.51 HG23 HG23 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.723 HD22 ' NH2' ' A' ' 83' ' ' ARG . 31.7 t30 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.665 HD11 HG22 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.723 ' NH2' HD22 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.487 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.759 HG13 HD21 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.841 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.475 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.588 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.747 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.737 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.747 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HD3' HG11 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.759 HD21 HG13 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.424 HG21 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.424 ' OE1' HG21 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' HB ' HG13 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG23 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HA ' HD11 ' A' ' 27' ' ' LEU . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG23 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 23' ' ' LYS . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.639 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.57 HG11 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.913 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CD2' HG23 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.896 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.452 ' CB ' HG23 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -55.11 -36.6 93.37 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -67.39 -20.01 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.01 -0.41 56.58 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.644 0.778 . . . . 0.0 112.681 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.8 -101.55 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 C-N-CA 126.43 1.967 . . . . 0.0 114.736 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -60.2 -4.12 2.85 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.368 2.712 . . . . 0.0 117.437 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.896 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -36.22 -46.43 0.52 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.391 1.876 . . . . 0.0 114.947 176.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -51.69 -67.44 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.66 1.984 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.0 mt -69.75 -34.75 74.25 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.298 21.2 pt -71.7 -45.15 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 23.45 58.08 0.32 Allowed Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 125.086 1.355 . . . . 0.0 113.204 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.695 HG11 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.524 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG12 ' CD1' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.661 ' HD2' HG23 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.433 HG23 HD12 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 82' ' ' ILE . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.47 ' HH ' ' CZ ' ' A' ' 96' ' ' ARG . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.82 HD22 ' NH1' ' A' ' 83' ' ' ARG . 7.2 t30 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.784 HD12 HD13 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.82 ' NH1' HD22 ' A' ' 81' ' ' ASN . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.784 HD13 HD12 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.891 ' HB3' ' HH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' CZ ' ' HH ' ' A' ' 80' ' ' TYR . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.691 ' HA ' HG22 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.525 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.695 ' HG2' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.504 HG22 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 109' ' ' LEU 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.891 ' HH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.954 HG13 HG21 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.954 HG21 HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.604 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG22 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG13 HG11 ' A' ' 26' ' ' VAL . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.829 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.559 HG22 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.784 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.51 -28.13 72.26 Favored 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -70.66 -26.2 63.34 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 14.1 p -88.24 54.76 3.17 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 124.274 1.988 . . . . 0.0 110.516 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.15 -125.34 39.37 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-N 111.77 -2.468 . . . . 0.0 109.833 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.4 -45.95 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.362 2.042 . . . . 0.0 113.421 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.784 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER 51.94 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -174.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -48.14 -26.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 mt -40.99 -32.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.887 2.075 . . . . 0.0 116.189 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 38' ' ' TRP . 2.5 pp -63.14 -31.65 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 174.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.85 99.74 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' HB3' HG13 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.829 ' HH ' ' HE3' ' A' ' 34' ' ' MET 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CD ' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.566 ' H ' ' CD ' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.473 HG13 ' HB3' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.482 ' C ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.642 HD22 ' NH2' ' A' ' 83' ' ' ARG 0.265 2.9 t30 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.642 ' NH2' HD22 ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.703 HG13 HD21 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.65 ' HE2' HD12 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.742 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.742 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.695 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.65 HD12 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.703 HD21 HG13 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.525 HG22 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.404 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.632 ' HE3' ' HE2' ' A' ' 98' ' ' GLU 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.695 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.597 HG13 HG23 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.434 ' HD2' ' CG ' ' A' ' 69' ' ' ASN . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.58 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.603 HG22 HG13 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA2' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.453 ' HB2' HG21 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.755 HG23 ' HB2' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.548 ' HE3' ' HH ' ' A' ' 59' ' ' TYR . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.847 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.884 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HB3' ' HD2' ' A' ' 71' ' ' ASP . 77.9 Cg_exo -56.14 -40.11 86.92 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -64.1 -21.46 66.55 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.2 t -90.82 26.15 2.16 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.796 1.284 . . . . 0.0 109.855 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 -115.12 7.51 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.03 -26.61 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.41 2.073 . . . . 0.0 115.489 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.884 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER 44.99 15.92 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 -176.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 9.9 mmtt -58.94 -11.01 2.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.01 -22.91 6.36 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.58 HD13 ' HG3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -69.89 -36.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.131 0.972 . . . . 0.0 111.462 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . -49.43 -45.48 77.38 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.847 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD13 HD13 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.601 ' HE2' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.779 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.779 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.755 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.78 HG23 HG22 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.638 ' HB3' HG21 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 16' ' ' ASP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.451 ' HD2' ' HB3' ' A' ' 40' ' ' PRO . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.679 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 15.8 t30 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.679 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.58 ' HG3' HD13 ' A' ' 48' ' ' ILE . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.439 HG23 HG21 ' A' ' 82' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.541 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.435 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.616 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' HA ' HG22 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' HG11 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.746 ' HA ' HD11 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.746 HD11 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.616 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG13 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' HB ' HG13 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.664 ' HH2' HG13 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 HD21 ' HA3' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.677 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.664 HG13 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.8 ' HB3' HD12 ' A' ' 48' ' ' ILE . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.39 -42.08 69.51 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -65.23 -14.86 61.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.26 -13.51 46.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.777 1.231 . . . . 0.0 112.386 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.72 -106.49 1.97 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 124.699 1.143 . . . . 0.0 110.78 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 23.3 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.555 2.17 . . . . 0.0 117.389 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.674 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -48.8 -30.83 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 37.0 mmtt -41.49 -30.16 0.19 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 176.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 pp -41.37 -34.83 0.57 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.8 HD12 ' HB3' ' A' ' 38' ' ' TRP . 1.4 pp -62.94 -35.25 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.332 . . -56.04 -53.22 65.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.661 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.605 ' HB3' HD11 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.547 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD11 HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 HG23 HD12 ' A' ' 68' ' ' LEU . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.652 HG23 ' SG ' ' A' ' 45' ' ' CYS . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.486 HG21 HD13 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 HG23 HD13 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.677 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.504 ' HB2' HG11 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.494 ' CZ ' ' HG ' ' A' ' 99' ' ' SER . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.494 ' HG ' ' CZ ' ' A' ' 96' ' ' ARG . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB2' HD23 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.498 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.661 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.774 HG23 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.799 ' HE3' ' HE1' ' A' ' 90' ' ' PHE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.715 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.616 ' HG3' ' HD2' ' A' ' 71' ' ' ASP . 58.0 Cg_endo -58.84 -33.99 98.82 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.71 -10.31 57.81 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.5 t -95.48 26.03 4.12 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.831 1.3 . . . . 0.0 109.015 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.81 -120.7 3.88 Favored Glycine 0 CA--C 1.548 2.125 0 C-N-CA 126.62 2.057 . . . . 0.0 112.736 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.59 37.88 0.67 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.58 2.853 . . . . 0.0 113.498 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.757 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -46.37 -39.8 10.94 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.946 2.098 . . . . 0.0 116.191 -176.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -56.71 -47.69 79.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.101 1.76 . . . . 0.0 112.13 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.2 mt -91.98 22.72 4.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 45' ' ' CYS . 7.6 mt -114.07 -61.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.634 -1.621 . . . . 0.0 107.388 171.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 22.39 55.11 0.24 Allowed Pre-proline 0 N--CA 1.506 2.347 0 C-N-CA 126.353 1.861 . . . . 0.0 114.162 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.635 HG11 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.715 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 1.0 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 1.0 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.774 ' HB3' HG23 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.604 ' HG3' ' HD2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.616 ' HD2' ' HG3' ' A' ' 40' ' ' PRO . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.479 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 6.6 t30 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.571 HG21 HG23 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB3' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.588 HG22 HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.537 HG13 HD12 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.799 ' HE1' ' HE3' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.663 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.663 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.588 HG22 HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HG2' HG11 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.537 HD12 HG13 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.771 HG22 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 116' ' ' TYR 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.561 ' CG ' ' HE2' ' A' ' 72' ' ' GLU . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.694 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG22 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HG2' HD11 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.741 HD21 ' HA3' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.673 ' HE2' HD13 ' A' ' 113' ' ' ILE . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG22 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.686 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.53 ' HD2' HG21 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.814 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.449 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.03 -36.19 95.72 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -65.64 -25.49 67.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.69 20.81 0.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.12 1.368 . . . . 0.0 111.754 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 42.4 -110.6 0.26 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.092 1.806 . . . . 0.0 111.848 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.23 39.67 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.127 2.551 . . . . 0.0 116.204 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.814 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.08 -30.49 62.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.04 -1.038 . . . . 0.0 113.392 174.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -51.1 -19.46 1.13 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.352 2.261 . . . . 0.0 116.012 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.2 -37.86 3.42 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 38' ' ' TRP . 1.1 pp -56.34 -33.37 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . -60.16 -49.69 89.65 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG11 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.756 ' HD2' ' NZ ' ' A' ' 67' ' ' LYS . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.773 HD21 ' HH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.585 ' HE2' ' HG1' ' A' ' 110' ' ' THR . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.773 ' HH ' HD21 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.672 ' HE3' HD11 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' HB3' HG23 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' NZ ' ' HD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.53 HG21 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.561 ' HE2' ' CG ' ' A' ' 16' ' ' ASP . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.426 ' C ' HD11 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HG ' HG22 ' A' ' 101' ' ' ILE . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.449 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.608 HG22 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.664 ' CE1' ' HE3' ' A' ' 34' ' ' MET . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.626 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.741 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.608 HG13 HG22 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HG2' HG11 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.518 ' HB3' HD13 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.413 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.673 HD13 ' HE2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.672 HD11 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG13 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HD2' ' CG ' ' A' ' 69' ' ' ASN . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.614 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.425 ' HD2' HG21 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.658 HG11 HG12 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG21 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.658 HG12 HG11 ' A' ' 26' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.777 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.735 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.728 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo -62.63 -35.54 69.42 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -67.03 -13.63 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 174.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.7 t -87.28 0.04 56.0 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.129 1.372 . . . . 0.0 111.156 171.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.62 -127.0 30.85 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.054 1.788 . . . . 0.0 109.84 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -76.11 79.9 2.81 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.592 1.528 . . . . 0.0 109.506 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.728 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -79.44 68.87 5.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.792 -176.476 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -63.32 -84.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.327 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 47' ' ' LEU . 4.0 mm? 19.74 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.582 2.353 . . . . 0.0 115.77 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.703 ' HB ' ' HB2' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -46.55 -58.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.512 1.525 . . . . 0.0 114.638 175.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . -54.88 -51.53 78.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -175.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG12 HD21 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.735 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.48 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.907 ' HB3' HD23 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 63' ' ' ILE . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.5 ' HB2' HG23 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.567 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' C ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD13 ' HB2' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' CG ' ' HD2' ' A' ' 16' ' ' ASP . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HG1' ' HA ' ' A' ' 39' ' ' ALA . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.446 HD22 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' CZ ' HD22 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HB3' HG22 ' A' ' 48' ' ' ILE . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.777 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.404 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.649 ' HB2' HD23 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.421 ' HG2' HG11 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.649 HD23 ' HB2' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.418 ' HG1' ' HE2' ' A' ' 58' ' ' GLU . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.448 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.421 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.542 ' H ' HG23 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.429 ' CH2' HG22 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' HD11 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.681 ' HA ' HG12 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' O ' HG22 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.478 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG22 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.798 ' HB2' HD13 ' A' ' 48' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.92 -37.21 35.24 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CH2' HD11 ' A' ' 85' ' ' ILE . 12.7 p-90 -67.16 -8.56 32.08 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' SG ' HG23 ' A' ' 85' ' ' ILE . 53.8 t -87.66 -13.61 42.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.804 1.242 . . . . 0.0 111.351 176.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.81 -139.17 14.35 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.164 1.364 . . . . 0.0 109.995 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.24 43.86 1.57 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.78 2.32 . . . . 0.0 113.15 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.619 ' O ' HG12 ' A' ' 48' ' ' ILE . 96.8 m -65.26 -15.73 62.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -53.48 -27.63 26.25 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.841 174.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -42.41 -40.31 2.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.776 2.031 . . . . 0.0 114.389 173.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.798 HD13 ' HB2' ' A' ' 36' ' ' ASP . 28.2 pt -59.37 -32.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' A' ' 50' ' ' PRO 0.256 . . -60.3 -47.31 96.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.38 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 49' ' ' ALA . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.696 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD21 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.696 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.427 ' HE2' ' HE2' ' A' ' 106' ' ' LYS . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.805 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.442 HG12 ' HE1' ' A' ' 34' ' ' MET . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.775 ' H ' HG22 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.494 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 89' ' ' LEU 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.494 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.581 HD11 ' CH2' ' A' ' 41' ' ' TRP . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.715 ' HB3' HD11 ' A' ' 48' ' ' ILE . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 82' ' ' ILE . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.412 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.412 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HG3' HG12 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.805 HG22 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.467 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.623 HD13 ' HH ' ' A' ' 59' ' ' TYR 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.476 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.808 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HH2' HG13 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.808 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 ' HA ' HG13 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.594 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.722 ' HE2' HG12 ' A' ' 63' ' ' ILE . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG13 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.618 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.535 ' HD2' HG21 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo -59.53 -26.65 82.74 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . 0.268 8.4 p-90 -66.81 -25.74 66.6 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.579 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 26.8 p -98.42 45.55 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 123.185 1.469 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 44' ' ' PRO . . . 36.4 -113.18 0.16 Allowed Glycine 0 CA--C 1.549 2.189 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.843 -178.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HD3' ' HA2' ' A' ' 43' ' ' GLY . 7.8 Cg_endo -80.14 38.71 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.596 2.864 . . . . 0.0 115.575 -176.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 1.3 m -56.43 -12.93 1.91 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 176.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -49.63 -26.54 3.72 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -50.62 -31.43 16.03 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 175.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 36' ' ' ASP . 17.4 mt -62.91 -36.92 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.977 0.911 . . . . 0.0 111.725 176.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . -54.08 -42.9 95.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.645 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.823 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.823 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.722 HG12 ' HE2' ' A' ' 34' ' ' MET . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' HB3' HG23 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.612 HG23 HD13 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.547 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.471 HD21 ' NH1' ' A' ' 83' ' ' ARG . 15.2 m120 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH1' HD21 ' A' ' 81' ' ' ASN . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG21 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.612 HD13 HG23 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.607 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HB2' HG11 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.594 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.607 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.588 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.644 HG13 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 14' ' ' VAL . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.644 ' HB ' HG13 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.423 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HG2' HD11 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.608 HD21 ' HA3' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 31' ' ' VAL . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.615 ' HG3' ' HZ1' ' A' ' 92' ' ' LYS . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 67' ' ' LYS . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CE2' HD23 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.599 ' HE3' ' HB2' ' A' ' 45' ' ' CYS . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.6 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo -58.27 -34.75 98.91 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -77.59 28.52 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 174.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 167.49 15.32 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 177.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.01 -81.41 0.96 Allowed Glycine 0 CA--C 1.55 2.239 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.026 170.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.38 88.28 1.3 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 121.705 1.603 . . . . 0.0 113.098 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.599 ' HB2' ' HE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -137.82 136.71 37.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.033 -178.109 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 72.7 tttt 63.37 -56.16 0.19 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.965 2.106 . . . . 0.0 114.873 176.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 tp -80.24 52.34 1.56 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 123.28 1.515 . . . . 0.0 111.078 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -158.32 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 111.952 -2.385 . . . . 0.0 110.824 -176.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.432 ' H ' HD11 ' A' ' 48' ' ' ILE . . . 37.29 43.03 0.36 Allowed Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 126.087 1.755 . . . . 0.0 111.739 -174.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 HG12 HD21 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 109' ' ' LEU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 HD11 HG12 ' A' ' 65' ' ' VAL . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.452 HD23 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.6 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG13 HD23 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.615 ' HZ1' ' HG3' ' A' ' 32' ' ' PRO . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.608 ' HA3' HD21 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.454 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.439 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.658 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HD2' ' HE2' ' A' ' 58' ' ' GLU . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.523 ' O ' HD11 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.573 HG21 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 109' ' ' LEU 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.573 ' OE1' HG21 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.722 ' HZ3' HG22 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.76 HG11 HG13 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.516 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 ' O ' HG21 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.76 HG13 HG11 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.714 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo -59.03 -37.27 94.02 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.907 ' HE1' ' HD2' ' A' ' 71' ' ' ASP . 6.5 p-90 -67.16 -13.08 61.61 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 175.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.539 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 29.6 p -108.85 42.42 1.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.724 0.773 . . . . 0.0 111.137 170.1 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 10.0 -81.37 0.0 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 129.308 3.337 . . . . 0.0 116.882 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.99 -18.18 2.88 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.407 3.405 . . . . 0.0 117.404 177.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 14.0 m -42.92 -38.7 2.3 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 46' ' ' LYS . 47.5 tptt -51.16 -34.77 32.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.997 1.319 . . . . 0.0 114.376 177.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.15 -22.97 63.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.533 HG13 ' HD2' ' A' ' 36' ' ' ASP . 12.9 pt -72.34 -23.16 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 176.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . -62.13 -44.19 88.37 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 174.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' HB3' ' HE2' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.8 ' HE2' HG22 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' CD2' HG12 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD22 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.503 HG21 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.907 ' HD2' ' HE1' ' A' ' 41' ' ' TRP . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.409 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.682 HG22 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG22 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.714 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HG3' HG12 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.8 HG22 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.734 HD13 ' HH ' ' A' ' 59' ' ' TYR 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.934 HG11 HG22 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG22 HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG21 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 HG11 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 117' ' ' LEU . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.616 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD22 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.698 HG13 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG13 ' A' ' 65' ' ' VAL . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' HB2' HG12 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.481 HG13 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' HG23 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.698 ' HG3' HG13 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 113' ' ' ILE . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 110' ' ' THR 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 32' ' ' PRO . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.736 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.515 ' HE1' HD12 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' HG21 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HE1' ' HB ' ' A' ' 100' ' ' ILE . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.405 HH21 ' CB ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' HH21 ' A' ' 96' ' ' ARG . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 103' ' ' ALA . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' HD11 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 ' HE1' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HH2' HG21 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HA ' HG11 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.508 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.426 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD12 HD12 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.857 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HD2' HG22 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' ALA . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.577 ' HE2' HG12 ' A' ' 100' ' ' ILE . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.748 ' HB2' HG13 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HG ' HG11 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' HD12 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG21 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.541 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.584 ' HE3' HG12 ' A' ' 63' ' ' ILE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG21 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.506 ' O ' HG22 ' A' ' 70' ' ' THR . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.267 . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.584 HG12 ' HE3' ' A' ' 34' ' ' MET 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CD2' HG22 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.754 ' HG2' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.556 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.463 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.795 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.425 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.795 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.635 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.434 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HZ3' HG11 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.575 ' HE2' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' HB3' HG11 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' C ' HG12 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.448 HD22 ' HE ' ' A' ' 83' ' ' ARG . 8.6 t-20 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.655 HG12 HG21 ' A' ' 70' ' ' THR . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.8 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.58 HG23 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HG2' HD22 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' A' ' 33' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.586 HD22 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.526 ' HZ2' ' ND2' ' A' ' 69' ' ' ASN . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 116.698 -1.62 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HD2' ' H ' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.526 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.537 HD13 HD11 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 101' ' ' ILE . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.74 ' HD2' HD23 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.942 HG11 HG22 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.942 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HZ3' HD22 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 HG11 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.511 HD22 ' HA2' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.664 HG11 HG13 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.631 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.479 ' OG ' HG22 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.693 ' HE1' HD13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.508 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.479 HG22 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' HG13 ' A' ' 51' ' ' VAL . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' OE2' HG22 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.609 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG22 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.74 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.622 HG13 HG11 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.784 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' HG13 ' A' ' 52' ' ' ILE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' SD ' ' A' ' 34' ' ' MET . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.938 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.413 ' HB3' HG21 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.404 ' HA ' HH21 ' A' ' 83' ' ' ARG . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.739 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.651 ' HB2' HG13 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.739 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' HG13 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 105' ' ' PRO . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.938 HG23 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.578 HG11 HG22 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG2' HD12 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG13 HG11 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE1' HD11 ' A' ' 113' ' ' ILE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 40' ' ' PRO . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HZ3' ' A' ' 38' ' ' TRP . 4.5 Cg_endo . . . . . 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.683 ' HE1' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.657 HG13 ' HB2' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.642 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.642 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.524 HD13 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 87' ' ' THR . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.511 HD13 ' HB1' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.683 HG23 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.54 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HH2' HG21 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.718 ' HG2' HD12 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HD2' HG23 ' A' ' 17' ' ' VAL . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.673 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.586 ' SD ' HG13 ' A' ' 63' ' ' ILE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' OH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' OE2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.615 ' OH ' HD22 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.483 HG21 HD11 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.691 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 39' ' ' ALA . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' PRO . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.697 ' HD2' HD23 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.649 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' HD12 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.517 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.56 HG22 HG11 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HG2' HD12 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG13 HG11 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HA2' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG11 HG13 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 113' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.613 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.855 ' HD3' HD13 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HB2' HG12 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.553 HD13 HG21 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.623 HG22 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.623 ' HE1' HG22 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' HA2' HD23 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HG23 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.677 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.613 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' OE1' HG22 ' A' ' 110' ' ' THR . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.855 HD13 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 67' ' ' LYS . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' HG11 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG2' HD12 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG13 HG11 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.802 HD12 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.708 HG11 HG13 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.527 ' HB2' HD12 ' A' ' 63' ' ' ILE . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.84 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' O ' HG22 ' A' ' 70' ' ' THR . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.77 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.688 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CD1' HG22 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.599 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.653 HG21 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 80' ' ' TYR . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CE2' HG23 ' A' ' 76' ' ' ILE . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.489 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.653 HG12 HG21 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.441 HG21 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD11 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HH2' HG21 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' NZ ' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HA ' HG23 ' A' ' 85' ' ' ILE . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.75 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.756 ' HB3' HG11 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' HB2' HG22 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.533 ' NZ ' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.786 HH11 HD22 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.455 HG22 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.485 HG23 HD23 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.486 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.75 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.665 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.427 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.462 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.41 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.881 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.881 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD22 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.616 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.665 ' HB3' HG11 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.538 ' C ' HG12 ' A' ' 17' ' ' VAL . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.643 HD22 HH21 ' A' ' 83' ' ' ARG . 16.5 t-20 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.664 HD13 HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.643 HH21 HD22 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.738 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' HD21 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.441 HG22 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.486 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.441 ' OE1' HG22 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.505 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' HH2' HG21 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.653 HG22 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HD12 ' A' ' 113' ' ' ILE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CD2' HG21 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.653 ' HD2' HG22 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 79' ' ' GLN . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.786 HD13 HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.786 HD11 HD13 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.583 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.499 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.492 HG23 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HE1' ' A' ' 34' ' ' MET 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.583 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' HA2' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.71 ' HE1' HD12 ' A' ' 113' ' ' ILE . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.615 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.475 ' OD1' ' NH2' ' A' ' 83' ' ' ARG 0.265 2.2 t-20 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.475 ' NH2' ' OD1' ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.687 HG11 HD22 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HE2' HD13 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.741 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.694 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.641 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.687 HD22 HG11 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.71 HD12 ' HE1' ' A' ' 34' ' ' MET 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 HG22 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 HG11 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HB2' HG22 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG22 ' HB3' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.623 ' HE1' HG21 ' A' ' 113' ' ' ILE . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.846 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.407 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 39' ' ' ALA . 77.9 Cg_exo . . . . . 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG13 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HE2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.627 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG22 HG23 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.635 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.407 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.732 HD22 HH21 ' A' ' 83' ' ' ARG . 15.7 t-20 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.732 HH21 HD22 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 101' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.617 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HD3' HG13 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.747 ' HA ' HD12 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.734 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.659 ' HH2' HG11 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 27' ' ' LEU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' HG11 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.618 ' HE1' HD12 ' A' ' 113' ' ' ILE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.332 . . . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 19' ' ' ASP . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 ' CB ' ' A' ' 39' ' ' ALA . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HE1' HG12 ' A' ' 100' ' ' ILE . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.66 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' HD12 ' A' ' 113' ' ' ILE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.716 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.411 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.347 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.999 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.999 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG21 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 17' ' ' VAL . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.475 ' H ' HG21 ' A' ' 101' ' ' ILE . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.596 HG21 HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.78 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.52 HD12 ' HE1' ' A' ' 34' ' ' MET 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG21 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HD12 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.721 HD22 ' HA2' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG21 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.687 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD22 ' OH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.591 ' OH ' HG23 ' A' ' 110' ' ' THR . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.681 ' HE3' HD13 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.591 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.428 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.51 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.681 HD13 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.823 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.823 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 113' ' ' ILE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.736 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.736 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.913 ' HB3' HD21 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' C ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.464 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.464 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.425 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 104' ' ' VAL . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.419 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.8 HG21 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.697 ' HA ' HG11 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.697 HG11 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.48 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.707 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.256 . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.707 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.706 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD22 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.794 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.8 ' H ' HG21 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.512 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.512 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.794 HG23 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 113' ' ' ILE 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HH2' HG11 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.796 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.621 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG11 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo . . . . . 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 50' ' ' PRO . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.646 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.813 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.813 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG13 ' A' ' 65' ' ' VAL . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.587 HG21 HD11 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' HB2' HG13 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.525 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.597 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.428 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' HD11 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.548 HD11 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 100' ' ' ILE . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.655 HG11 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.655 ' HB ' HG11 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.415 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' HA2' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.652 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.731 ' HE1' HD12 ' A' ' 113' ' ' ILE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.586 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.464 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.599 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.669 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.585 HG22 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.731 HD12 ' HE1' ' A' ' 34' ' ' MET 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.585 ' OE1' HG22 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' H ' HD12 ' A' ' 68' ' ' LEU . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.713 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.74 HG13 HG11 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 HG13 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.421 ' CE ' HD12 ' A' ' 113' ' ' ILE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.713 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 70' ' ' THR . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo . . . . . 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG13 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' HG13 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' HD13 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.779 HG23 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 113' ' ' ILE 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.446 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.461 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.934 HG11 HG22 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG22 HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG21 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 HG11 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 117' ' ' LEU . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.616 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD22 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -55.13 -39.09 92.74 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -67.6 -15.56 63.72 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.3 t -76.92 -17.54 58.86 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.705 0.802 . . . . 0.0 110.413 169.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.42 -150.46 17.01 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.361 1.458 . . . . 0.0 110.333 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.87 45.44 1.78 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.367 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.7 -14.47 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 7.4 ttpt -61.93 -50.91 70.26 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.309 175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.6 mt -83.39 7.06 17.87 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.01 -59.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 25.54 60.0 0.45 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 126.142 1.777 . . . . 0.0 112.275 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.698 HG13 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG13 ' A' ' 65' ' ' VAL . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' HB2' HG12 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.481 HG13 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' HG23 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.698 ' HG3' HG13 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 113' ' ' ILE . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 110' ' ' THR 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 32' ' ' PRO . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.736 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.515 ' HE1' HD12 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' HG21 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.96 -43.47 51.96 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -61.34 -17.77 55.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.6 p -113.06 3.64 16.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 35.66 -105.29 0.03 OUTLIER Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.01 1.767 . . . . 0.0 113.528 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -73.33 82.37 1.63 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 107.71 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 t -85.03 72.99 10.75 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.616 -2.538 . . . . 0.0 110.222 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.06 -45.31 7.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD12 ' HG3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -51.97 -33.74 39.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 125.378 1.674 . . . . 0.0 114.009 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 86' ' ' PRO 0.269 10.7 tp -112.46 79.12 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 123.721 1.724 . . . . 0.0 113.772 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.42 -50.17 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 110.462 -3.063 . . . . 0.0 117.76 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.714 ' HG3' HD12 ' A' ' 47' ' ' LEU . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 48' ' ' ILE . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HE1' ' HB ' ' A' ' 100' ' ' ILE . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.405 HH21 ' CB ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' HH21 ' A' ' 96' ' ' ARG . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 103' ' ' ALA . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' HD11 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 ' HE1' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HH2' HG21 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HA ' HG11 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.508 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.426 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HB3' HD11 ' A' ' 48' ' ' ILE . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.65 -31.55 87.71 Favored 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -67.65 -17.19 64.51 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.66 -4.26 55.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.708 0.803 . . . . 0.0 110.897 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 -121.86 5.74 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.25 50.32 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.364 2.043 . . . . 0.0 113.084 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.86 -10.86 10.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 177.03 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 15.0 tptm -59.71 -9.19 2.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 mt -48.85 -35.2 14.09 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -56.52 -33.05 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 171.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . -57.14 -46.76 99.82 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD12 HD12 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.857 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HD2' HG22 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.567 HG22 ' SG ' ' A' ' 45' ' ' CYS . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.577 ' HE2' HG12 ' A' ' 100' ' ' ILE . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.748 ' HB2' HG13 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HG ' HG11 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' HD12 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG21 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.541 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.584 ' HE3' HG12 ' A' ' 63' ' ' ILE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG21 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.839 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo -61.79 -40.79 42.53 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.46 -28.26 66.83 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.8 t -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.017 0.927 . . . . 0.0 113.038 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 72.1 -111.16 3.48 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 125.225 1.393 . . . . 0.0 110.263 -176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 9.0 Cg_exo -78.17 53.07 4.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.475 2.117 . . . . 0.0 114.008 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.839 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.74 -7.36 38.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 174.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -58.54 -19.16 35.34 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 8.0 mt -36.2 -44.37 0.4 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.5 pp -58.05 -36.67 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.267 . . -55.33 -50.13 88.47 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.584 HG12 ' HE3' ' A' ' 34' ' ' MET 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CD2' HG22 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.754 ' HG2' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.556 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.463 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.795 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.795 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.635 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.434 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HZ3' HG11 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.575 ' HE2' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.2 -27.52 83.86 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.541 ' HH2' HD13 ' A' ' 85' ' ' ILE . 6.9 p-90 -80.69 8.43 8.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.556 1.542 . . . . 0.0 114.826 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 t -127.27 107.94 10.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.325 1.05 . . . . 0.0 111.863 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.21 -61.74 5.98 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 112.556 -2.111 . . . . 0.0 113.197 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.31 -28.18 70.65 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.615 2.21 . . . . 0.0 115.941 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 85' ' ' ILE . 83.5 m -63.6 -35.11 79.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -61.47 -37.75 84.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.873 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.76 -36.6 73.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.501 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.576 HG21 ' O ' ' A' ' 103' ' ' ALA 0.333 2.6 pp -69.2 -26.61 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . -57.26 -49.09 95.92 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' HB3' HG11 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' C ' HG12 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.448 HD22 ' HE ' ' A' ' 83' ' ' ARG . 8.6 t-20 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.724 HG22 ' SG ' ' A' ' 45' ' ' CYS . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.8 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 48' ' ' ILE . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.58 HG23 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HG2' HD22 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' A' ' 33' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.586 HD22 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.866 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo -53.4 -44.39 49.37 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -63.43 -15.72 58.5 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.563 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -65.62 -36.12 82.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.948 0.899 . . . . 0.0 112.133 177.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.69 -100.13 1.65 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 117.642 -1.643 . . . . 0.0 109.577 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' O ' HG12 ' A' ' 48' ' ' ILE . 61.3 Cg_endo -75.8 24.04 0.43 Allowed 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 123.418 2.746 . . . . 0.0 115.615 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.866 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 5.7 m -73.67 154.37 39.72 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.851 0.834 . . . . 0.0 111.878 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 51.4 tttp 75.74 -46.65 0.56 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 111.343 -2.662 . . . . 0.0 110.733 -168.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.89 -30.65 71.28 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.7 0.762 . . . . 0.0 109.606 172.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.687 ' C ' ' HD3' ' A' ' 50' ' ' PRO 0.253 8.1 pt -89.81 55.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.587 1.661 . . . . 0.0 112.761 170.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . -105.64 19.16 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 111.613 -2.54 . . . . 0.0 113.785 161.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' C ' ' A' ' 48' ' ' ILE . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.526 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.537 HD13 HD11 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 101' ' ' ILE . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.74 ' HD2' HD23 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.942 HG11 HG22 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.942 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HZ3' HD22 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 HG11 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD22 ' HA2' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.664 HG11 HG13 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.631 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.57 -41.97 64.92 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -75.27 4.96 6.14 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.5 t -111.06 111.79 23.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.636 0.731 . . . . 0.0 112.642 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.81 -62.96 5.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 113.249 -1.796 . . . . 0.0 112.01 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.61 41.87 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.184 3.256 . . . . 0.0 115.141 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.867 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 77.2 m -121.2 -152.53 0.51 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.77 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' H ' ' HB2' ' A' ' 38' ' ' TRP . 17.8 ttpt -43.58 -42.11 4.92 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.303 1.441 . . . . 0.0 114.408 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 47' ' ' LEU . 3.6 mp -38.33 -36.13 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.024 1.73 . . . . 0.0 114.135 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -129.69 -38.74 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 38.59 36.69 0.12 Allowed Pre-proline 0 N--CA 1.5 2.039 0 C-N-CA 127.257 2.223 . . . . 0.0 116.427 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.479 ' OG ' HG22 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.693 ' HE1' HD13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.508 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.479 HG22 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' HG13 ' A' ' 51' ' ' VAL . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' OE2' HG22 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.609 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG22 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.622 HG13 HG11 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.784 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' HG13 ' A' ' 52' ' ' ILE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.823 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.07 -37.19 78.87 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -72.65 -9.81 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 17.2 p -114.99 73.9 0.85 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -18.81 -64.09 0.01 OUTLIER Glycine 0 CA--C 1.547 2.069 0 CA-C-N 114.065 -1.425 . . . . 0.0 115.309 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' HD12 ' A' ' 47' ' ' LEU . 72.1 Cg_exo -60.98 -12.41 22.44 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 123.987 3.124 . . . . 0.0 119.403 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 26.2 m -50.04 -35.86 26.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -57.47 -32.69 67.21 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 172.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER -67.2 -33.35 75.2 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 45' ' ' CYS 0.337 0.8 OUTLIER -73.13 -19.21 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.181 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . -62.05 -46.3 91.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' SD ' ' A' ' 34' ' ' MET . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.938 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.413 ' HB3' HG21 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.404 ' HA ' HH21 ' A' ' 83' ' ' ARG . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.739 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.651 ' HB2' HG13 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.739 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' HG13 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 105' ' ' PRO . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.938 HG23 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG11 HG22 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG2' HD12 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG13 HG11 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE1' HD11 ' A' ' 113' ' ' ILE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 40' ' ' PRO . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HZ3' ' A' ' 38' ' ' TRP . 4.5 Cg_endo -57.5 -37.13 98.22 Favored 'Trans proline' 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -67.34 -19.16 65.4 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 38.4 t -67.94 -27.57 66.72 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 110.989 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.34 -137.8 13.5 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.54 34.32 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.353 2.035 . . . . 0.0 114.66 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.7 m -57.66 -24.05 54.61 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 38' ' ' TRP . 1.6 tmmt? -60.09 -51.09 71.11 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.505 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.57 -16.7 63.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.029 1.731 . . . . 0.0 113.936 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.268 3.1 pt -110.48 -61.76 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 37.12 51.26 1.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 119.0 0.818 . . . . 0.0 111.928 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.683 ' HE1' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.657 HG13 ' HB2' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.642 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.642 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.524 HD13 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 87' ' ' THR . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.511 HD13 ' HB1' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.683 HG23 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.54 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HH2' HG21 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.718 ' HG2' HD12 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HD2' HG23 ' A' ' 17' ' ' VAL . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.586 ' SD ' HG13 ' A' ' 63' ' ' ILE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 46' ' ' LYS . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -56.19 -36.88 97.16 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -75.58 14.27 0.65 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 35.5 t -95.96 -17.74 20.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.788 1.235 . . . . 0.0 113.357 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.51 -137.83 14.34 Favored Glycine 0 CA--C 1.537 1.447 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.86 50.54 3.6 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.305 2.003 . . . . 0.0 112.544 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.3 m -86.36 154.83 20.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.724 -1.126 . . . . 0.0 107.973 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 50.8 tttp 85.19 -60.12 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 128.169 2.587 . . . . 0.0 108.222 -164.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.88 -45.96 71.21 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.585 1.554 . . . . 0.0 113.329 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 49' ' ' ALA . 24.5 pt -63.17 -67.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 48' ' ' ILE . . . 33.86 39.92 0.1 Allowed Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' OH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' OE2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.615 ' OH ' HD22 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.483 HG21 HD11 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.691 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 39' ' ' ALA . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' PRO . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.697 ' HD2' HD23 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.649 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' HD12 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.517 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.56 HG22 HG11 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HG2' HD12 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG13 HG11 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HA2' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG11 HG13 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 113' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.919 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.44 -34.84 98.62 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -71.77 -18.8 62.09 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 12.2 p -93.62 48.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 124.263 1.982 . . . . 0.0 108.83 169.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.7 42.76 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 111.837 -2.438 . . . . 0.0 110.345 -173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.5 -34.65 19.58 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.388 2.059 . . . . 0.0 113.698 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.919 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER 54.61 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 121.328 3.825 . . . . 0.0 121.328 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -43.33 -24.84 0.11 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.322 2.249 . . . . 0.0 116.904 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.19 -23.86 3.74 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.964 1.706 . . . . 0.0 114.021 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.3 -31.85 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.877 0.471 . . . . 0.0 111.245 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . -54.11 -40.75 84.28 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.613 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.855 ' HD3' HD13 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HB2' HG12 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.553 HD13 HG21 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.623 HG22 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.623 ' HE1' HG22 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' HA2' HD23 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HG23 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.677 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.613 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' OE1' HG22 ' A' ' 110' ' ' THR . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.855 HD13 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 67' ' ' LYS . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' HG11 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG2' HD12 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG13 HG11 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.802 HD12 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.708 HG11 HG13 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.527 ' HB2' HD12 ' A' ' 63' ' ' ILE . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.84 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.927 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.23 -35.31 75.01 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -66.48 -13.92 61.52 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 174.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.3 t -91.63 17.89 8.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.198 1.399 . . . . 0.0 110.872 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.5 -109.17 0.64 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.325 1.917 . . . . 0.0 111.979 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.3 48.69 2.54 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 122.16 1.907 . . . . 0.0 114.407 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -56.57 -23.19 38.68 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -53.26 -20.03 3.77 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 65.8 mt -53.09 -28.04 23.27 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.7 pp -59.24 -38.61 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . -54.91 -48.69 95.2 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.77 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.688 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CD1' HG22 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.599 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.653 HG21 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 80' ' ' TYR . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CE2' HG23 ' A' ' 76' ' ' ILE . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.489 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.653 HG12 HG21 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.441 HG21 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD11 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HH2' HG21 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' NZ ' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' A' ' 48' ' ' ILE . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.94 -34.47 48.01 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -67.34 -21.04 65.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 8.7 t -71.95 -24.18 61.57 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.744 1.218 . . . . 0.0 111.359 171.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.43 -157.62 14.86 Favored Glycine 0 CA--C 1.543 1.787 0 C-N-CA 126.684 2.087 . . . . 0.0 108.366 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -78.89 73.88 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.684 1.589 . . . . 0.0 108.885 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -81.29 24.41 0.55 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -64.51 -23.27 67.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.944 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 mt -41.43 -37.8 1.12 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.827 2.051 . . . . 0.0 115.345 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -67.64 -29.16 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.33 -46.45 99.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.75 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.756 ' HB3' HG11 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' HB2' HG22 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.533 ' NZ ' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.786 HH11 HD22 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.455 HG22 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.485 HG23 HD23 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.486 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.75 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.665 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.462 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.41 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.881 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.23 -38.17 88.16 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -71.06 -12.55 61.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.8 t -73.28 -21.03 60.69 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.713 1.205 . . . . 0.0 113.149 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.25 -140.4 15.21 Favored Glycine 0 CA--C 1.542 1.768 0 C-N-CA 124.265 0.936 . . . . 0.0 111.104 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.9 34.62 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 123.495 2.797 . . . . 0.0 114.967 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.94 -23.48 65.32 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 tmmt? -69.09 -57.83 4.89 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.72 -33.33 34.0 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.533 1.933 . . . . 0.0 115.632 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -105.42 -51.55 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . . . 33.81 55.41 1.57 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.881 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD22 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.616 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.665 ' HB3' HG11 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.538 ' C ' HG12 ' A' ' 17' ' ' VAL . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.643 HD22 HH21 ' A' ' 83' ' ' ARG . 16.5 t-20 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.664 HD13 HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.643 HH21 HD22 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.738 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' HD21 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.441 HG22 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.486 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.441 ' OE1' HG22 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' HH2' HG21 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.653 HG22 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HD12 ' A' ' 113' ' ' ILE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CD2' HG21 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.897 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -55.11 -36.6 93.37 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -67.39 -20.01 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.01 -0.41 56.58 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.644 0.778 . . . . 0.0 112.681 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.8 -101.55 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 C-N-CA 126.43 1.967 . . . . 0.0 114.736 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -60.2 -4.12 2.85 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.368 2.712 . . . . 0.0 117.437 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.897 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -36.22 -46.43 0.52 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.391 1.876 . . . . 0.0 114.947 176.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -51.69 -67.44 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.66 1.984 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.0 mt -69.75 -34.75 74.25 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.298 21.2 pt -71.7 -45.15 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 23.45 58.08 0.32 Allowed Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 125.086 1.355 . . . . 0.0 113.204 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.653 ' HD2' HG22 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 79' ' ' GLN . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.786 HD13 HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.786 HD11 HD13 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.583 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.499 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.492 HG23 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HE1' ' A' ' 34' ' ' MET 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.583 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' HA2' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.71 ' HE1' HD12 ' A' ' 113' ' ' ILE . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.615 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.51 -28.13 72.26 Favored 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -70.66 -26.2 63.34 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 14.1 p -88.24 54.76 3.17 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 124.274 1.988 . . . . 0.0 110.516 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.15 -125.34 39.37 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-N 111.77 -2.468 . . . . 0.0 109.833 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.4 -45.95 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.362 2.042 . . . . 0.0 113.421 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER 51.94 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -174.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -48.14 -26.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 mt -40.99 -32.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.887 2.075 . . . . 0.0 116.189 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 38' ' ' TRP . 2.5 pp -63.14 -31.65 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 174.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.85 99.74 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.475 ' OD1' ' NH2' ' A' ' 83' ' ' ARG 0.265 2.2 t-20 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.475 ' NH2' ' OD1' ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.687 HG11 HD22 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HE2' HD13 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.741 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.694 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.641 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.687 HD22 HG11 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.71 HD12 ' HE1' ' A' ' 34' ' ' MET 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 HG22 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 HG11 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HB2' HG22 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG22 ' HB3' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.623 ' HE1' HG21 ' A' ' 113' ' ' ILE . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.846 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 39' ' ' ALA . 77.9 Cg_exo -56.14 -40.11 86.92 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -64.1 -21.46 66.55 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.2 t -90.82 26.15 2.16 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.796 1.284 . . . . 0.0 109.855 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 -115.12 7.51 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.03 -26.61 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.41 2.073 . . . . 0.0 115.489 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.885 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER 44.99 15.92 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 -176.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.94 -11.01 2.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.01 -22.91 6.36 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' HG3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -69.89 -36.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.131 0.972 . . . . 0.0 111.462 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . -49.43 -45.48 77.38 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG13 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HE2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.627 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG22 HG23 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.635 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.407 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.732 HD22 HH21 ' A' ' 83' ' ' ARG . 15.7 t-20 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.732 HH21 HD22 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.582 ' HG3' HD12 ' A' ' 48' ' ' ILE . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 101' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.617 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HD3' HG13 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.747 ' HA ' HD12 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.734 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.659 ' HH2' HG11 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 27' ' ' LEU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' HG11 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.618 ' HE1' HD12 ' A' ' 113' ' ' ILE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.8 ' HB3' HD11 ' A' ' 48' ' ' ILE . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.39 -42.08 69.51 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -65.23 -14.86 61.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.26 -13.51 46.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.777 1.231 . . . . 0.0 112.386 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.72 -106.49 1.97 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 124.699 1.143 . . . . 0.0 110.78 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 23.3 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.555 2.17 . . . . 0.0 117.389 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -48.8 -30.83 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -41.49 -30.16 0.19 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 pp -41.37 -34.83 0.57 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.4 pp -62.94 -35.25 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.332 . . -56.04 -53.22 65.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 19' ' ' ASP . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.658 HG22 ' SG ' ' A' ' 45' ' ' CYS . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HE1' HG12 ' A' ' 100' ' ' ILE . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.66 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' HD12 ' A' ' 113' ' ' ILE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.716 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.76 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -58.84 -33.99 98.82 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.71 -10.31 57.81 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.5 t -95.48 26.03 4.12 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.831 1.3 . . . . 0.0 109.015 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.81 -120.7 3.88 Favored Glycine 0 CA--C 1.548 2.125 0 C-N-CA 126.62 2.057 . . . . 0.0 112.736 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.59 37.88 0.67 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.58 2.853 . . . . 0.0 113.498 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.76 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -46.37 -39.8 10.94 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.946 2.098 . . . . 0.0 116.191 -176.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -56.71 -47.69 79.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.101 1.76 . . . . 0.0 112.13 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.2 mt -91.98 22.72 4.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' CYS . 7.6 mt -114.07 -61.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.634 -1.621 . . . . 0.0 107.388 171.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 22.39 55.11 0.24 Allowed Pre-proline 0 N--CA 1.506 2.347 0 C-N-CA 126.353 1.861 . . . . 0.0 114.162 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.999 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.999 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG21 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 17' ' ' VAL . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.475 ' H ' HG21 ' A' ' 101' ' ' ILE . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.596 HG21 HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.78 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.52 HD12 ' HE1' ' A' ' 34' ' ' MET 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG21 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HD12 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.721 HD22 ' HA2' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG21 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.687 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.813 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.03 -36.19 95.72 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -65.64 -25.49 67.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.69 20.81 0.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.12 1.368 . . . . 0.0 111.754 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 42.4 -110.6 0.26 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.092 1.806 . . . . 0.0 111.848 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.23 39.67 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.127 2.551 . . . . 0.0 116.204 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.08 -30.49 62.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.04 -1.038 . . . . 0.0 113.392 174.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -51.1 -19.46 1.13 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.352 2.261 . . . . 0.0 116.012 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.2 -37.86 3.42 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.1 pp -56.34 -33.37 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . -60.16 -49.69 89.65 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD22 ' OH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.591 ' OH ' HG23 ' A' ' 110' ' ' THR . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.681 ' HE3' HD13 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.591 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.428 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.51 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.681 HD13 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.823 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.823 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 113' ' ' ILE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo -62.63 -35.54 69.42 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -67.03 -13.63 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 174.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.7 t -87.28 0.04 56.0 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.129 1.372 . . . . 0.0 111.156 171.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.62 -127.0 30.85 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.054 1.788 . . . . 0.0 109.84 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -76.11 79.9 2.81 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.592 1.528 . . . . 0.0 109.506 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -79.44 68.87 5.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.792 -176.476 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -63.32 -84.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.327 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD22 ' H ' ' A' ' 47' ' ' LEU . 4.0 mm? 19.74 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.582 2.353 . . . . 0.0 115.77 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.739 ' HB ' ' HB2' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -46.55 -58.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.512 1.525 . . . . 0.0 114.638 175.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . -54.88 -51.53 78.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -175.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.736 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.913 ' HB3' HD21 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' C ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.464 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.464 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HB3' HG23 ' A' ' 48' ' ' ILE . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.425 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 104' ' ' VAL . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.419 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.8 HG21 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.697 ' HA ' HG11 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.697 HG11 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.48 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 48' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.92 -37.21 35.24 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CH2' HD13 ' A' ' 85' ' ' ILE . 12.7 p-90 -67.16 -8.56 32.08 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 85' ' ' ILE . 53.8 t -87.66 -13.61 42.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.804 1.242 . . . . 0.0 111.351 176.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.81 -139.17 14.35 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.164 1.364 . . . . 0.0 109.995 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.24 43.86 1.57 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.78 2.32 . . . . 0.0 113.15 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.62 ' O ' HG12 ' A' ' 48' ' ' ILE . 96.8 m -65.26 -15.73 62.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -53.48 -27.63 26.25 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.841 174.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -42.41 -40.31 2.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.776 2.031 . . . . 0.0 114.389 173.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 36' ' ' ASP . 28.2 pt -59.37 -32.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.256 . . -60.3 -47.31 96.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.38 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.707 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.706 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD22 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.794 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.8 ' H ' HG21 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.512 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.512 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.582 HD13 ' CH2' ' A' ' 41' ' ' TRP . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.715 ' HB3' HD13 ' A' ' 48' ' ' ILE . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.794 HG23 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 113' ' ' ILE 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HH2' HG11 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.796 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.621 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG11 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo -59.53 -26.65 82.74 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . 0.268 8.4 p-90 -66.81 -25.74 66.6 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 26.8 p -98.42 45.55 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 123.185 1.469 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 36.4 -113.18 0.16 Allowed Glycine 0 CA--C 1.549 2.189 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.843 -178.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 7.8 Cg_endo -80.14 38.71 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.596 2.864 . . . . 0.0 115.575 -176.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 1.3 m -56.43 -12.93 1.91 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 176.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -49.63 -26.54 3.72 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -50.62 -31.43 16.03 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 175.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.91 -36.92 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.977 0.911 . . . . 0.0 111.725 176.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . -54.08 -42.9 95.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 50' ' ' PRO . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.646 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.813 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.813 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG13 ' A' ' 65' ' ' VAL . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.587 HG21 HD11 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' HB2' HG13 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.525 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.597 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.428 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' HD11 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.548 HD11 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 100' ' ' ILE . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.655 HG11 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.655 ' HB ' HG11 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.415 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' HA2' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.652 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.731 ' HE1' HD12 ' A' ' 113' ' ' ILE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' HE3' ' HB2' ' A' ' 45' ' ' CYS . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo -58.27 -34.75 98.91 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -77.59 28.52 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 174.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 167.49 15.32 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 177.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.01 -81.41 0.96 Allowed Glycine 0 CA--C 1.55 2.239 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.026 170.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.38 88.28 1.3 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 121.705 1.603 . . . . 0.0 113.098 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.597 ' HB2' ' HE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -137.82 136.71 37.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.033 -178.109 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 72.7 tttt 63.37 -56.16 0.19 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.965 2.106 . . . . 0.0 114.873 176.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 tp -80.24 52.34 1.56 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 123.28 1.515 . . . . 0.0 111.078 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -158.32 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 111.952 -2.385 . . . . 0.0 110.824 -176.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' H ' HD12 ' A' ' 48' ' ' ILE . . . 37.29 43.03 0.36 Allowed Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 126.087 1.755 . . . . 0.0 111.739 -174.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 48' ' ' ILE . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.586 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.464 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.599 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.669 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.585 HG22 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.731 HD12 ' HE1' ' A' ' 34' ' ' MET 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.585 ' OE1' HG22 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' H ' HD12 ' A' ' 68' ' ' LEU . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.713 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.74 HG13 HG11 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 HG13 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.421 ' CE ' HD12 ' A' ' 113' ' ' ILE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.713 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo -59.03 -37.27 94.02 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -67.16 -13.08 61.61 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 175.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 29.6 p -108.85 42.42 1.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.724 0.773 . . . . 0.0 111.137 170.1 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 10.0 -81.37 0.0 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 129.308 3.337 . . . . 0.0 116.882 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.99 -18.18 2.88 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.407 3.405 . . . . 0.0 117.404 177.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 14.0 m -42.92 -38.7 2.3 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -51.16 -34.77 32.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.997 1.319 . . . . 0.0 114.376 177.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.15 -22.97 63.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 45' ' ' CYS . 12.9 pt -72.34 -23.16 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 176.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . -62.13 -44.19 88.37 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 174.319 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG13 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' HG13 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' HD13 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.779 HG23 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 113' ' ' ILE 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.446 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.461 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.934 HG11 HG22 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.934 HG22 HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG21 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 HG11 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 117' ' ' LEU . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.616 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD22 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo . . . . . 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.698 HG13 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG13 ' A' ' 65' ' ' VAL . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.602 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' HB2' HG12 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.481 HG13 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' HG23 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.698 ' HG3' HG13 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 113' ' ' ILE . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 110' ' ' THR 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 32' ' ' PRO . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.736 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.515 ' HE1' HD12 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' HG21 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo . . . . . 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HE1' ' HB ' ' A' ' 100' ' ' ILE . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.405 HH21 ' CB ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' HH21 ' A' ' 96' ' ' ARG . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 103' ' ' ALA . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' HD11 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 ' HE1' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HH2' HG21 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HA ' HG11 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.508 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.426 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.448 HD12 HD12 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.857 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HD2' HG22 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.772 HD21 ' NH2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.772 ' NH2' HD21 ' A' ' 81' ' ' ASN . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' ALA . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.577 ' HE2' HG12 ' A' ' 100' ' ' ILE . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.748 ' HB2' HG13 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HG ' HG11 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' HD12 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG21 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.541 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.584 ' HE3' HG12 ' A' ' 63' ' ' ILE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.449 HG21 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.506 ' O ' HG22 ' A' ' 70' ' ' THR . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.267 . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.584 HG12 ' HE3' ' A' ' 34' ' ' MET 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CD2' HG22 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.754 ' HG2' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.556 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.463 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.795 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.425 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.795 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.635 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.434 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HZ3' HG11 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.575 ' HE2' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' HB3' HG11 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' C ' HG12 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.648 HD21 ' NH2' ' A' ' 83' ' ' ARG . 47.5 t30 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' HD21 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.655 HG12 HG21 ' A' ' 70' ' ' THR . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.8 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.58 HG23 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HG2' HD22 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' A' ' 33' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.586 HD22 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.526 ' HZ2' ' ND2' ' A' ' 69' ' ' ASN . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo . . . . . 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 116.698 -1.62 . . . . 0.0 113.785 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HD2' ' H ' ' A' ' 51' ' ' VAL . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.526 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.537 HD13 HD11 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 101' ' ' ILE . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.74 ' HD2' HD23 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.942 HG11 HG22 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.942 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HZ3' HD22 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 HG11 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.511 HD22 ' HA2' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.664 HG11 HG13 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.631 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.479 ' OG ' HG22 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.693 ' HE1' HD13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.508 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.479 HG22 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' HG13 ' A' ' 51' ' ' VAL . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' OE2' HG22 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.609 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG22 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.74 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.622 HG13 HG11 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.784 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' HG13 ' A' ' 52' ' ' ILE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' SD ' ' A' ' 34' ' ' MET . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.938 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.413 ' HB3' HG21 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.404 ' HA ' HH21 ' A' ' 83' ' ' ARG . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.739 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.651 ' HB2' HG13 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.739 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' HG13 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 105' ' ' PRO . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.938 HG23 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.578 HG11 HG22 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG2' HD12 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG13 HG11 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE1' HD11 ' A' ' 113' ' ' ILE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 40' ' ' PRO . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HZ3' ' A' ' 38' ' ' TRP . 4.5 Cg_endo . . . . . 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.683 ' HE1' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.657 HG13 ' HB2' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.642 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.642 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.524 HD13 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 87' ' ' THR . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.511 HD13 ' HB1' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.683 HG23 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.54 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HH2' HG21 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.718 ' HG2' HD12 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HD2' HG23 ' A' ' 17' ' ' VAL . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.673 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.586 ' SD ' HG13 ' A' ' 63' ' ' ILE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' OH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' OE2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.615 ' OH ' HD22 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.483 HG21 HD11 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.691 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 39' ' ' ALA . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' PRO . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.697 ' HD2' HD23 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.649 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' HD12 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.517 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.56 HG22 HG11 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HG2' HD12 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.805 HG13 HG11 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HA2' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.805 HG11 HG13 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 113' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.456 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.613 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.855 ' HD3' HD13 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HB2' HG12 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.553 HD13 HG21 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.623 HG22 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.623 ' HE1' HG22 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.474 ' HA2' HD23 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HG23 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.677 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.613 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' OE1' HG22 ' A' ' 110' ' ' THR . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.855 HD13 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 67' ' ' LYS . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' HG11 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG2' HD12 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.708 HG13 HG11 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.802 HD12 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.708 HG11 HG13 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.527 ' HB2' HD12 ' A' ' 63' ' ' ILE . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.84 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' O ' HG22 ' A' ' 70' ' ' THR . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.77 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.688 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CD1' HG22 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.599 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.653 HG21 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 80' ' ' TYR . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CE2' HG23 ' A' ' 76' ' ' ILE . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.489 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.653 HG12 HG21 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.441 HG21 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD11 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HH2' HG21 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' NZ ' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.401 ' HA ' HG23 ' A' ' 85' ' ' ILE . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.75 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.756 ' HB3' HG11 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' HB2' HG22 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.667 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.667 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.533 ' NZ ' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.786 HH11 HD22 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.455 HG22 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.485 HG23 HD23 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.486 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.75 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.665 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.427 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.462 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.41 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.881 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . . . . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.881 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD22 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.616 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.665 ' HB3' HG11 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.538 ' C ' HG12 ' A' ' 17' ' ' VAL . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.734 HD21 ' NH2' ' A' ' 83' ' ' ARG . 31.7 t30 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.664 HD13 HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.734 ' NH2' HD21 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.518 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.738 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' HD21 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.441 HG22 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.486 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.441 ' OE1' HG22 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.505 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' HH2' HG21 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.653 HG22 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HD12 ' A' ' 113' ' ' ILE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CD2' HG21 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.653 ' HD2' HG22 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 79' ' ' GLN . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.833 HD21 ' NH1' ' A' ' 83' ' ' ARG . 7.2 t30 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.786 HD13 HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.833 ' NH1' HD21 ' A' ' 81' ' ' ASN . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.786 HD11 HD13 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.583 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.499 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.492 HG23 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HE1' ' A' ' 34' ' ' MET 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.583 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' HA2' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.71 ' HE1' HD12 ' A' ' 113' ' ' ILE . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.615 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo . . . . . 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.644 HD21 ' NH2' ' A' ' 83' ' ' ARG 0.265 2.9 t30 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' HD21 ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.687 HG11 HD22 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HE2' HD13 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.741 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.694 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.641 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.687 HD22 HG11 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.71 HD12 ' HE1' ' A' ' 34' ' ' MET 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 HG22 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 HG11 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HB2' HG22 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.768 HG22 ' HB3' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.623 ' HE1' HG21 ' A' ' 113' ' ' ILE . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.846 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.407 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 39' ' ' ALA . 77.9 Cg_exo . . . . . 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG13 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HE2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.627 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG22 HG23 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.635 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.407 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.696 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 15.8 t30 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.696 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 101' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.617 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HD3' HG13 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.747 ' HA ' HD12 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.734 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.659 ' HH2' HG11 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 27' ' ' LEU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' HG11 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.618 ' HE1' HD12 ' A' ' 113' ' ' ILE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.332 . . . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 19' ' ' ASP . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG21 ' CB ' ' A' ' 39' ' ' ALA . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HE1' HG12 ' A' ' 100' ' ' ILE . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.66 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' HD12 ' A' ' 113' ' ' ILE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.716 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.411 ' NE1' ' HA ' ' A' ' 69' ' ' ASN . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.347 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.999 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.999 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG21 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 17' ' ' VAL . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.491 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 6.6 t30 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.596 HG21 HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.78 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.52 HD12 ' HE1' ' A' ' 34' ' ' MET 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.598 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG21 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HD12 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.721 HD22 ' HA2' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.522 HG21 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.687 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD22 ' OH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.591 ' OH ' HG23 ' A' ' 110' ' ' THR . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.681 ' HE3' HD13 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.591 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.428 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.51 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.681 HD13 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.823 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.823 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 113' ' ' ILE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.736 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.736 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.913 ' HB3' HD21 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.472 ' C ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.464 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.464 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.425 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 104' ' ' VAL . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.419 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.8 HG21 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.697 ' HA ' HG11 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.697 HG11 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.48 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.707 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.256 . . . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.707 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.706 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD22 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.794 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.8 ' H ' HG21 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.512 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.512 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.794 HG23 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 113' ' ' ILE 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HH2' HG11 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.796 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.621 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.596 HG11 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo . . . . . 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 50' ' ' PRO . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.646 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.813 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.813 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG13 ' A' ' 65' ' ' VAL . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.587 HG21 HD11 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.489 HD22 ' NH1' ' A' ' 83' ' ' ARG . 15.2 m120 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.489 ' NH1' HD22 ' A' ' 81' ' ' ASN . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' HB2' HG13 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.525 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.597 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.428 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' HD11 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.548 HD11 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 100' ' ' ILE . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.655 HG11 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.655 ' HB ' HG11 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.415 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' HA2' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.652 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.731 ' HE1' HD12 ' A' ' 113' ' ' ILE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.586 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.464 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.599 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.669 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.585 HG22 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.731 HD12 ' HE1' ' A' ' 34' ' ' MET 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.585 ' OE1' HG22 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' H ' HD12 ' A' ' 68' ' ' LEU . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.713 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.74 HG13 HG11 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 HG13 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.421 ' CE ' HD12 ' A' ' 113' ' ' ILE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.713 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.524 ' O ' HG22 ' A' ' 70' ' ' THR . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo . . . . . 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG13 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.779 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' HG13 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' HD13 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.779 HG23 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 113' ' ' ILE 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.446 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.461 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.934 HG11 HG22 ' A' ' 17' ' ' VAL . 1.9 p . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.839 0.828 . . . . 0.0 113.103 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -80.86 -43.27 20.21 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.715 -2.039 . . . . 0.0 110.654 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -173.19 116.76 0.28 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 127.587 2.355 . . . . 0.0 109.552 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.934 HG22 HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -82.85 132.41 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.305 179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.516 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 16.8 p30 -137.17 -175.94 4.22 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 112.489 -2.141 . . . . 0.0 108.471 174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.76 -40.54 66.3 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -69.47 -53.52 18.78 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.251 0.62 . . . . 0.0 110.822 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 p -68.42 -19.15 64.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' HH2' HG21 ' A' ' 35' ' ' VAL . 67.5 t-105 -53.97 -52.9 59.24 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.405 0.682 . . . . 0.0 112.194 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -68.01 -31.42 71.09 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 29.3 mt-10 -82.79 -46.76 12.7 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.578 -1.647 . . . . 0.0 112.603 -172.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -92.33 -46.63 7.6 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.569 HG13 HG11 ' A' ' 33' ' ' VAL . 56.9 t -81.22 -52.87 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.906 -174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.5 mt -84.74 -8.79 58.7 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.019 -1.072 . . . . 0.0 113.529 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 -130.99 59.47 1.68 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 p -110.13 -16.16 13.85 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.465 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.96 -9.9 1.29 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.957 2.503 . . . . 0.0 113.852 -175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 33' ' ' VAL . 31.2 m -123.32 155.26 65.36 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.384 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 117' ' ' LEU . 31.9 Cg_exo -45.65 133.16 13.36 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.184 2.589 . . . . 0.0 111.624 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 3.8 t -122.84 142.0 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.663 -1.608 . . . . 0.0 112.592 -171.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.616 ' HE1' ' CE2' ' A' ' 90' ' ' PHE . 21.6 ptp -137.57 136.37 37.53 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 112.822 -1.99 . . . . 0.0 114.332 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 66' ' ' TYR . 11.7 m -125.97 114.64 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 112.986 -1.916 . . . . 0.0 115.258 -172.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG21 ' A' ' 52' ' ' ILE . 14.4 t70 -83.87 121.29 27.15 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.036 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' CE2' HD22 ' A' ' 68' ' ' LEU . 19.9 m-85 -94.07 109.68 21.43 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.689 0.618 . . . . 0.0 109.646 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -114.67 159.31 20.65 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 125.145 1.528 . . . . 0.0 110.185 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -133.99 138.61 31.07 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.33 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -55.13 -39.09 92.74 Favored 'Trans proline' 0 N--CA 1.481 0.756 0 C-N-CA 123.029 2.486 . . . . 0.0 112.326 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -67.6 -15.56 63.72 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.3 t -76.92 -17.54 58.86 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.705 0.802 . . . . 0.0 110.413 169.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.42 -150.46 17.01 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.361 1.458 . . . . 0.0 110.333 -174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -83.87 45.44 1.78 Allowed 'Trans proline' 0 N--CA 1.487 1.128 0 C-N-CA 122.707 2.271 . . . . 0.0 111.367 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.7 -14.47 8.6 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 -172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HG3' ' HG3' ' A' ' 67' ' ' LYS . 7.4 ttpt -61.93 -50.91 70.26 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.546 -1.207 . . . . 0.0 111.309 175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.6 mt -83.39 7.06 17.87 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.3 mm -98.01 -59.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 25.54 60.0 0.45 Allowed Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 126.142 1.777 . . . . 0.0 112.275 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -50.35 -81.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.823 2.349 . . . . 0.0 116.622 -162.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.698 HG13 ' HG3' ' A' ' 106' ' ' LYS . 45.3 t -56.55 -35.73 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.437 0.295 . . . . 0.0 111.705 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -63.85 -37.69 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.557 1.143 . . . . 0.0 112.007 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.0 t70 -62.93 -38.27 90.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.656 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.81 -40.81 65.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 109' ' ' LEU . 67.7 mt -61.99 -20.8 64.27 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 174.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -64.92 -57.72 8.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.88 1.272 . . . . 0.0 110.983 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -71.9 -28.96 63.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 13.2 mt-10 -66.2 -45.21 81.55 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 123.701 0.626 . . . . 0.0 112.107 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.66 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 75.9 m-85 -117.28 51.56 1.01 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.489 1.138 . . . . 0.0 113.131 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.4 m -60.64 105.58 0.46 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.001 -1.909 . . . . 0.0 111.856 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.86 -51.22 0.72 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 113.295 -1.775 . . . . 0.0 110.996 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.0 mptt -44.67 -47.54 10.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.432 1.493 . . . . 0.0 113.409 175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG13 ' A' ' 65' ' ' VAL . 2.8 pp -125.28 151.8 31.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -104.67 108.57 20.1 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 108.757 -3.838 . . . . 0.0 108.939 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.602 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -92.51 115.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.502 -175.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' HB2' HG12 ' A' ' 35' ' ' VAL . 50.8 m-85 -123.62 158.3 31.8 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 113.334 -1.757 . . . . 0.0 113.805 -178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.434 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -135.9 110.18 8.41 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.927 177.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -85.84 124.84 32.78 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 112.487 -2.142 . . . . 0.0 114.239 -178.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.78 92.69 6.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 111.063 -2.789 . . . . 0.0 107.589 174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 26.8 p -50.9 -46.41 60.63 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.776 -1.556 . . . . 0.0 114.966 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -62.7 -25.56 68.22 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -88.4 -17.68 29.97 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.197 0.936 . . . . 0.0 112.947 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -126.82 75.99 75.41 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -83.03 32.03 0.52 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 122.687 2.258 . . . . 0.0 113.638 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.17 -46.6 0.12 Allowed Glycine 0 N--CA 1.473 1.16 0 C-N-CA 125.939 1.733 . . . . 0.0 110.259 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 68' ' ' LEU . 37.2 mm -62.81 -59.03 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 122.91 0.484 . . . . 0.0 111.378 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.32 -39.46 31.43 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -61.86 -62.89 1.48 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.219 1.808 . . . . 0.0 109.943 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -54.34 -37.06 64.47 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.89 -1.505 . . . . 0.0 113.367 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -92.06 0.91 57.47 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.52 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 56.31 47.04 19.94 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.988 1.375 . . . . 0.0 113.867 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.286 0.6 OUTLIER -91.61 104.4 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 124.907 2.289 . . . . 0.0 109.684 -176.566 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 -99.1 -13.91 19.61 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 108.571 -3.922 . . . . 0.0 113.106 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.5 t -123.54 143.56 50.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.079 0.942 . . . . 0.0 112.594 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 49.4 mm -119.39 113.2 35.28 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.051 174.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.9 Cg_endo -84.85 161.02 66.1 Favored 'Cis proline' 0 N--CA 1.485 0.995 0 O-C-N 125.31 2.216 . . . . 0.0 116.156 -0.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.8 m -136.26 145.74 45.92 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.042 -2.799 . . . . 0.0 107.202 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.481 HG13 ' HE1' ' A' ' 90' ' ' PHE . 7.6 p -134.36 136.93 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.765 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HD2' ' A' ' 96' ' ' ARG . 6.6 mp -116.18 140.3 49.44 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 112.726 -2.034 . . . . 0.0 110.225 176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' CE2' ' HE1' ' A' ' 34' ' ' MET . 8.1 m-85 -117.18 113.28 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.361 1.864 . . . . 0.0 109.582 -175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.588 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 45.6 m-85 -111.35 156.89 20.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 109.666 -3.425 . . . . 0.0 107.198 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 32' ' ' PRO . 77.3 tttt -98.4 -99.83 0.21 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.747 -1.57 . . . . 0.0 107.144 169.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -111.95 79.11 1.18 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 122.749 1.262 . . . . 0.0 108.683 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.07 32.13 79.22 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-N 111.478 -2.601 . . . . 0.0 114.275 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -139.89 128.01 22.36 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -94.45 134.68 36.72 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.367 1.08 . . . . 0.0 111.995 -171.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -115.57 -54.19 2.54 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 112.467 -2.151 . . . . 0.0 112.171 -168.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -141.67 140.87 33.32 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.813 -1.085 . . . . 0.0 113.08 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 62.2 p -126.97 111.99 14.74 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.451 HD11 ' OG ' ' A' ' 112' ' ' SER . 4.7 mp -100.89 100.74 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 123.711 1.719 . . . . 0.0 108.773 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.0 mm -70.49 132.65 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 110.831 -2.895 . . . . 0.0 107.715 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.47 -42.22 2.48 Favored Glycine 0 N--CA 1.482 1.707 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.168 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.62 39.46 28.27 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.305 2.8 m -113.91 -36.96 0.1 OUTLIER Pre-proline 0 CA--C 1.557 1.239 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -173.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD3' HG23 ' A' ' 104' ' ' VAL . 73.9 Cg_endo -77.81 98.41 1.21 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 CA-C-N 122.369 1.882 . . . . 0.0 109.528 175.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.698 ' HG3' HG13 ' A' ' 51' ' ' VAL . 55.0 tttt -43.23 -47.2 6.39 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 111.717 -2.492 . . . . 0.0 114.364 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.4 p -57.09 -44.09 82.81 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 18.2 m -62.44 -42.97 99.85 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.94 1.296 . . . . 0.0 114.239 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.9 mp -61.64 -40.26 94.27 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.847 173.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 113' ' ' ILE . 12.3 m -66.97 -49.44 65.4 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 122.662 1.22 . . . . 0.0 111.2 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' THR . 63.5 t0 -47.77 -41.42 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 112.731 -2.031 . . . . 0.0 111.728 171.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 100' ' ' ILE . 58.2 m -62.43 -33.72 75.35 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 118.505 2.78 . . . . 0.0 118.505 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 110' ' ' THR 0.256 0.0 OUTLIER -73.4 -56.07 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-O 122.302 1.049 . . . . 0.0 110.514 175.128 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.0 -26.66 62.67 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 111.69 -2.505 . . . . 0.0 113.785 -170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.256 24.0 ttmm -44.87 -54.44 6.43 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 128.849 2.86 . . . . 0.0 112.001 169.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.513 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 47.0 p90 -105.41 -36.7 7.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.226 1.81 . . . . 0.0 114.472 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 32' ' ' PRO . 2.7 tm? . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 124.885 2.278 . . . . 0.0 105.263 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.736 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 122.46 1.124 . . . . 0.0 110.504 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -89.05 66.67 7.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.079 -1.873 . . . . 0.0 106.804 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 59.66 104.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 109.986 -3.279 . . . . 0.0 113.747 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.736 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.9 p -76.84 143.14 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 112.337 -2.21 . . . . 0.0 109.808 -177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.4 p30 -145.68 -178.65 6.2 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 111.614 -2.539 . . . . 0.0 107.592 -173.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.78 -42.18 57.71 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.2 m -71.7 -42.63 67.14 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.4 p -81.52 -15.68 54.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.7 t-105 -53.53 -44.07 68.89 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 75.4 mttt -76.87 -6.8 53.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 13.4 pt-20 -116.33 -50.88 2.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.78 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -97.6 33.13 2.11 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' O ' HG21 ' A' ' 33' ' ' VAL . 55.4 t -158.64 -68.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 129.447 3.099 . . . . 0.0 105.146 172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -62.04 -41.41 98.08 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.9 mt-10 -116.29 41.93 2.51 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -172.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 m -84.62 -10.5 57.29 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.741 172.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 66.2 4.24 3.06 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 128.911 2.884 . . . . 0.0 114.851 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 33' ' ' VAL . 26.8 m -119.18 157.12 51.79 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.864 2.066 . . . . 0.0 108.66 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -54.89 134.79 65.2 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.445 2.097 . . . . 0.0 109.275 170.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.7 t -121.36 143.77 32.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.774 -1.557 . . . . 0.0 112.287 -171.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.515 ' HE1' HD12 ' A' ' 113' ' ' ILE . 27.3 ttm -125.5 138.28 53.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 111.689 -2.505 . . . . 0.0 109.278 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 14.7 p -136.37 128.49 44.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.304 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.436 ' HB2' HG21 ' A' ' 52' ' ' ILE . 12.3 t70 -96.28 131.52 42.7 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 111.492 -2.594 . . . . 0.0 108.613 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.591 ' CE2' HD22 ' A' ' 68' ' ' LEU . 69.5 m-85 -118.99 122.64 42.66 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 124.537 1.148 . . . . 0.0 112.613 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -101.81 179.8 4.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 112.616 -2.084 . . . . 0.0 108.041 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.651 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -133.15 140.12 36.43 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.128 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.96 -43.47 51.96 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.949 2.432 . . . . 0.0 112.243 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -61.34 -17.77 55.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.6 p -113.06 3.64 16.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 35.66 -105.29 0.03 OUTLIER Glycine 0 CA--C 1.548 2.103 0 C-N-CA 126.01 1.767 . . . . 0.0 113.528 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -73.33 82.37 1.63 Allowed 'Trans proline' 0 N--CA 1.479 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 107.71 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 t -85.03 72.99 10.75 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 111.616 -2.538 . . . . 0.0 110.222 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.06 -45.31 7.95 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -175.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.714 HD12 ' HG3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -51.97 -33.74 39.19 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 125.378 1.674 . . . . 0.0 114.009 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 86' ' ' PRO 0.269 10.7 tp -112.46 79.12 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 123.721 1.724 . . . . 0.0 113.772 -178.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.42 -50.17 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.024 0 CA-C-N 110.462 -3.063 . . . . 0.0 117.76 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -55.66 -51.15 10.47 Favored 'Trans proline' 0 N--CA 1.48 0.716 0 C-N-CA 124.648 3.565 . . . . 0.0 111.28 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG11 HD22 ' A' ' 109' ' ' LEU . 91.5 t -49.55 -52.81 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 123.555 0.742 . . . . 0.0 112.104 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -65.11 -32.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -67.96 -27.38 66.55 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -79.75 -47.63 14.94 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.309 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 69.7 mt -58.25 -22.11 51.04 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.19 -62.59 1.76 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.011 1.725 . . . . 0.0 111.276 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -71.31 -27.98 63.78 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 7.1 mt-10 -62.08 -43.72 98.22 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.021 -0.99 . . . . 0.0 112.165 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.787 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 60.5 m-85 -117.37 52.6 0.96 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 123.215 1.483 . . . . 0.0 112.421 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.2 t -62.35 112.22 2.33 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.39 -2.187 . . . . 0.0 109.143 174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.63 -36.06 4.6 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.085 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.787 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 11.4 mptt -70.32 -65.31 0.74 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.937 1.295 . . . . 0.0 113.618 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 59' ' ' TYR 0.278 2.9 pp -113.75 125.97 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -81.19 102.93 10.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 111.228 -2.715 . . . . 0.0 109.645 174.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.39 110.05 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.721 2.009 . . . . 0.0 114.678 -174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' CZ ' ' HB1' ' A' ' 64' ' ' ALA . 23.3 m-85 -120.12 145.41 46.94 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.953 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.33 112.43 19.01 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.959 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.591 HD22 ' CE2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -87.51 117.92 26.62 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.199 -1.819 . . . . 0.0 114.334 -176.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -80.38 89.23 5.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 112.246 -2.252 . . . . 0.0 107.207 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 p -54.3 -36.64 63.92 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -60.48 -29.37 69.02 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.457 172.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.2 -3.26 51.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.899 1.28 . . . . 0.0 112.726 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -143.74 73.31 17.01 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.32 -42.74 20.92 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 122.3 2.0 . . . . 0.0 113.631 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.65 -44.27 97.77 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 126.532 2.015 . . . . 0.0 114.036 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.3 mm -61.3 -52.85 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 122.659 0.384 . . . . 0.0 110.057 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.54 -38.25 59.37 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.8 m -62.36 -62.06 2.02 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.475 1.109 . . . . 0.0 110.825 172.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.48 -32.81 58.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.737 -1.574 . . . . 0.0 114.23 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -102.53 0.96 34.37 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 37.85 50.0 1.2 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 123.992 1.853 . . . . 0.0 113.666 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 85' ' ' ILE . 2.2 pp -77.0 0.26 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -173.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -34.4 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.9 t -98.21 75.62 2.29 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.674 1.226 . . . . 0.0 111.061 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 39' ' ' ALA . 40.6 mm -77.15 133.73 68.37 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 112.711 -2.04 . . . . 0.0 108.109 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.714 ' HG3' HD12 ' A' ' 47' ' ' LEU . 36.1 Cg_exo -69.51 132.03 20.73 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 N-CA-C 115.87 1.45 . . . . 0.0 115.87 3.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.48 117.9 23.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.894 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.432 HG22 HD11 ' A' ' 48' ' ' ILE . 15.3 t -122.17 123.19 68.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 113.425 -1.716 . . . . 0.0 107.24 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.88 141.27 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.473 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.5 ' HE1' ' HB ' ' A' ' 100' ' ' ILE . 47.9 m-85 -118.43 112.0 19.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 112.042 -2.344 . . . . 0.0 108.034 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 97.4 m-85 -109.66 152.14 25.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 108.535 -3.939 . . . . 0.0 109.434 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -95.24 -105.42 0.15 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.384 -2.189 . . . . 0.0 106.565 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 75.1 m-20 -106.36 75.12 1.06 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.73 33.18 66.93 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 110.272 -3.149 . . . . 0.0 113.35 -170.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 21.3 mt-10 -124.55 136.63 54.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.405 HH21 ' CB ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -96.53 129.02 43.99 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.45 -173.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -112.48 -48.57 3.01 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 112.649 -2.069 . . . . 0.0 112.926 -170.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -149.14 139.5 22.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.236 0.96 . . . . 0.0 110.333 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.405 ' CB ' HH21 ' A' ' 96' ' ' ARG . 79.4 p -127.13 110.46 12.93 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.06 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 103' ' ' ALA . 1.1 mp -84.16 97.33 4.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 113.574 -1.648 . . . . 0.0 108.706 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.64 113.19 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 111.537 -2.574 . . . . 0.0 108.048 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.19 -43.09 2.63 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 124.952 1.263 . . . . 0.0 114.359 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 100' ' ' ILE . . . -65.55 103.7 0.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 123.45 1.595 . . . . 0.0 113.979 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 8.9 p -110.06 9.31 0.08 OUTLIER Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 118.089 2.626 . . . . 0.0 118.089 175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 13.9 Cg_endo -65.11 120.32 7.52 Favored 'Trans proline' 0 C--N 1.358 1.052 0 CA-C-N 122.647 1.981 . . . . 0.0 110.046 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -40.68 -46.83 2.69 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 111.693 -2.503 . . . . 0.0 114.244 -175.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.5 p -61.93 -48.17 81.62 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.487 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -56.55 -43.01 79.49 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.273 1.035 . . . . 0.0 112.731 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 103' ' ' ALA . 6.4 mp -62.23 -35.56 79.3 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.861 172.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.463 ' HA ' HD11 ' A' ' 113' ' ' ILE . 8.1 m -67.43 -46.39 73.27 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.871 0.732 . . . . 0.0 110.809 174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 108' ' ' THR . 29.9 t70 -50.07 -46.98 53.84 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 113.265 -1.789 . . . . 0.0 109.85 173.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 71.2 m -57.69 -34.63 69.64 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.515 HD12 ' HE1' ' A' ' 34' ' ' MET 0.285 0.0 OUTLIER -75.23 -52.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 123.436 1.589 . . . . 0.0 112.271 174.456 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -61.5 -21.9 64.63 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 111.126 -2.761 . . . . 0.0 112.267 -172.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.258 24.8 ttmm -46.99 -48.64 21.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.888 2.475 . . . . 0.0 112.149 168.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 90' ' ' PHE . 44.0 p90 -104.34 -42.62 5.43 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.305 2.7 pp . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 125.623 2.63 . . . . 0.0 109.3 171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 17' ' ' VAL . 52.7 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -105.38 75.86 1.18 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER 75.66 106.08 0.08 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 110.51 -3.041 . . . . 0.0 113.241 -172.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -67.7 149.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 111.884 -2.416 . . . . 0.0 111.237 178.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -146.56 170.59 16.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.239 -2.255 . . . . 0.0 108.305 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -44.93 -47.71 11.31 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.8 m -63.0 -53.39 54.72 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.907 0.754 . . . . 0.0 112.638 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -69.89 -27.19 64.6 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HH2' HG21 ' A' ' 35' ' ' VAL . 52.4 t-105 -51.6 -51.15 57.89 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.716 1.207 . . . . 0.0 111.346 -178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -77.85 3.92 13.16 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -112.61 -65.32 1.19 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.365 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -81.4 -33.73 32.07 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.536 2.421 . . . . 0.0 117.536 -172.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.668 ' HA ' HG11 ' A' ' 33' ' ' VAL . 48.9 t -87.77 -42.67 15.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.421 ' HG ' ' HA2' ' A' ' 94' ' ' GLY . 9.6 mp -74.57 -22.69 58.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.508 ' HG3' ' OD1' ' A' ' 93' ' ' ASN . 23.7 tt0 -161.27 105.21 1.3 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.585 1.183 . . . . 0.0 112.921 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.7 p -145.66 -102.56 0.1 Allowed 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 112.96 -1.927 . . . . 0.0 111.513 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -76.81 1.34 17.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.19 1.796 . . . . 0.0 112.922 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.454 96.4 t 79.42 -73.47 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 128.644 2.777 . . . . 0.0 111.505 -171.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -74.55 122.07 7.16 Favored 'Trans proline' 0 C--N 1.354 0.865 0 CA-C-N 124.071 2.49 . . . . 0.0 107.659 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 26' ' ' VAL . 43.9 t -126.11 145.22 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.385 -177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.426 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 59.6 ttm -127.68 136.23 51.3 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.374 -1.284 . . . . 0.0 111.961 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.4 m -134.68 121.8 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 113.824 -1.535 . . . . 0.0 113.174 177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.9 p30 -76.17 -38.47 56.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 120.721 3.6 . . . . 0.0 120.721 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 56.01 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.174 2.19 . . . . 0.0 115.693 -176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HB3' HD11 ' A' ' 48' ' ' ILE . 5.4 p-90 -137.83 151.77 48.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB3' HG21 ' A' ' 85' ' ' ILE . . . -134.64 132.0 20.5 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.076 -173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.65 -31.55 87.71 Favored 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.253 2.635 . . . . 0.0 113.923 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.5 p-90 -67.65 -17.19 64.51 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.66 -4.26 55.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.708 0.803 . . . . 0.0 110.897 168.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.6 -121.86 5.74 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -81.25 50.32 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.364 2.043 . . . . 0.0 113.084 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -61.86 -10.86 10.33 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 177.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 46' ' ' LYS . 15.0 tptm -59.71 -9.19 2.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.5 mt -48.85 -35.2 14.09 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -56.52 -33.05 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 171.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.265 . . -57.14 -46.76 99.82 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.2 -47.59 25.44 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.394 3.396 . . . . 0.0 112.546 170.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 106' ' ' LYS . 96.0 t -56.98 -48.05 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 122.734 0.413 . . . . 0.0 110.228 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.724 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.4 mp -61.57 -36.87 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.289 1.035 . . . . 0.0 113.254 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -67.16 -27.34 67.21 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 114.147 -1.388 . . . . 0.0 113.396 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 4.3 mt-10 -80.24 -48.56 12.89 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.833 1.253 . . . . 0.0 111.616 172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.448 HD12 HD12 ' A' ' 52' ' ' ILE . 20.5 mt -55.77 -24.88 38.1 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -54.25 -61.16 2.49 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.82 1.648 . . . . 0.0 111.394 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 54' ' ' GLU 0.275 0.0 OUTLIER -79.79 -23.57 42.04 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 179.184 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -63.07 -36.03 82.23 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.722 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.857 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 43.9 m-85 -120.22 58.24 0.92 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 122.869 1.318 . . . . 0.0 112.088 173.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 t -62.69 109.03 1.28 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.79 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.63 11.91 61.58 Favored Glycine 0 N--CA 1.485 1.941 0 CA-C-N 113.013 -1.903 . . . . 0.0 114.228 -175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 10.4 mptt -109.24 -81.15 0.57 Allowed 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 117.615 0.707 . . . . 0.0 112.385 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -96.83 114.89 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -171.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.61 88.77 1.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.763 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 56' ' ' ALA . 3.2 m -63.5 105.46 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 112.263 -2.244 . . . . 0.0 115.563 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HD2' HG22 ' A' ' 26' ' ' VAL . 18.8 m-85 -121.23 155.75 33.95 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 113.415 -1.72 . . . . 0.0 112.23 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.91 127.4 38.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 112.336 -2.211 . . . . 0.0 110.817 178.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.3 142.46 49.08 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.409 -1.268 . . . . 0.0 113.066 170.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 11.5 m-20 -75.04 114.15 13.19 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 170.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -58.31 -28.9 65.44 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.083 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.77 -15.89 55.26 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 174.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 18.9 tt0 -81.16 -34.63 32.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.209 0.604 . . . . 0.0 109.432 169.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.7 74.85 55.13 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -67.35 -42.01 8.18 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.153 2.569 . . . . 0.0 110.902 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.89 -34.09 57.08 Favored Glycine 0 N--CA 1.478 1.471 0 C-N-CA 127.03 2.252 . . . . 0.0 113.358 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -67.36 -55.18 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.768 0.827 . . . . 0.0 109.378 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.58 63.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.502 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.9 m -60.03 -61.0 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.523 1.129 . . . . 0.0 109.465 173.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -55.77 -36.78 67.72 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 113.568 -1.651 . . . . 0.0 114.238 -173.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -96.41 2.57 52.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.021 1.451 . . . . 0.0 113.222 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.772 HD21 ' NH2' ' A' ' 83' ' ' ARG . 1.0 OUTLIER 45.83 47.18 12.16 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 123.884 1.802 . . . . 0.0 113.433 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 82' ' ' ILE . 1.1 pp -93.45 118.28 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.666 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.772 ' NH2' HD21 ' A' ' 81' ' ' ASN . 65.8 mtt180 -110.43 -24.73 10.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 111.357 -2.656 . . . . 0.0 113.596 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 p -111.77 106.04 14.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 122.893 1.33 . . . . 0.0 111.429 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.567 HG22 ' SG ' ' A' ' 45' ' ' CYS . 17.7 mm -94.07 132.75 28.74 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 111.962 -2.381 . . . . 0.0 107.0 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.09 147.13 82.43 Favored 'Cis proline' 0 N--CA 1.486 1.059 0 O-C-N 124.193 1.628 . . . . 0.0 114.283 1.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -127.01 110.05 12.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.495 -177.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.528 HG11 ' HG ' ' A' ' 109' ' ' LEU . 7.5 p -100.34 111.9 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.831 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.653 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.3 mp -99.34 142.5 30.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 112.925 -1.943 . . . . 0.0 110.352 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.577 ' HE2' HG12 ' A' ' 100' ' ' ILE . 49.0 m-85 -122.15 121.35 36.68 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 123.516 1.627 . . . . 0.0 109.432 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 77.2 m-85 -115.19 143.49 45.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 109.753 -3.385 . . . . 0.0 111.029 -175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -135.55 84.21 2.07 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 112.543 -2.117 . . . . 0.0 108.682 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.748 ' HB2' HG13 ' A' ' 31' ' ' VAL . 6.7 t30 50.97 84.62 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 109.163 -3.653 . . . . 0.0 112.178 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' HA2' ' HG ' ' A' ' 27' ' ' LEU . . . 63.82 17.17 60.26 Favored Glycine 0 N--CA 1.479 1.516 0 CA-C-N 112.061 -2.336 . . . . 0.0 115.43 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 60.0 mt-10 -127.96 129.87 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -104.32 109.46 21.31 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 125.169 1.543 . . . . 0.0 108.709 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -86.29 -52.84 5.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 111.05 -2.795 . . . . 0.0 111.202 -169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -143.88 140.86 29.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.596 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.9 p -133.42 107.04 7.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 123.248 1.499 . . . . 0.0 111.511 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 90' ' ' PHE . 34.0 mm -88.28 87.72 2.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.641 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.3 pp -69.41 71.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 111.223 -2.717 . . . . 0.0 114.526 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.35 71.81 0.15 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.636 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.6 78.49 8.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -172.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 68.6 t -110.86 -51.82 0.05 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 CA-C-N 114.104 -1.407 . . . . 0.0 114.637 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -80.11 109.54 2.37 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.095 1.864 . . . . 0.0 110.976 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.4 tttm -45.04 -50.47 10.81 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 112.924 -1.944 . . . . 0.0 112.432 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -58.89 -32.09 69.19 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.9 m -63.71 -44.55 93.3 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HG ' HG11 ' A' ' 88' ' ' VAL . 9.2 mp -53.27 -47.17 69.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.987 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' HD12 ' A' ' 113' ' ' ILE . 11.8 m -61.0 -51.33 69.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.169 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.01 -49.24 41.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 112.761 -2.018 . . . . 0.0 111.214 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 75.5 m -61.85 -18.02 58.55 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 110' ' ' THR . 2.8 mt -89.98 -57.36 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 122.202 1.001 . . . . 0.0 108.814 176.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -46.82 -34.43 5.31 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 112.095 -2.321 . . . . 0.0 111.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -38.36 -52.88 1.53 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 112.091 -2.322 . . . . 0.0 114.021 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -101.52 -18.29 16.02 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 123.133 1.444 . . . . 0.0 112.338 167.264 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.754 HG11 ' HG2' ' A' ' 67' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 117.321 2.341 . . . . 0.0 117.321 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.05 63.21 1.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 111.727 -2.488 . . . . 0.0 106.74 157.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 42.41 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG23 HD23 ' A' ' 68' ' ' LEU . 1.7 m -82.3 34.42 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 CA-C-N 111.543 -2.571 . . . . 0.0 116.485 -175.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -83.51 80.69 9.02 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.862 0.839 . . . . 0.0 110.847 -174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.6 -40.03 0.46 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 126.58 1.952 . . . . 0.0 112.886 -167.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 p -57.75 101.38 0.07 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.84 2.056 . . . . 0.0 111.635 174.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.0 m 65.05 10.59 6.43 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 111.673 -2.512 . . . . 0.0 116.801 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.449 ' CH2' HG21 ' A' ' 35' ' ' VAL . 15.9 t-105 -51.48 -46.17 63.05 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -67.64 -4.44 11.99 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -126.57 -48.87 1.53 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.987 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 3.6 t80 -70.54 -11.89 61.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.472 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.436 HG22 ' CD2' ' A' ' 66' ' ' TYR . 57.0 t -125.32 -65.27 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 174.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -126.35 49.31 2.02 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 122.354 1.073 . . . . 0.0 111.781 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.5 t -101.08 -135.28 0.31 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.86 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 39.7 tt0 -81.02 67.84 7.08 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 172.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.588 0.4 OUTLIER 4.5 -60.08 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.208 0 CA-C-N 109.284 -3.598 . . . . 0.0 119.831 -175.961 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.541 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 30.7 Cg_exo -66.55 102.69 0.62 Allowed 'Trans proline' 0 N--CA 1.479 0.657 0 N-CA-C 106.159 -2.285 . . . . 0.0 106.159 167.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 75.7 t -117.76 142.6 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.986 0.898 . . . . 0.0 112.607 -170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.584 ' HE3' HG12 ' A' ' 63' ' ' ILE . 13.9 ttm -116.17 133.47 55.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 111.67 -2.513 . . . . 0.0 111.063 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.449 HG21 ' CH2' ' A' ' 22' ' ' TRP . 10.0 p -141.13 134.36 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 112.202 -2.272 . . . . 0.0 113.083 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.679 ' HB3' HG13 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.09 124.25 51.82 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.393 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -106.58 128.73 54.37 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 113.282 -1.781 . . . . 0.0 109.924 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.839 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.9 p-90 -132.17 167.26 20.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.106 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -133.17 133.4 22.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 CA-C-N 114.847 -1.069 . . . . 0.0 111.139 -173.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.566 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 1.6 Cg_endo -61.79 -40.79 42.53 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.154 1.902 . . . . 0.0 112.287 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -59.46 -28.26 66.83 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.8 t -69.64 -10.38 57.99 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.017 0.927 . . . . 0.0 113.038 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 72.1 -111.16 3.48 Favored Glycine 0 N--CA 1.476 1.36 0 C-N-CA 125.225 1.393 . . . . 0.0 110.263 -176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 9.0 Cg_exo -78.17 53.07 4.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.475 2.117 . . . . 0.0 114.008 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.839 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -69.74 -7.36 38.8 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.846 1.795 . . . . 0.0 115.846 174.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -58.54 -19.16 35.34 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 8.0 mt -36.2 -44.37 0.4 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.811 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.5 pp -58.05 -36.67 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.267 . . -55.33 -50.13 88.47 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 117.413 2.375 . . . . 0.0 117.413 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 42.2 Cg_exo -63.41 -41.93 24.14 Favored 'Trans proline' 0 N--CA 1.479 0.632 0 C-N-CA 125.069 3.846 . . . . 0.0 112.155 174.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 ' HG2' ' A' ' 106' ' ' LYS . 75.3 t -56.84 -48.79 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.395 0.678 . . . . 0.0 110.169 175.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 36' ' ' ASP . 10.4 mm -61.76 -38.76 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 20.8 m-20 -63.97 -31.51 72.72 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.697 1.237 . . . . 0.0 114.134 175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.4 -48.36 34.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.797 -1.547 . . . . 0.0 112.124 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 45.2 mt -55.04 -23.57 20.51 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -59.81 -59.27 5.7 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.839 1.256 . . . . 0.0 110.387 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -70.05 -33.9 72.53 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 16.0 mt-10 -55.62 -40.77 72.57 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.859 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 49.7 m-85 -121.56 59.32 0.97 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 123.199 1.476 . . . . 0.0 112.298 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.7 m -65.5 107.7 1.77 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 112.536 -2.12 . . . . 0.0 111.526 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.71 -24.95 29.72 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-N 112.562 -2.108 . . . . 0.0 111.738 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 12.3 mptt -77.6 -71.62 0.4 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.831 1.253 . . . . 0.0 113.638 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.584 HG12 ' HE3' ' A' ' 34' ' ' MET 0.342 2.7 pp -106.07 121.21 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 117.02 2.23 . . . . 0.0 117.02 -173.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 30' ' ' GLU . . . -75.69 117.75 17.79 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 112.026 -2.352 . . . . 0.0 108.78 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -102.74 112.62 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -167.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CD2' HG22 ' A' ' 26' ' ' VAL . 51.7 m-85 -126.58 156.59 40.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.554 -1.657 . . . . 0.0 114.618 -176.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.754 ' HG2' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -128.56 126.47 40.4 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.991 177.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -110.28 125.46 53.16 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 110.997 -2.82 . . . . 0.0 111.819 179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -84.53 92.96 8.23 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 103.378 -2.823 . . . . 0.0 103.378 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 38' ' ' TRP . 11.1 t -46.63 -46.16 19.59 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -171.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 4.6 m-20 -70.36 -22.72 62.75 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.887 -1.96 . . . . 0.0 113.39 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -76.69 -31.17 57.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.274 174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.1 77.91 76.07 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -59.1 -38.36 87.39 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.89 2.393 . . . . 0.0 112.261 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.36 -40.71 94.52 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 126.618 2.056 . . . . 0.0 113.159 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mm -64.0 -54.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.716 0.293 . . . . 0.0 110.247 173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -53.16 -41.37 65.11 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.67 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 35.6 m -57.32 -57.17 13.8 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.477 1.111 . . . . 0.0 109.74 173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -58.39 -25.95 62.66 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.769 1.628 . . . . 0.0 113.42 -173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -103.86 9.07 37.01 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 55.97 34.05 22.92 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 123.286 1.517 . . . . 0.0 114.497 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.556 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.348 0.0 OUTLIER -105.11 101.34 12.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 113.628 -1.623 . . . . 0.0 110.578 177.058 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.463 HH21 ' CB ' ' A' ' 77' ' ' ALA . 5.5 mmp_? -121.14 6.43 10.27 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 109.853 -3.339 . . . . 0.0 113.696 173.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.7 p -93.41 -67.79 0.84 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 82' ' ' ILE . 46.3 mm 69.82 132.08 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 125.403 1.481 . . . . 0.0 112.174 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -84.64 136.31 23.64 Favored 'Cis proline' 0 N--CA 1.483 0.859 0 O-C-N 123.054 1.029 . . . . 0.0 110.136 -3.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' HG13 ' A' ' 82' ' ' ILE . 39.3 m -127.76 129.38 46.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.627 0.727 . . . . 0.0 110.076 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 97.4 t -118.82 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.955 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.5 149.53 23.98 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.307 -1.77 . . . . 0.0 112.587 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.795 ' HE2' HG12 ' A' ' 100' ' ' ILE . 21.4 m-85 -126.31 111.05 14.08 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.235 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.9 m-85 -104.18 155.2 18.91 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 110.674 -2.966 . . . . 0.0 111.443 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.85 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 40.7 tptt -113.65 -100.6 0.42 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 111.938 -2.392 . . . . 0.0 108.489 169.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.425 ' H ' ' HB3' ' A' ' 92' ' ' LYS . 15.8 p-10 -93.72 63.27 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.794 1.283 . . . . 0.0 110.919 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.56 33.43 81.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 112.753 -2.022 . . . . 0.0 111.762 -171.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -138.52 109.89 6.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.76 -1.22 . . . . 0.0 109.246 -165.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.09 108.36 8.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 123.811 1.767 . . . . 0.0 113.123 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.85 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 32.3 mtpt -81.13 -60.26 2.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 109.902 -3.317 . . . . 0.0 109.092 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -126.63 141.15 51.95 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.601 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.7 m -132.53 104.34 6.63 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.25 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.795 HG12 ' HE2' ' A' ' 90' ' ' PHE . 18.0 mm -79.87 89.39 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.8 mt -58.24 -40.86 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.183 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -111.12 78.29 0.24 Allowed Glycine 0 N--CA 1.479 1.503 0 O-C-N 125.024 1.452 . . . . 0.0 110.653 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.37 80.83 8.96 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 123.523 1.63 . . . . 0.0 114.153 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.383 6.3 p -123.85 -33.85 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 111.924 -2.398 . . . . 0.0 116.349 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -92.49 113.91 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 CA-C-N 122.553 1.947 . . . . 0.0 111.07 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.623 ' HG2' HG13 ' A' ' 51' ' ' VAL . 9.3 tmtm? -42.81 -46.7 5.32 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.952 2.101 . . . . 0.0 114.037 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.3 p -56.2 -46.18 79.55 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 23.4 m -55.64 -38.98 70.26 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.61 -47.64 84.51 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 113.892 -1.504 . . . . 0.0 111.076 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' HD12 ' A' ' 113' ' ' ILE . 4.8 m -63.97 -48.85 74.84 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 122.069 0.938 . . . . 0.0 111.658 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -48.81 -47.16 42.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.272 -2.24 . . . . 0.0 111.349 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.635 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 6.6 t -64.61 -24.38 67.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 -177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 110' ' ' THR . 3.2 mt -83.75 -53.79 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.242 1.02 . . . . 0.0 109.051 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -50.34 -34.4 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.061 -2.336 . . . . 0.0 112.293 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 24.2 ttmm -42.66 -45.07 4.53 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 128.963 2.905 . . . . 0.0 114.736 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.434 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 20.9 p90 -107.67 -29.07 9.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.263 1.2 pp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 125.354 2.502 . . . . 0.0 108.582 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG11 ' HD1' ' A' ' 66' ' ' TYR . 2.8 p . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 68.64 -49.76 0.57 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.242 2.217 . . . . 0.0 114.004 -169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -151.08 110.42 3.96 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.538 1.535 . . . . 0.0 109.52 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 HD12 ' A' ' 68' ' ' LEU . 7.5 p -87.64 133.99 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.028 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 24.9 p30 -142.7 -175.56 4.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 112.406 -2.179 . . . . 0.0 110.033 -172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.43 -47.14 66.54 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -64.85 -50.55 66.19 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.082 0.953 . . . . 0.0 111.653 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 p -72.36 -23.7 61.17 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HZ3' HG11 ' A' ' 35' ' ' VAL . 61.3 t-105 -48.88 -57.46 6.39 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.768 1.227 . . . . 0.0 113.644 -176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 94.6 mttt -71.88 -30.1 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.59 -39.2 15.29 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -88.47 -55.97 3.5 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 33' ' ' VAL . 77.8 t -73.3 -59.6 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 113.963 -1.471 . . . . 0.0 108.724 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.4 mm? -61.58 -31.88 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.937 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -118.58 61.43 0.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 31' ' ' VAL . 69.0 m -106.34 -23.18 12.61 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.629 165.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 59.47 12.67 2.85 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 128.396 2.678 . . . . 0.0 115.447 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 29' ' ' SER . 26.9 m -125.1 165.62 24.91 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 127.048 2.139 . . . . 0.0 108.479 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.23 123.04 12.81 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.721 1.614 . . . . 0.0 109.817 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.8 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 44.0 t -112.07 140.72 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 113.555 -1.657 . . . . 0.0 110.228 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.575 ' HE2' ' HE2' ' A' ' 90' ' ' PHE . 45.6 ttm -124.51 123.7 40.67 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.162 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 66' ' ' TYR . 4.8 t -126.59 116.97 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.034 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.956 ' HB3' HG13 ' A' ' 52' ' ' ILE . 10.1 p-10 -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.507 1.129 . . . . 0.0 111.217 173.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 68' ' ' LEU . 2.5 m-85 -104.59 101.51 11.16 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.612 1.195 . . . . 0.0 109.691 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.671 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 4.4 p-90 -115.77 160.38 20.19 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.554 -2.112 . . . . 0.0 109.897 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -136.64 133.19 18.9 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.271 -173.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.2 -27.52 83.86 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.395 2.063 . . . . 0.0 114.014 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.541 ' HH2' HD13 ' A' ' 85' ' ' ILE . 6.9 p-90 -80.69 8.43 8.04 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.556 1.542 . . . . 0.0 114.826 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.0 t -127.27 107.94 10.43 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.325 1.05 . . . . 0.0 111.863 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.21 -61.74 5.98 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 112.556 -2.111 . . . . 0.0 113.197 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -56.31 -28.18 70.65 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.615 2.21 . . . . 0.0 115.941 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.724 ' SG ' HG22 ' A' ' 85' ' ' ILE . 83.5 m -63.6 -35.11 79.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -61.47 -37.75 84.75 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.873 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.76 -36.6 73.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.501 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.576 HG21 ' O ' ' A' ' 103' ' ' ALA 0.333 2.6 pp -69.2 -26.61 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.308 . . -57.26 -49.09 95.92 Favored Pre-proline 0 N--CA 1.479 0.979 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -58.95 -45.89 25.89 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.615 3.543 . . . . 0.0 111.721 168.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -51.65 -49.4 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 123.695 0.622 . . . . 0.0 112.066 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.956 HG13 ' HB3' ' A' ' 36' ' ' ASP . 27.8 mm -62.57 -39.56 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 176.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -64.95 -32.98 74.96 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.813 -1.54 . . . . 0.0 114.195 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.669 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 40.2 mt-10 -75.35 -37.69 60.52 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.065 -1.425 . . . . 0.0 113.069 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 ' OH ' ' A' ' 59' ' ' TYR . 79.2 mt -56.37 -24.76 46.46 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 173.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.98 75.67 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.67 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.669 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 5.2 pttt -92.34 -15.95 26.66 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.0 mt-10 -55.08 -39.44 69.29 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 123.943 0.777 . . . . 0.0 110.362 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -120.4 65.87 0.84 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 170.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.5 t -0.62 83.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 118.032 2.605 . . . . 0.0 118.032 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.53 29.62 67.67 Favored Glycine 0 N--CA 1.486 1.978 0 CA-C-N 113.654 -1.612 . . . . 0.0 115.635 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 59' ' ' TYR . 2.3 tppt? -64.51 -63.86 1.02 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -102.71 134.73 42.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 112.037 -2.347 . . . . 0.0 113.564 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.83 88.07 1.32 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 113.364 -1.744 . . . . 0.0 107.676 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 52' ' ' ILE . 7.2 p -70.7 110.2 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-N 109.251 -3.613 . . . . 0.0 114.406 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' HB3' HG11 ' A' ' 17' ' ' VAL . 55.0 m-85 -123.61 139.49 53.95 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 111.941 -2.391 . . . . 0.0 113.407 -173.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' C ' HG12 ' A' ' 17' ' ' VAL . 3.7 mppt? -113.03 101.88 9.88 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.652 -1.613 . . . . 0.0 114.354 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -93.67 104.53 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 123.919 1.819 . . . . 0.0 114.236 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -71.71 101.66 2.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 111.439 -2.619 . . . . 0.0 106.402 170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.655 HG21 HG12 ' A' ' 85' ' ' ILE . 47.2 p -48.18 -42.84 30.9 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -61.87 -30.71 71.04 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 113.834 -1.53 . . . . 0.0 113.794 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -86.28 -24.61 25.89 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.13 0.972 . . . . 0.0 113.076 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.585 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -136.48 75.36 51.58 Favored Pre-proline 0 CA--C 1.555 1.149 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.36 -42.86 20.17 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.889 2.392 . . . . 0.0 111.35 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.73 -35.46 89.83 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 127.021 2.248 . . . . 0.0 113.312 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 47.5 mm -68.7 -50.65 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.035 0.534 . . . . 0.0 110.501 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.55 -37.81 68.48 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.235 175.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.7 m -61.61 -61.2 2.69 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.366 1.066 . . . . 0.0 110.538 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -52.75 -33.36 47.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.708 1.603 . . . . 0.0 113.665 -174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -97.92 8.17 45.16 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.648 HD21 ' NH2' ' A' ' 83' ' ' ARG . 47.5 t30 41.99 47.07 3.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.91 2.084 . . . . 0.0 113.432 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.74 102.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 113.178 -1.828 . . . . 0.0 106.29 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' HD21 ' A' ' 81' ' ' ASN . 96.7 mtt180 -91.93 -12.13 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 109.837 -3.347 . . . . 0.0 112.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.6 t -119.38 126.54 51.64 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.431 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.724 HG22 ' SG ' ' A' ' 45' ' ' CYS . 4.6 mp -118.48 118.85 33.45 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.6 Cg_endo -87.04 145.81 30.62 Favored 'Cis proline' 0 CA--C 1.537 0.671 0 N-CA-C 119.171 2.72 . . . . 0.0 119.171 5.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.2 m -132.98 134.57 44.66 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.169 -1.832 . . . . 0.0 107.908 171.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.39 130.47 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.469 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.73 137.85 50.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.437 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.575 ' HE2' ' HE2' ' A' ' 34' ' ' MET . 29.5 m-85 -119.13 113.29 20.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 112.907 -1.952 . . . . 0.0 109.797 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.8 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 43.5 m-85 -106.85 141.45 38.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 109.925 -3.307 . . . . 0.0 110.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -75.3 -57.48 3.87 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -113.22 -50.66 2.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.562 0.745 . . . . 0.0 111.192 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . -165.79 26.64 0.17 Allowed Glycine 0 CA--C 1.546 1.985 0 CA-C-N 112.9 -1.954 . . . . 0.0 111.079 168.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.95 129.14 43.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.073 1.749 . . . . 0.0 107.882 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PHE 0.318 0.0 OUTLIER -86.37 139.4 30.99 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 123.005 1.384 . . . . 0.0 114.297 -171.066 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.91 -29.9 3.88 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 108.782 -3.826 . . . . 0.0 113.137 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.409 ' HG2' ' HD2' ' A' ' 115' ' ' LYS . 7.1 mp0 -130.07 137.18 50.08 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 76.1 p -135.41 103.82 5.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.8 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.8 mp -96.33 99.34 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 122.043 0.925 . . . . 0.0 110.394 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.84 135.96 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 112.282 -2.236 . . . . 0.0 109.194 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.69 47.94 18.97 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.297 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.576 ' O ' HG21 ' A' ' 48' ' ' ILE . . . -76.59 81.78 3.26 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.219 1.408 . . . . 0.0 114.127 -173.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.07 -50.22 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.111 0 CA-C-O 116.988 -1.482 . . . . 0.0 114.492 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.9 111.48 2.85 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.141 2.561 . . . . 0.0 108.647 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -40.09 -44.45 1.79 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.827 1.651 . . . . 0.0 113.139 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 p -57.72 -40.52 79.77 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.492 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 51.9 m -63.74 -44.38 93.7 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.026 1.331 . . . . 0.0 112.0 173.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD23 HD11 ' A' ' 52' ' ' ILE . 6.9 mp -58.74 -35.33 72.54 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.127 1.371 . . . . 0.0 111.255 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.58 HG23 ' OH ' ' A' ' 59' ' ' TYR . 7.0 m -75.15 -47.64 27.51 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 122.232 1.015 . . . . 0.0 111.785 175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 108' ' ' THR . 31.3 t70 -44.21 -47.22 9.23 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.86 1.664 . . . . 0.0 110.745 174.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.75 -44.83 63.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -75.03 -55.57 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 O-C-N 124.549 1.155 . . . . 0.0 110.014 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 32.2 mt-10 -60.87 -21.6 63.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 112.045 -2.343 . . . . 0.0 114.248 -171.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 98' ' ' GLU 0.267 16.8 ttmm -45.75 -54.95 7.14 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.24 2.216 . . . . 0.0 112.074 166.357 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -102.93 -29.13 11.61 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.135 1.374 . . . . 0.0 112.286 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 7.5 tp . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 125.802 2.715 . . . . 0.0 105.225 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 17' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.893 0.378 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -67.32 -55.72 12.7 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.444 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 17.0 m-20 -151.49 118.68 5.93 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.742 1.217 . . . . 0.0 112.385 173.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.86 -73.11 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 114.217 -1.356 . . . . 0.0 112.333 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 58.52 166.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.173 1.789 . . . . 0.0 112.138 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -39.21 -39.47 0.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 p -51.05 -46.54 61.69 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.73 2.012 . . . . 0.0 115.709 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 m -111.92 -13.05 13.69 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -47.29 -48.77 24.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.234 1.413 . . . . 0.0 114.094 -174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' HG2' HD22 ' A' ' 27' ' ' LEU . 93.4 mttt -75.5 -7.97 55.52 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 117.476 2.398 . . . . 0.0 117.476 -176.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.51 -46.57 3.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.747 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -78.81 -48.65 14.37 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.469 ' HA ' HG11 ' A' ' 33' ' ' VAL . 98.5 t -88.58 -39.5 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 113.486 -1.688 . . . . 0.0 110.117 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.586 HD22 ' HG2' ' A' ' 23' ' ' LYS . 11.3 mp -79.92 -6.39 57.37 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.18 102.24 1.94 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 172.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 31' ' ' VAL . 28.1 m -124.25 8.55 8.51 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.363 -1.461 . . . . 0.0 111.373 165.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 68.78 -43.63 0.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 130.167 3.387 . . . . 0.0 111.297 -169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 29' ' ' SER . 33.3 m -83.86 157.97 62.75 Favored Pre-proline 0 N--CA 1.477 0.877 0 CA-C-N 111.005 -2.816 . . . . 0.0 109.218 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 90.2 Cg_exo -54.9 149.01 44.03 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.998 1.799 . . . . 0.0 109.397 167.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 26' ' ' VAL . 74.1 t -119.54 142.61 34.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.916 -172.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 55.5 ttm -120.73 134.15 55.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.984 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 20.3 m -124.81 137.93 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 114.776 -1.102 . . . . 0.0 113.712 175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -113.96 116.2 28.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 125.836 1.96 . . . . 0.0 109.099 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -93.48 119.77 32.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.054 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.866 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 21.6 p-90 -122.37 155.47 35.96 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 124.756 1.285 . . . . 0.0 110.692 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -132.32 134.11 24.56 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.795 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 4.2 Cg_exo -53.4 -44.39 49.37 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.064 1.843 . . . . 0.0 112.251 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.6 p-90 -63.43 -15.72 58.5 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 116.947 2.203 . . . . 0.0 116.947 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.563 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -65.62 -36.12 82.79 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.948 0.899 . . . . 0.0 112.133 177.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.69 -100.13 1.65 Allowed Glycine 0 CA--C 1.535 1.293 0 CA-C-O 117.642 -1.643 . . . . 0.0 109.577 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' O ' HG12 ' A' ' 48' ' ' ILE . 61.3 Cg_endo -75.8 24.04 0.43 Allowed 'Trans proline' 0 N--CA 1.478 0.613 0 C-N-CA 123.418 2.746 . . . . 0.0 115.615 -175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.866 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 5.7 m -73.67 154.37 39.72 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.851 0.834 . . . . 0.0 111.878 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 51.4 tttp 75.74 -46.65 0.56 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 111.343 -2.662 . . . . 0.0 110.733 -168.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.89 -30.65 71.28 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.7 0.762 . . . . 0.0 109.606 172.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.687 ' C ' ' HD3' ' A' ' 50' ' ' PRO 0.253 8.1 pt -89.81 55.69 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 123.587 1.661 . . . . 0.0 112.761 170.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' N ' ' HD3' ' A' ' 50' ' ' PRO . . . -105.64 19.16 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 111.613 -2.54 . . . . 0.0 113.785 161.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' C ' ' A' ' 48' ' ' ILE . 1.7 Cg_endo -69.7 -47.25 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.227 2.618 . . . . 0.0 110.642 -171.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.616 HG13 ' HG2' ' A' ' 106' ' ' LYS . 95.0 t -50.48 -53.89 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.393 1.077 . . . . 0.0 109.183 176.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.07 -43.92 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.84 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 72.9 m-20 -63.59 -32.56 74.07 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 36.7 mt-10 -75.13 -47.41 28.75 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.002 1.321 . . . . 0.0 111.024 175.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 81.7 mt -54.11 -31.62 52.63 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.184 0.928 . . . . 0.0 113.301 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -55.63 -52.2 64.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 112.239 -2.255 . . . . 0.0 112.738 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 35.3 pttt -89.11 -24.04 22.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -58.19 -46.52 85.64 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.314 1.446 . . . . 0.0 111.56 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 3.8 p90 -124.93 70.8 1.15 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.25 135.8 9.89 Favored 'General case' 0 N--CA 1.472 0.627 1 CA-C-N 107.875 -4.239 . . . . 0.0 116.682 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.12 -9.43 4.03 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 113.382 -1.736 . . . . 0.0 115.693 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.624 ' HG3' ' HB2' ' A' ' 59' ' ' TYR . 34.9 mmtt -65.39 -54.14 33.0 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 114.642 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.5 pp -125.25 137.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.809 -176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.87 104.58 15.66 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 113.575 -1.648 . . . . 0.0 110.357 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.25 98.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.918 1.687 . . . . 0.0 115.174 -173.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 22.3 m-85 -113.42 146.89 38.79 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 112.56 -2.109 . . . . 0.0 113.457 -178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -134.46 131.08 37.67 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 176.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.673 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.6 148.94 43.22 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 174.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.526 ' ND2' ' HZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -72.21 98.28 2.13 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 173.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.0 t -51.61 -41.45 61.26 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.451 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 6.2 m-20 -67.77 -30.47 69.93 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 112.663 -2.062 . . . . 0.0 113.425 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 23.0 tt0 -81.83 -20.96 37.94 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.084 0.865 . . . . 0.0 112.189 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -117.87 71.2 7.78 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.083 0.553 . . . . 0.0 111.583 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -60.58 -38.84 69.62 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.889 3.059 . . . . 0.0 112.387 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.57 -40.61 97.73 Favored Glycine 0 CA--C 1.543 1.835 0 C-N-CA 125.749 1.642 . . . . 0.0 112.195 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -64.14 -54.78 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.04 60.93 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.734 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.2 m -60.44 -60.31 4.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.731 0.813 . . . . 0.0 110.312 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -58.04 -34.81 70.49 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.622 -1.172 . . . . 0.0 113.514 -174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.53 12.2 30.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.3 p30 45.36 46.28 10.34 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.094 1.426 . . . . 0.0 114.399 173.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.537 HD13 HD11 ' A' ' 85' ' ' ILE 0.3 0.9 OUTLIER -80.62 105.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.492 -1.685 . . . . 0.0 109.817 -177.54 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' H ' HD11 ' A' ' 101' ' ' ILE . 34.0 mmt-85 -110.41 9.59 23.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 111.008 -2.815 . . . . 0.0 113.858 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -162.39 142.58 9.83 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.599 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 82' ' ' ILE . 35.2 mm -120.25 132.5 24.09 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.221 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 141.44 54.09 Favored 'Cis proline' 0 N--CA 1.483 0.887 0 O-C-N 123.947 1.499 . . . . 0.0 114.512 -1.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -104.3 139.26 39.54 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.7 p -129.93 121.68 52.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 O-C-N 124.638 1.211 . . . . 0.0 112.143 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 96' ' ' ARG . 5.3 mp -121.02 146.61 46.52 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 112.823 -1.99 . . . . 0.0 110.952 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 2.2 m-85 -125.86 118.43 25.46 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 123.38 1.562 . . . . 0.0 108.134 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.447 ' C ' ' HE2' ' A' ' 97' ' ' LYS . 95.1 m-85 -118.26 150.91 38.65 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 111.002 -2.817 . . . . 0.0 114.012 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 50.3 tptt -104.65 71.33 0.98 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 112.968 -1.924 . . . . 0.0 105.869 168.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 61.27 66.62 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.225 -2.261 . . . . 0.0 110.222 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 73.27 2.51 59.29 Favored Glycine 0 N--CA 1.475 1.262 0 CA-C-N 112.198 -2.274 . . . . 0.0 116.508 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.66 99.83 9.84 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 122.097 0.951 . . . . 0.0 108.589 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.74 ' HD2' HD23 ' A' ' 89' ' ' LEU . 14.4 ttp180 -63.76 117.76 7.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 112.788 -2.006 . . . . 0.0 115.278 -171.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 51.6 mtmt -94.65 -47.06 6.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 111.605 -2.543 . . . . 0.0 110.354 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 6.3 tp10 -156.33 151.93 27.01 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.19 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.7 p -141.57 126.26 17.97 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.979 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.7 mm -109.9 107.37 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 113.006 -1.906 . . . . 0.0 107.393 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.655 ' HA ' HG23 ' A' ' 87' ' ' THR . 1.9 tp -56.84 -30.79 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -121.44 96.61 0.59 Allowed Glycine 0 N--CA 1.48 1.6 0 C-N-CA 124.42 1.01 . . . . 0.0 112.379 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.75 39.53 0.29 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.311 51.1 t -102.25 -50.52 0.16 Allowed Pre-proline 0 CA--C 1.555 1.141 0 CA-C-O 116.872 -1.537 . . . . 0.0 113.384 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.73 96.11 1.04 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 CA-C-N 121.819 1.685 . . . . 0.0 111.035 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.616 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.4 tmtt? -38.59 -50.49 1.59 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.423 2.289 . . . . 0.0 114.892 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.4 p -58.31 -42.05 85.85 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.8 m -57.9 -44.38 86.74 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.371 1.068 . . . . 0.0 112.908 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.0 mp -60.42 -43.65 96.54 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.628 -1.624 . . . . 0.0 110.412 174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.7 m -63.94 -45.77 87.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.833 1.301 . . . . 0.0 111.668 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -55.73 -47.86 76.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.951 -1.931 . . . . 0.0 111.114 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.4 m -62.2 -30.47 71.1 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.586 HD12 ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -93.98 -42.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 122.052 0.929 . . . . 0.0 111.595 177.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -80.74 12.32 3.26 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.011 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.327 23.9 ttmm -75.92 -48.16 22.42 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 130.042 3.337 . . . . 0.0 108.665 167.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -103.53 -61.89 1.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.297 1.439 . . . . 0.0 113.655 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 117' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 126.236 2.922 . . . . 0.0 109.981 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.942 HG11 HG22 ' A' ' 17' ' ' VAL . 7.9 p . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 76.03 -52.95 0.62 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.07 2.148 . . . . 0.0 112.738 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.42 111.73 3.88 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.942 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -88.89 151.26 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.554 174.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -140.21 176.1 9.04 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.62 -33.53 72.9 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 p -64.7 -58.55 5.99 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.658 1.583 . . . . 0.0 112.282 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.4 p -73.87 -21.55 60.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.795 ' HZ3' HD22 ' A' ' 68' ' ' LEU . 60.2 t-105 -44.88 -51.03 10.05 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.952 1.301 . . . . 0.0 112.836 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 47.3 mtmt -64.37 -16.05 61.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.374 2.361 . . . . 0.0 117.374 -176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -111.1 -53.18 2.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.981 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.68 21.51 3.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.664 HG13 HG11 ' A' ' 33' ' ' VAL . 77.7 t -148.11 -49.14 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.995 2.118 . . . . 0.0 107.977 169.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD22 ' HA2' ' A' ' 94' ' ' GLY . 19.5 mt -85.68 -30.27 23.32 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -122.3 32.71 5.69 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -175.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -80.7 7.57 9.94 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 67.42 -3.79 1.0 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.72 2.808 . . . . 0.0 114.826 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.73 155.02 70.41 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.16 1.784 . . . . 0.0 111.057 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.49 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 40.9 Cg_exo -64.38 149.27 90.39 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.092 1.861 . . . . 0.0 108.064 169.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.664 HG11 HG13 ' A' ' 26' ' ' VAL . 37.1 t -130.03 147.88 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -166.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.631 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 48.0 ttm -125.07 146.92 49.22 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 111.807 -2.452 . . . . 0.0 108.484 172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 5.4 m -129.94 141.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.487 172.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB3' HG12 ' A' ' 52' ' ' ILE . 6.9 p-10 -91.86 -24.06 19.46 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 124.752 1.282 . . . . 0.0 114.171 175.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.525 ' CE2' HD11 ' A' ' 68' ' ' LEU . 27.7 m-85 48.45 103.9 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.291 1.436 . . . . 0.0 112.144 -164.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.867 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.4 p-90 -113.96 148.01 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.351 -0.841 . . . . 0.0 113.086 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 85' ' ' ILE . . . -134.23 141.61 39.98 Favored Pre-proline 0 N--CA 1.476 0.874 0 CA-C-N 113.908 -1.497 . . . . 0.0 108.074 -176.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.57 -41.97 64.92 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.564 2.843 . . . . 0.0 113.889 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -75.27 4.96 6.14 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' O ' HD13 ' A' ' 47' ' ' LEU . 11.5 t -111.06 111.79 23.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.636 0.731 . . . . 0.0 112.642 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.81 -62.96 5.77 Favored Glycine 0 CA--C 1.545 1.95 0 CA-C-N 113.249 -1.796 . . . . 0.0 112.01 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.61 41.87 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.184 3.256 . . . . 0.0 115.141 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.867 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 77.2 m -121.2 -152.53 0.51 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.77 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' H ' ' HB2' ' A' ' 38' ' ' TRP . 17.8 ttpt -43.58 -42.11 4.92 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 125.303 1.441 . . . . 0.0 114.408 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 47' ' ' LEU . 3.6 mp -38.33 -36.13 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.024 1.73 . . . . 0.0 114.135 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -129.69 -38.74 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 38.59 36.69 0.12 Allowed Pre-proline 0 N--CA 1.5 2.039 0 C-N-CA 127.257 2.223 . . . . 0.0 116.427 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.48 -59.67 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 121.398 1.398 . . . . 0.0 114.093 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 40.6 t -50.33 -53.28 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.664 1.185 . . . . 0.0 110.438 177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -59.39 -43.51 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.934 0.894 . . . . 0.0 112.692 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.5 -40.8 88.25 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 122.261 1.029 . . . . 0.0 113.194 176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 34.9 mt-10 -71.52 -45.01 63.59 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.462 -2.154 . . . . 0.0 113.579 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 44.6 mt -58.29 -28.41 64.96 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.13 -45.61 72.0 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.365 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -100.18 -20.89 15.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.491 1.516 . . . . 0.0 115.056 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 29.9 tt0 -61.07 -54.1 48.96 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.522 1.529 . . . . 0.0 111.035 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' OH ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -111.88 77.6 1.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 164.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.7 m -33.62 106.65 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 109.724 -3.398 . . . . 0.0 114.167 -175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.59 -15.52 18.81 Favored Glycine 0 CA--C 1.541 1.702 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.28 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.609 ' HG3' ' HG ' ' A' ' 117' ' ' LEU . 12.9 mptt -39.7 -55.02 1.98 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.794 1.637 . . . . 0.0 115.196 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 34' ' ' MET . 2.1 pp -125.95 113.74 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 113.443 -1.708 . . . . 0.0 111.355 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.93 107.96 2.86 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.792 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -76.61 103.56 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 33' ' ' VAL . 22.5 m-85 -114.39 139.96 49.06 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.258 -1.792 . . . . 0.0 113.639 -175.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -119.63 104.87 10.65 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.708 -174.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.795 HD22 ' HZ3' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -100.16 144.76 28.81 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 117.009 2.225 . . . . 0.0 117.009 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 27.2 m-20 -80.14 87.51 5.48 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 111.777 -2.465 . . . . 0.0 105.36 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.5 p -48.95 -45.48 41.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.46 -34.59 75.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.802 -1.545 . . . . 0.0 113.108 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -75.48 -30.22 59.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.535 1.134 . . . . 0.0 112.286 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.46 68.01 49.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.05 -39.74 47.68 Favored 'Trans proline' 0 N--CA 1.485 0.995 0 C-N-CA 122.726 2.284 . . . . 0.0 112.377 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.55 64.7 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 127.508 2.48 . . . . 0.0 113.484 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 68' ' ' LEU . 35.4 mm -63.96 -55.6 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 123.853 0.861 . . . . 0.0 110.12 173.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.4 -37.55 67.76 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 113.998 -1.456 . . . . 0.0 111.963 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.4 m -58.71 -63.29 1.34 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.06 0.944 . . . . 0.0 111.426 175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -60.38 -30.11 69.37 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -173.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -95.29 6.36 49.23 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.928 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 51.28 43.84 29.13 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 123.19 1.472 . . . . 0.0 114.156 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.269 0.4 OUTLIER -90.74 103.85 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 112.574 -2.103 . . . . 0.0 108.308 -176.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -101.68 -3.8 27.63 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 110.489 -3.05 . . . . 0.0 113.721 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.479 ' OG ' HG22 ' A' ' 101' ' ' ILE . 54.7 p -150.26 115.98 5.55 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 123.018 1.39 . . . . 0.0 113.011 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 39' ' ' ALA . 3.4 mt -92.03 128.98 43.35 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 112.947 -1.933 . . . . 0.0 107.762 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.6 Cg_endo -79.98 152.45 85.05 Favored 'Cis proline' 0 C--O 1.239 0.557 0 N-CA-C 117.091 1.92 . . . . 0.0 117.091 1.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.471 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 21.3 m -125.38 124.04 40.64 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 113.336 -1.757 . . . . 0.0 107.68 174.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 70.8 t -111.03 104.18 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 113.862 -1.517 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.14 139.12 42.07 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 112.302 -2.226 . . . . 0.0 108.724 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.693 ' HE1' HD13 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -115.63 123.58 48.77 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 123.453 1.597 . . . . 0.0 108.3 179.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.518 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 76.1 m-85 -111.06 137.52 48.61 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 108.787 -3.824 . . . . 0.0 109.502 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 23.2 tptm -93.7 63.97 3.45 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 167.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 t30 54.36 78.31 0.17 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 111.677 -2.51 . . . . 0.0 110.539 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 82.1 -20.67 7.93 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 112.73 -2.032 . . . . 0.0 115.741 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 92' ' ' LYS . 13.2 mm-40 -88.46 104.54 16.89 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.63 111.26 7.63 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.935 -170.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 11.0 mtpt -91.44 -58.98 2.26 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 111.876 -2.42 . . . . 0.0 113.407 -173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.508 ' HB3' ' HD1' ' A' ' 90' ' ' PHE . 4.6 tp10 -149.38 148.09 29.07 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 124.342 1.026 . . . . 0.0 110.125 -176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 p -131.94 106.05 7.81 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.3 1.524 . . . . 0.0 113.577 -176.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 90' ' ' PHE . 1.7 mp -93.27 95.94 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 113.05 -1.887 . . . . 0.0 109.165 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.479 HG22 ' OG ' ' A' ' 84' ' ' SER . 5.6 mt -92.13 105.44 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.549 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.29 60.11 0.68 Allowed Glycine 0 N--CA 1.477 1.395 0 CA-C-N 113.167 -1.833 . . . . 0.0 108.541 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.69 76.0 3.35 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 123.764 1.745 . . . . 0.0 113.103 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -109.44 -45.96 0.1 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.875 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.91 101.67 1.04 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 CA-C-N 122.195 1.82 . . . . 0.0 111.399 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' HG13 ' A' ' 51' ' ' VAL . 14.3 tmtt? -30.81 -59.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 127.208 2.203 . . . . 0.0 113.812 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.2 p -55.6 -41.43 73.4 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.6 m -53.38 -46.73 69.75 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.106 0.963 . . . . 0.0 111.939 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD13 HG21 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -92.14 35.9 0.99 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 124.752 2.215 . . . . 0.0 113.475 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.448 ' HA ' HD13 ' A' ' 113' ' ' ILE . 20.5 m -138.13 -50.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 111.784 -2.462 . . . . 0.0 109.33 172.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -51.72 -45.09 63.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 111.177 -2.738 . . . . 0.0 109.905 170.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.4 t -63.92 -21.71 66.59 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 117.566 2.432 . . . . 0.0 117.566 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.4 mp -83.46 -56.14 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' OE2' HG22 ' A' ' 110' ' ' THR . 42.8 mt-10 -57.35 -13.53 3.51 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 126.348 2.28 . . . . 0.0 116.246 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.292 7.8 ttmm -59.87 -42.07 92.92 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 126.914 2.085 . . . . 0.0 111.832 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.585 ' HD1' ' HB2' ' A' ' 117' ' ' LEU . 3.1 p90 -123.74 -53.23 1.78 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.07 1.748 . . . . 0.0 114.127 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.609 ' HG ' ' HG3' ' A' ' 62' ' ' LYS . 13.7 tp . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 124.318 2.009 . . . . 0.0 106.137 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG22 ' A' ' 17' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -94.1 83.08 4.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 113.57 -1.65 . . . . 0.0 107.351 167.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 p30 52.28 108.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.211 -176.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG22 HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -73.53 92.8 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.763 176.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -87.24 -173.77 4.56 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.979 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.07 -33.18 67.01 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.5 p -80.52 -54.79 5.36 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.528 0.517 . . . . 0.0 111.476 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -58.04 -28.85 64.88 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 71.2 t-105 -44.3 -47.12 9.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.804 0.842 . . . . 0.0 111.347 177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -63.18 -58.83 5.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -58.45 -35.51 72.24 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 23.0 m-85 -91.85 -47.84 7.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 -177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.622 HG13 HG11 ' A' ' 33' ' ' VAL . 62.8 t -89.11 -39.87 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 113.805 -1.543 . . . . 0.0 110.468 -172.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.784 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 8.3 mp -89.77 -32.43 16.97 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.709 -1.132 . . . . 0.0 113.175 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -123.66 43.94 2.83 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -174.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 45.1 m -158.85 125.45 4.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -0.965 . . . . 0.0 113.539 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 72.22 -40.69 0.48 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 129.737 3.215 . . . . 0.0 112.515 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.476 84.7 t 104.25 -63.82 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.793 1 C-N-CA 132.216 4.206 . . . . 0.0 109.446 -178.897 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.543 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 17.7 Cg_exo -74.67 124.37 8.73 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 N-CA-C 107.229 -1.874 . . . . 0.0 107.229 171.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 26' ' ' VAL . 17.2 t -127.1 145.83 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.942 -172.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.518 ' SD ' HG13 ' A' ' 52' ' ' ILE . 58.6 ttm -121.73 136.07 54.94 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 113.106 -1.861 . . . . 0.0 108.388 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.4 p -132.22 119.4 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.631 -1.168 . . . . 0.0 113.626 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' HB2' HG12 ' A' ' 52' ' ' ILE . 17.2 t70 -89.6 119.55 30.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.591 -2.095 . . . . 0.0 109.44 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -105.53 124.72 50.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.092 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.823 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 11.3 p-90 -128.74 152.8 48.02 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 113.468 -1.697 . . . . 0.0 109.72 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.68 31.26 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.023 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.07 -37.19 78.87 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.025 2.484 . . . . 0.0 114.45 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 3.0 p-90 -72.65 -9.81 59.05 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 17.2 p -114.99 73.9 0.85 Allowed 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -18.81 -64.09 0.01 OUTLIER Glycine 0 CA--C 1.547 2.069 0 CA-C-N 114.065 -1.425 . . . . 0.0 115.309 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' HD12 ' A' ' 47' ' ' LEU . 72.1 Cg_exo -60.98 -12.41 22.44 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 123.987 3.124 . . . . 0.0 119.403 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 26.2 m -50.04 -35.86 26.61 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -57.47 -32.69 67.21 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 172.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD12 ' HA ' ' A' ' 44' ' ' PRO . 0.8 OUTLIER -67.2 -33.35 75.2 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 45' ' ' CYS 0.337 0.8 OUTLIER -73.13 -19.21 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 115.922 1.823 . . . . 0.0 115.922 176.181 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.271 . . -62.05 -46.3 91.61 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -58.6 -48.6 14.5 Favored 'Trans proline' 0 N--CA 1.481 0.774 1 C-N-CA 125.585 4.19 . . . . 0.0 110.17 170.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG13 ' HD2' ' A' ' 106' ' ' LYS . 4.1 t -48.33 -51.28 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 123.707 0.63 . . . . 0.0 111.539 173.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' SD ' ' A' ' 34' ' ' MET . 1.5 mp -56.95 -44.92 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.04 0.936 . . . . 0.0 112.805 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.34 -30.66 69.68 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.973 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.55 -43.33 18.87 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 113.597 -1.638 . . . . 0.0 113.416 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 52' ' ' ILE . 70.5 mt -52.84 -29.54 28.48 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.31 -52.81 63.14 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 112.35 -2.204 . . . . 0.0 112.087 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -85.18 -20.61 29.94 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -60.64 -60.27 4.07 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.193 1.397 . . . . 0.0 110.089 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.938 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -104.27 73.39 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 168.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.1 m -20.15 96.49 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 109.292 -3.595 . . . . 0.0 116.026 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.58 19.88 71.39 Favored Glycine 0 N--CA 1.483 1.791 0 CA-C-N 112.43 -2.168 . . . . 0.0 116.6 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 9.8 mptt -59.4 -50.81 72.5 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.1 130.45 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.516 1.526 . . . . 0.0 111.565 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -74.4 103.23 4.69 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 52' ' ' ILE . 17.1 m -74.56 115.82 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -175.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.413 ' HB3' HG21 ' A' ' 17' ' ' VAL . 26.3 m-85 -121.95 152.91 39.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 111.317 -2.674 . . . . 0.0 111.693 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.74 121.27 11.74 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.865 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -121.6 149.27 43.4 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 117.063 2.246 . . . . 0.0 117.063 176.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -81.16 100.98 9.37 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.245 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -49.31 -38.48 27.8 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.44 -37.62 73.1 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.81 175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -85.38 -28.31 25.24 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.812 1.245 . . . . 0.0 113.864 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.0 70.52 40.69 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.94 -43.26 50.37 Favored 'Trans proline' 0 C--O 1.216 -0.575 0 C-N-CA 123.389 2.726 . . . . 0.0 112.145 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -56.31 -41.52 87.29 Favored Glycine 0 N--CA 1.488 2.138 0 C-N-CA 126.281 1.895 . . . . 0.0 113.052 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.0 mm -67.5 -53.82 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.421 0.689 . . . . 0.0 109.482 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.2 -37.99 56.54 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.404 ' HA ' HH21 ' A' ' 83' ' ' ARG . 24.7 m -60.89 -63.35 1.33 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.042 1.337 . . . . 0.0 109.042 173.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -50.58 -37.62 40.82 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.306 -1.77 . . . . 0.0 114.355 -174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -95.61 -4.95 43.6 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 47.64 36.76 5.84 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.867 1.267 . . . . 0.0 114.159 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.96 31.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . 31.4 mmt180 -54.74 -13.96 1.21 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 117.164 2.283 . . . . 0.0 117.164 -172.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.4 t -102.98 80.45 1.87 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 mt -90.95 129.26 44.73 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 111.565 -2.561 . . . . 0.0 106.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.89 142.87 72.32 Favored 'Cis proline' 0 N--CA 1.486 1.032 0 N-CA-C 118.365 2.41 . . . . 0.0 118.365 5.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.73 140.43 38.7 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 113.035 -1.893 . . . . 0.0 108.567 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG11 ' HG ' ' A' ' 109' ' ' LEU . 11.7 p -135.82 115.83 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 121.762 0.792 . . . . 0.0 111.398 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.04 149.4 27.62 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.594 -1.639 . . . . 0.0 112.702 -176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.739 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 5.4 m-85 -123.7 123.84 41.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.671 1.701 . . . . 0.0 109.416 177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 96' ' ' ARG . 83.5 m-85 -116.41 171.61 7.73 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 108.915 -3.766 . . . . 0.0 109.899 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' LYS . 29.5 tttp -160.96 97.85 1.17 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 110.68 -2.963 . . . . 0.0 105.419 173.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.651 ' HB2' HG13 ' A' ' 31' ' ' VAL . 1.9 t30 63.97 51.89 2.19 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 108.97 -3.741 . . . . 0.0 109.954 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 48.62 39.0 22.63 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-N 113.391 -1.731 . . . . 0.0 116.163 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -100.42 -43.13 6.34 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.0 OUTLIER 79.5 127.58 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.388 1.875 . . . . 0.0 115.035 176.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 92' ' ' LYS . 1.6 mptp? -114.73 -51.12 2.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 110.296 -3.138 . . . . 0.0 112.594 -172.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.739 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 1.4 tm-20 -139.32 144.9 38.48 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.665 -1.607 . . . . 0.0 112.251 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.0 p -137.36 119.32 15.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.936 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.3 mm -98.94 114.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 123.238 1.494 . . . . 0.0 111.2 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mm -87.02 141.36 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 110.004 -3.271 . . . . 0.0 106.744 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.02 54.45 37.31 Favored Glycine 0 N--CA 1.489 2.192 0 O-C-N 124.416 1.072 . . . . 0.0 111.027 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.26 90.41 1.25 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.538 1.135 . . . . 0.0 114.06 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.5 t -125.61 -55.53 0.03 OUTLIER Pre-proline 0 CA--C 1.564 1.505 0 CA-C-N 113.826 -1.534 . . . . 0.0 113.454 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.8 Cg_exo -73.08 113.93 3.91 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.49 2.127 . . . . 0.0 110.372 -175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HD2' HG13 ' A' ' 51' ' ' VAL . 55.4 tptt -36.28 -43.31 0.36 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.666 1.986 . . . . 0.0 113.532 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 p -61.86 -50.56 71.75 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 m -54.63 -45.58 73.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.826 1.25 . . . . 0.0 110.65 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 105' ' ' PRO . 10.5 mp -67.03 0.0 2.88 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 129.751 3.22 . . . . 0.0 116.324 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.938 HG23 ' HE2' ' A' ' 59' ' ' TYR . 94.1 m -120.11 -52.22 2.19 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.111 1.764 . . . . 0.0 109.711 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -44.31 -45.54 8.76 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.036 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.6 p -59.26 -22.04 60.53 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.962 2.578 . . . . 0.0 117.962 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 117' ' ' LEU . 4.6 mp -96.57 -55.76 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.28 -17.45 7.66 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 126.165 2.166 . . . . 0.0 115.531 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.283 14.4 ttmm -53.72 -38.09 63.96 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 127.713 2.405 . . . . 0.0 112.53 168.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -130.55 -45.42 1.08 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.553 ' O ' HG22 ' A' ' 113' ' ' ILE . 46.7 tp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 124.087 1.898 . . . . 0.0 107.681 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG11 HG22 ' A' ' 17' ' ' VAL . 1.8 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 119.169 3.025 . . . . 0.0 119.169 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -27.98 0.18 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 -170.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -170.23 113.82 0.47 Allowed 'General case' 0 C--N 1.318 -0.798 0 O-C-N 126.375 2.297 . . . . 0.0 110.741 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.596 ' HB ' ' HA ' ' A' ' 68' ' ' LEU . 2.0 t -87.83 128.05 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 117.958 -1.497 . . . . 0.0 109.119 176.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.2 p30 -132.95 -179.13 5.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.128 172.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.86 -43.77 63.38 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -72.36 -50.7 24.77 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 124.306 1.004 . . . . 0.0 111.279 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.2 p -63.21 -25.64 68.43 Favored 'General case' 0 C--O 1.216 -0.693 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -54.79 -47.33 74.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.658 0.783 . . . . 0.0 112.121 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG2' HD12 ' A' ' 27' ' ' LEU . 51.6 mttp -69.15 -35.74 76.66 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -86.53 -41.23 14.51 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 117.064 -1.445 . . . . 0.0 113.537 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.09 -49.28 8.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG13 HG11 ' A' ' 33' ' ' VAL . 94.2 t -81.43 -44.73 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.469 -173.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 94' ' ' GLY . 60.3 mt -88.85 -3.91 58.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.653 -1.158 . . . . 0.0 113.545 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.12 73.86 0.47 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.3 p -105.5 -7.93 18.36 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.645 -1.284 . . . . 0.0 111.738 169.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 84.16 -6.44 1.05 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 129.753 3.221 . . . . 0.0 114.579 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.6 m -118.64 153.39 52.18 Favored Pre-proline 0 N--CA 1.487 1.383 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.513 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.61 148.17 55.45 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.061 1.84 . . . . 0.0 110.907 172.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 63.1 t -125.71 143.73 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE1' HD11 ' A' ' 113' ' ' ILE . 58.3 ttm -122.05 135.46 54.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 111.989 -2.368 . . . . 0.0 109.554 168.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 3.1 m -125.84 115.96 44.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 113.183 -1.826 . . . . 0.0 111.252 177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.0 t70 -66.56 -50.68 62.35 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 82' ' ' ILE . 2.1 m-85 64.12 109.61 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 127.529 2.332 . . . . 0.0 112.357 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.451 ' HZ3' ' HA ' ' A' ' 40' ' ' PRO . 34.9 p-90 -114.44 160.46 19.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.574 -1.193 . . . . 0.0 107.906 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -120.81 146.88 44.71 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -175.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.451 ' HA ' ' HZ3' ' A' ' 38' ' ' TRP . 4.5 Cg_endo -57.5 -37.13 98.22 Favored 'Trans proline' 0 N--CA 1.476 0.5 0 C-N-CA 122.175 1.917 . . . . 0.0 112.611 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -67.34 -19.16 65.4 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 38.4 t -67.94 -27.57 66.72 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.263 1.025 . . . . 0.0 110.989 172.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.34 -137.8 13.5 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.54 34.32 0.52 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.353 2.035 . . . . 0.0 114.66 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.7 m -57.66 -24.05 54.61 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 38' ' ' TRP . 1.6 tmmt? -60.09 -51.09 71.11 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 112.668 -2.06 . . . . 0.0 110.505 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.57 -16.7 63.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.029 1.731 . . . . 0.0 113.936 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.268 3.1 pt -110.48 -61.76 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 37.12 51.26 1.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 CA-C-N 119.0 0.818 . . . . 0.0 111.928 -172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -51.9 -61.72 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.795 2.997 . . . . 0.0 114.038 -167.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG13 ' HG3' ' A' ' 106' ' ' LYS . 54.4 t -51.46 -51.41 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 124.264 1.026 . . . . 0.0 111.299 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.7 mp -61.66 -43.58 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.333 1.453 . . . . 0.0 112.095 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.93 -34.71 76.59 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.153 0.908 . . . . 0.0 113.386 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.76 -38.16 39.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.76 -1.563 . . . . 0.0 113.937 173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 93.8 mt -56.16 -26.21 49.5 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.28 78.63 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 113.317 -1.765 . . . . 0.0 111.567 174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -69.52 -39.32 77.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.173 0.989 . . . . 0.0 110.99 176.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -57.68 -48.15 80.33 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 113.766 -1.561 . . . . 0.0 112.506 -177.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.683 ' HE1' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -119.98 64.08 0.82 Allowed 'General case' 0 N--CA 1.472 0.662 0 O-C-N 124.692 1.245 . . . . 0.0 110.11 172.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.2 t -12.78 88.66 0.0 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 110.815 -2.902 . . . . 0.0 116.021 172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.51 74.99 Favored Glycine 0 C--N 1.312 -0.783 0 CA-C-N 110.375 -3.102 . . . . 0.0 115.303 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HG3' HG23 ' A' ' 63' ' ' ILE . 48.3 tptt -50.08 -59.52 3.83 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 118.687 1.243 . . . . 0.0 112.724 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' A' ' 62' ' ' LYS . 1.9 pp -129.93 126.25 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -166.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.97 94.33 3.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.366 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.46 96.92 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 110.373 -3.103 . . . . 0.0 117.773 -177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD2' HG22 ' A' ' 26' ' ' VAL . 20.5 m-85 -112.06 149.19 32.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.748 -177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.27 104.83 9.38 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.1 tp -67.66 118.54 11.07 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 112.98 -1.918 . . . . 0.0 113.899 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -77.9 88.78 4.09 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 111.425 -2.625 . . . . 0.0 105.536 175.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 85' ' ' ILE . 17.1 p -50.88 -35.35 32.33 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.648 -1.615 . . . . 0.0 115.011 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' A' ' 40' ' ' PRO . 3.3 p-10 -61.75 -31.07 71.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.229 1.812 . . . . 0.0 113.461 173.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.71 -21.19 18.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.43 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -137.03 78.04 41.67 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -68.17 -40.87 7.97 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.593 2.195 . . . . 0.0 112.639 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.56 91.71 Favored Glycine 0 N--CA 1.483 1.773 0 C-N-CA 126.43 1.967 . . . . 0.0 112.388 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 68' ' ' LEU . 49.2 mm -60.49 -54.14 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.094 0.473 . . . . 0.0 110.205 173.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.02 -36.02 65.05 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.894 -1.048 . . . . 0.0 113.11 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.5 m -63.24 -62.47 1.67 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.586 0.754 . . . . 0.0 110.285 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' HG3' ' CE2' ' A' ' 80' ' ' TYR . 11.6 pt20 -64.64 -16.76 63.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' CE2' ' HG3' ' A' ' 79' ' ' GLN . 25.9 m-85 -108.62 7.95 26.85 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.06 53.38 10.69 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 118.925 2.935 . . . . 0.0 118.925 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 37' ' ' PHE 0.316 0.2 OUTLIER -99.49 98.83 7.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 108.758 -3.837 . . . . 0.0 109.347 -174.327 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -111.98 16.7 20.19 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 109.625 -3.443 . . . . 0.0 111.16 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.7 p -114.39 -80.11 0.59 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.657 HG13 ' HB2' ' A' ' 39' ' ' ALA . 30.8 mm 74.7 114.83 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 126.904 2.082 . . . . 0.0 110.484 -172.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.9 Cg_endo -83.33 153.36 70.99 Favored 'Cis proline' 0 CA--C 1.532 0.416 0 O-C-N 123.244 1.128 . . . . 0.0 111.156 -3.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.5 HG23 HG13 ' A' ' 101' ' ' ILE . 4.8 m -129.97 97.81 4.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.969 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.4 m -90.85 114.79 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 113.858 -1.519 . . . . 0.0 113.244 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.9 mp -106.39 143.58 34.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.367 -2.197 . . . . 0.0 110.424 175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.642 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 17.1 m-85 -114.68 117.7 31.57 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 123.843 1.783 . . . . 0.0 109.43 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.671 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.6 m-85 -114.6 149.15 37.04 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 109.66 -3.427 . . . . 0.0 111.573 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 81.7 tttt -112.88 63.96 0.64 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 112.721 -2.036 . . . . 0.0 106.958 160.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 76.95 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 109.229 -3.623 . . . . 0.0 109.56 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -99.83 33.54 6.18 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.201 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -149.0 117.1 6.37 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.2 118.77 37.6 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 123.668 1.699 . . . . 0.0 112.59 -178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 17.2 mttt -84.04 -52.47 6.28 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 109.551 -3.477 . . . . 0.0 111.618 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.642 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 9.8 tp10 -151.55 145.75 25.37 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.8 t -130.96 129.02 41.61 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.296 0.998 . . . . 0.0 112.535 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.524 HD13 ' HE2' ' A' ' 90' ' ' PHE . 1.9 mp -107.79 107.78 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.784 -1.553 . . . . 0.0 107.798 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 87' ' ' THR . 2.4 mp -92.74 96.21 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 112.112 -2.313 . . . . 0.0 108.031 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.1 59.3 0.55 Allowed Glycine 0 N--CA 1.474 1.204 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.511 ' HB1' HD13 ' A' ' 109' ' ' LEU . . . -83.37 77.37 9.81 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 123.217 1.484 . . . . 0.0 113.331 -173.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.287 88.9 t -104.98 -49.02 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 CA-C-O 117.272 -1.347 . . . . 0.0 114.346 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -83.43 109.21 1.58 Allowed 'Trans proline' 0 N--CA 1.477 0.529 0 CA-C-N 122.087 1.781 . . . . 0.0 109.571 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HG3' HG13 ' A' ' 51' ' ' VAL . 61.1 tttm -37.42 -45.07 0.68 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.381 1.473 . . . . 0.0 114.734 -177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.4 p -57.95 -41.56 83.12 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.7 m -57.27 -42.92 82.51 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.908 1.283 . . . . 0.0 111.78 176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.511 HD13 ' HB1' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -98.86 43.68 1.05 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 124.524 2.107 . . . . 0.0 112.394 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.683 HG23 ' HE1' ' A' ' 59' ' ' TYR . 96.1 m -142.8 -52.39 0.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 109.795 -3.366 . . . . 0.0 106.434 173.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -44.45 -46.99 9.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 112.041 -2.345 . . . . 0.0 109.371 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.54 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.1 p -60.49 -22.03 63.07 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 118.819 2.896 . . . . 0.0 118.819 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.62 HD13 ' OH ' ' A' ' 59' ' ' TYR . 4.3 mp -89.28 -57.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 117' ' ' LEU . 44.6 mt-10 -45.39 -28.59 0.89 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.608 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 18.4 ttmm -43.43 -50.44 6.92 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 127.805 2.442 . . . . 0.0 112.466 170.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 9.3 p90 -110.27 -29.13 8.28 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 114' ' ' GLU . 32.5 tp . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 124.884 1.274 . . . . 0.0 111.923 170.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 67' ' ' LYS . 15.0 p . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 38.51 54.26 1.86 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 125.431 1.492 . . . . 0.0 112.296 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 45.52 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 111.556 -2.565 . . . . 0.0 111.749 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.252 13.5 p -78.85 65.5 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 122.834 1.302 . . . . 0.0 114.321 -179.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -62.15 167.01 4.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.893 1.677 . . . . 0.0 112.519 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.77 -44.89 4.6 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.344 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.7 p -54.76 -41.63 70.69 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 124.481 1.113 . . . . 0.0 113.282 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -96.19 -24.51 16.22 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' HH2' HG21 ' A' ' 35' ' ' VAL . 45.8 t-105 -44.52 -48.34 10.18 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -170.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.718 ' HG2' HD12 ' A' ' 27' ' ' LEU . 92.7 mttt -73.15 -2.28 20.92 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -175.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -58.72 1.92 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 112.833 -1.985 . . . . 0.0 108.059 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' HD2' HG23 ' A' ' 17' ' ' VAL . 31.3 t80 -80.05 5.03 15.27 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -171.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' HG21 ' A' ' 33' ' ' VAL . 25.3 t -133.85 -65.05 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 126.216 1.806 . . . . 0.0 106.172 170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 23' ' ' LYS . 79.1 mt -68.25 -24.97 64.96 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -171.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -126.43 63.4 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 123.99 1.852 . . . . 0.0 109.674 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -128.12 -133.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.424 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.56 67.11 9.24 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG23 ' HD3' ' A' ' 32' ' ' PRO 0.619 6.1 m 7.87 -58.49 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.186 2 CA-C-N 105.512 -5.313 . . . . 0.0 122.223 -176.361 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.673 ' HD3' HG23 ' A' ' 31' ' ' VAL . 6.5 Cg_exo -75.78 58.4 5.36 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 CA-C-N 123.115 2.148 . . . . 0.0 111.533 173.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 26' ' ' VAL . 92.1 t -69.1 143.21 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 113.697 -1.592 . . . . 0.0 111.597 -169.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.586 ' SD ' HG13 ' A' ' 63' ' ' ILE . 59.2 mtp -124.82 147.57 48.67 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 111.027 -2.806 . . . . 0.0 111.539 -173.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.7 p -150.15 131.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 112.479 -2.146 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.781 ' HB2' HG12 ' A' ' 52' ' ' ILE . 38.3 t70 -82.01 -37.7 26.17 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 57.55 122.45 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.266 1.426 . . . . 0.0 114.44 -167.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 46' ' ' LYS . 5.1 p-90 -130.98 167.69 18.61 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.432 174.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -145.14 143.17 19.63 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-N 113.083 -1.872 . . . . 0.0 109.316 -173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -56.19 -36.88 97.16 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.739 1.626 . . . . 0.0 114.986 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -75.58 14.27 0.65 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 35.5 t -95.96 -17.74 20.8 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.788 1.235 . . . . 0.0 113.357 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.51 -137.83 14.34 Favored Glycine 0 CA--C 1.537 1.447 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.86 50.54 3.6 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.305 2.003 . . . . 0.0 112.544 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 55.3 m -86.36 154.83 20.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.724 -1.126 . . . . 0.0 107.973 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 50.8 tttp 85.19 -60.12 0.08 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 128.169 2.587 . . . . 0.0 108.222 -164.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 mt -53.88 -45.96 71.21 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.585 1.554 . . . . 0.0 113.329 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 49' ' ' ALA . 24.5 pt -63.17 -67.08 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 175.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 48' ' ' ILE . . . 33.86 39.92 0.1 Allowed Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.23 -60.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 0.0 112.881 -165.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 77.2 t -54.07 -45.49 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.321 1.048 . . . . 0.0 110.349 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.781 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -62.04 -40.86 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.49 -40.13 95.71 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.742 1.258 . . . . 0.0 112.736 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.29 -47.26 71.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 113.42 -1.718 . . . . 0.0 114.925 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.615 HD22 ' OH ' ' A' ' 59' ' ' TYR . 92.5 mt -56.1 -22.63 29.23 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -61.37 -52.24 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 113.324 -1.762 . . . . 0.0 111.701 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 -19.08 25.34 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' OE2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.06 -46.24 90.21 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.028 176.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.615 ' OH ' HD22 ' A' ' 55' ' ' LEU 0.293 0.1 OUTLIER -117.65 72.06 0.83 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 123.658 1.694 . . . . 0.0 109.327 165.94 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 64.8 p -40.43 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 108.72 -3.855 . . . . 0.0 113.084 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.48 64.56 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 111.522 -2.581 . . . . 0.0 116.712 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -85.65 -43.75 13.18 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -177.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 32' ' ' PRO . 0.0 OUTLIER -125.66 165.38 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.574 -170.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB1' ' CE2' ' A' ' 66' ' ' TYR . . . -109.71 116.53 31.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 112.963 -1.926 . . . . 0.0 107.035 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -101.85 107.93 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.067 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.616 ' HB3' HG11 ' A' ' 17' ' ' VAL . 75.4 m-85 -114.14 164.6 13.64 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.154 1.909 . . . . 0.0 116.154 -174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -153.98 91.02 1.41 Allowed 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 123.162 1.458 . . . . 0.0 111.696 176.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD21 ' HB3' ' A' ' 73' ' ' ALA . 43.4 tp -73.93 141.07 45.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.147 -1.842 . . . . 0.0 112.598 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.57 87.08 2.11 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 102.561 -3.125 . . . . 0.0 102.561 171.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.483 HG21 HD11 ' A' ' 85' ' ' ILE . 13.8 t -51.85 -38.58 56.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 113.726 -1.579 . . . . 0.0 114.735 -170.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.42 -15.61 63.33 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.504 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -90.79 -33.63 15.64 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.443 1.097 . . . . 0.0 112.251 175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.599 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -124.82 75.86 65.49 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.2 -38.84 83.68 Favored 'Trans proline' 0 N--CA 1.481 0.761 0 C-N-CA 123.617 2.878 . . . . 0.0 113.492 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.95 -40.03 64.33 Favored Glycine 0 N--CA 1.482 1.718 0 C-N-CA 126.352 1.93 . . . . 0.0 113.669 -177.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.7 mm -66.68 -54.04 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.399 0.68 . . . . 0.0 110.825 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.15 61.37 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.336 -1.302 . . . . 0.0 112.57 174.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.42 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 26.6 m -60.23 -60.04 4.45 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.844 0.857 . . . . 0.0 109.807 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -58.26 -36.46 73.28 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.554 1.542 . . . . 0.0 113.741 -173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -98.61 1.51 46.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.688 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.691 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 46.8 t30 47.98 52.36 13.14 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 123.453 1.597 . . . . 0.0 112.024 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.258 0.5 OUTLIER -90.61 111.26 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.483 -1.69 . . . . 0.0 106.738 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 91.0 mtt180 -106.06 -18.74 13.94 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 109.573 -3.467 . . . . 0.0 114.19 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.507 ' OG ' HG23 ' A' ' 101' ' ' ILE . 27.8 p -120.47 147.31 45.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.536 -2.12 . . . . 0.0 112.742 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 39' ' ' ALA . 46.1 mm -118.6 116.03 35.15 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.828 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 64.1 Cg_endo -83.13 173.0 46.03 Favored 'Cis proline' 0 CA--C 1.541 0.847 0 O-C-N 124.952 2.028 . . . . 0.0 114.623 0.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 95.5 m -148.73 111.05 4.67 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 171.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 35' ' ' VAL 0.321 11.9 p -105.17 99.23 8.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 112.356 -2.202 . . . . 0.0 113.201 -175.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.697 HD23 ' HD2' ' A' ' 96' ' ' ARG . 1.4 mp -95.23 153.65 17.56 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 110.922 -2.854 . . . . 0.0 110.862 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.1 m-85 -132.21 120.55 22.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.863 -1.971 . . . . 0.0 108.183 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' PRO . 61.4 m-85 -111.96 149.44 31.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 109.44 -3.527 . . . . 0.0 109.889 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 44.8 tptt -107.68 -109.19 0.31 Allowed 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.929 1.393 . . . . 0.0 109.234 173.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.53 73.87 3.23 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 27' ' ' LEU . . . 59.28 36.24 88.06 Favored Glycine 0 CA--C 1.542 1.732 0 CA-C-N 113.273 -1.785 . . . . 0.0 113.029 -173.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -136.71 130.46 32.09 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.395 0.678 . . . . 0.0 109.998 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.697 ' HD2' HD23 ' A' ' 89' ' ' LEU . 3.2 ttp180 -96.6 105.9 18.08 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.339 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HD3' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -104.59 -35.27 7.9 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 111.779 -2.464 . . . . 0.0 115.134 -176.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.649 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 3.5 mp0 -129.42 139.1 51.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.809 0.844 . . . . 0.0 109.926 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.9 p -149.4 129.47 13.54 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.92 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.484 HG12 ' HE2' ' A' ' 90' ' ' PHE . 27.8 mm -114.62 108.05 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.367 173.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.2 mp -87.6 114.55 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 112.364 -2.198 . . . . 0.0 108.372 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.16 -55.6 3.98 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 114.197 -1.365 . . . . 0.0 115.656 175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.67 88.46 1.72 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -172.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 4.1 p -82.22 5.42 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 120.017 3.34 . . . . 0.0 120.017 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 30.1 Cg_exo -51.39 129.62 29.8 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 CA-C-N 122.282 1.851 . . . . 0.0 112.451 171.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -45.85 -54.87 7.41 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 110.811 -2.904 . . . . 0.0 113.866 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 p -62.95 -38.67 92.0 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.6 m -61.05 -42.19 98.01 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 113' ' ' ILE . 15.0 mt -68.15 -43.87 77.29 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.385 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.638 ' HA ' HD12 ' A' ' 113' ' ' ILE . 18.0 m -61.07 -42.93 99.42 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.882 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.8 -50.77 72.15 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.423 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.5 m -65.62 -25.83 67.56 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 110' ' ' THR 0.413 0.0 OUTLIER -93.86 -43.11 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 122.697 1.236 . . . . 0.0 111.862 -176.522 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.475 ' N ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt-10 -62.33 -29.22 70.3 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.025 -1.898 . . . . 0.0 113.471 -175.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -38.28 -46.04 1.05 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.581 2.752 . . . . 0.0 113.693 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p90 -104.07 -32.03 9.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.517 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.5 pp . . . . . 0 N--CA 1.479 0.981 0 CA-C-O 124.896 2.284 . . . . 0.0 111.005 172.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 17' ' ' VAL 0.256 2.9 p . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 121.197 3.777 . . . . 0.0 121.197 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 57.02 63.0 2.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.385 2.274 . . . . 0.0 108.926 -171.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.34 125.87 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 111.408 -2.633 . . . . 0.0 111.731 -173.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.56 HG22 HG11 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -86.01 113.64 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.58 177.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.636 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 67.1 m-20 -125.33 164.82 19.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.042 -2.345 . . . . 0.0 105.655 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -48.14 -38.76 18.67 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.9 p -64.81 -56.13 15.36 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 173.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 p -69.37 -24.02 63.82 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -52.83 -48.84 66.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.734 0.814 . . . . 0.0 112.128 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HG2' HD12 ' A' ' 27' ' ' LEU . 89.4 mttt -67.49 -40.57 85.23 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 117.368 2.359 . . . . 0.0 117.368 -174.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 17.1 pt-20 -81.77 -46.41 14.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.779 -1.555 . . . . 0.0 113.828 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -85.47 -34.58 21.59 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.805 HG13 HG11 ' A' ' 33' ' ' VAL . 57.9 t -96.88 -42.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.346 -174.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD23 ' HA2' ' A' ' 94' ' ' GLY . 88.0 mt -92.32 -24.04 19.07 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 mt-10 -122.89 1.04 9.28 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 120.994 3.701 . . . . 0.0 120.994 -169.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.8 p -71.63 -15.65 62.25 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 83.84 -10.7 0.92 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.325 2.25 . . . . 0.0 112.918 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.41 137.74 20.38 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 125.583 1.553 . . . . 0.0 110.676 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -53.24 147.75 34.59 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.345 2.696 . . . . 0.0 109.683 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.805 HG11 HG13 ' A' ' 26' ' ' VAL . 77.2 t -126.79 146.04 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -167.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 113' ' ' ILE . 40.7 ttm -128.9 122.45 30.31 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.47 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG12 ' HB2' ' A' ' 66' ' ' TYR . 3.6 m -123.24 113.35 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -84.34 116.41 23.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 111.287 -2.688 . . . . 0.0 109.897 177.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CD2' HD22 ' A' ' 68' ' ' LEU . 4.0 m-85 -105.23 128.06 53.24 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.813 176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.919 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 23.3 p-90 -124.01 156.24 36.82 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.141 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -131.05 137.49 30.84 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.222 -173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -57.44 -34.84 98.62 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.129 2.553 . . . . 0.0 111.839 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -71.77 -18.8 62.09 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 12.2 p -93.62 48.83 1.31 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 124.263 1.982 . . . . 0.0 108.83 169.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.01 -129.7 42.76 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 111.837 -2.438 . . . . 0.0 110.345 -173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -68.5 -34.65 19.58 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.388 2.059 . . . . 0.0 113.698 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.919 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER 54.61 -23.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 121.328 3.825 . . . . 0.0 121.328 -179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.2 mmtt -43.33 -24.84 0.11 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.322 2.249 . . . . 0.0 116.904 175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.8 mt -51.19 -23.86 3.74 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.964 1.706 . . . . 0.0 114.021 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.3 -31.85 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.877 0.471 . . . . 0.0 111.245 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.251 . . -54.11 -40.75 84.28 Favored Pre-proline 0 N--CA 1.477 0.882 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -53.94 -48.66 20.51 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 125.04 3.827 . . . . 0.0 113.548 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.3 t -52.8 -45.31 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.476 0.71 . . . . 0.0 110.82 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.73 -40.17 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.609 1.164 . . . . 0.0 112.269 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 62.4 m-20 -65.66 -29.24 69.77 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 38.1 mt-10 -75.76 -42.19 51.08 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 113.908 -1.496 . . . . 0.0 112.164 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 75.6 mt -55.27 -26.79 42.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.34 -36.52 75.85 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.223 1.409 . . . . 0.0 113.654 177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 54' ' ' GLU . 11.7 pttp -100.99 -19.17 15.96 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -57.78 -40.74 80.56 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.685 -174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.613 ' CZ ' HG13 ' A' ' 113' ' ' ILE . 7.7 p90 -129.31 39.79 3.7 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 122.247 1.022 . . . . 0.0 110.885 172.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 p 61.01 -176.76 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.765 2.026 . . . . 0.0 111.4 -172.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.46 40.05 0.75 Allowed Glycine 0 N--CA 1.484 1.869 0 C-N-CA 126.45 1.976 . . . . 0.0 114.062 -177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.855 ' HD3' HD13 ' A' ' 117' ' ' LEU . 45.8 mttm -60.91 -38.35 85.43 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.358 2.263 . . . . 0.0 113.598 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.544 HG13 ' HE2' ' A' ' 59' ' ' TYR . 1.6 pp -122.8 133.15 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.557 ' HB1' ' CZ ' ' A' ' 66' ' ' TYR . . . -73.11 91.52 1.63 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 111.584 -2.553 . . . . 0.0 109.795 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.1 m -73.27 101.46 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-N 111.52 -2.582 . . . . 0.0 113.039 -176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.578 ' HB2' HG12 ' A' ' 35' ' ' VAL . 16.0 m-85 -116.24 153.6 31.61 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.786 -176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -120.41 113.4 20.28 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.634 -1.621 . . . . 0.0 114.217 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.428 HD22 ' CD2' ' A' ' 37' ' ' PHE . 4.1 tt -95.67 116.74 29.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 113.242 -1.799 . . . . 0.0 115.067 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 19.5 m-20 -81.44 103.55 11.27 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.804 -1.998 . . . . 0.0 109.521 169.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 85' ' ' ILE . 12.1 p -49.92 -38.87 38.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.47 -28.56 69.37 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.347 1.459 . . . . 0.0 112.911 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.45 -30.73 14.9 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 114.791 -1.095 . . . . 0.0 113.851 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -125.8 73.51 70.0 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -62.78 -44.68 15.85 Favored 'Trans proline' 0 N--CA 1.485 0.986 0 C-N-CA 122.744 2.296 . . . . 0.0 111.49 174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -53.33 -39.92 59.87 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 127.143 2.306 . . . . 0.0 114.037 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -63.6 -59.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.99 0.916 . . . . 0.0 110.495 175.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.87 -38.56 61.74 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.598 176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 28.6 m -58.22 -63.49 1.25 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.293 1.037 . . . . 0.0 109.788 172.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -46.73 -44.93 19.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.198 1.799 . . . . 0.0 113.718 -175.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CZ ' ' HG2' ' A' ' 79' ' ' GLN . 31.1 m-85 -92.83 -0.2 57.29 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.361 -1.745 . . . . 0.0 114.134 -173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 46.82 32.71 1.87 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 89' ' ' LEU . 2.2 pp -86.33 35.1 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 116.59 2.07 . . . . 0.0 116.59 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -42.46 -25.31 0.08 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.873 2.469 . . . . 0.0 116.7 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.8 m -82.89 64.63 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.719 2.008 . . . . 0.0 109.432 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.553 HD13 HG21 ' A' ' 70' ' ' THR . 15.8 mt -86.49 130.74 48.13 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.76 137.01 36.3 Favored 'Cis proline' 0 N--CA 1.481 0.773 0 N-CA-C 117.141 1.939 . . . . 0.0 117.141 5.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.82 124.34 22.19 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 112.523 -2.126 . . . . 0.0 107.61 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.623 HG22 ' HE1' ' A' ' 90' ' ' PHE 0.257 9.6 p -116.56 110.76 32.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.017 -177.745 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 35' ' ' VAL . 10.2 mp -94.53 131.8 39.87 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.57 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.623 ' HE1' HG22 ' A' ' 88' ' ' VAL . 7.5 m-30 -116.99 102.95 9.78 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 124.241 1.972 . . . . 0.0 111.541 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 80.5 m-85 -102.87 148.9 25.07 Favored 'General case' 0 N--CA 1.473 0.686 1 CA-C-N 108.21 -4.086 . . . . 0.0 110.658 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . 25.2 ttpt -111.92 65.73 0.63 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 112.57 -2.105 . . . . 0.0 107.831 166.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.7 t30 57.0 95.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 109.085 -3.688 . . . . 0.0 112.504 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.474 ' HA2' HD23 ' A' ' 27' ' ' LEU . . . 60.07 17.03 43.21 Favored Glycine 0 N--CA 1.484 1.87 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.783 -175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -129.24 102.45 6.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -92.02 127.35 37.46 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.274 -171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HE3' ' HB3' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -115.67 -60.02 1.92 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 112.777 -2.011 . . . . 0.0 111.578 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -110.59 138.15 47.35 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.9 104.83 5.16 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.455 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.18 106.42 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.652 -1.613 . . . . 0.0 111.299 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mp -71.27 132.78 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 111.257 -2.702 . . . . 0.0 108.611 173.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.56 -46.4 1.96 Allowed Glycine 0 N--CA 1.481 1.636 0 CA-C-N 113.733 -1.576 . . . . 0.0 110.638 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 51.34 27.41 3.63 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG23 ' HD3' ' A' ' 105' ' ' PRO 0.356 2.2 m -95.13 -43.1 0.28 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 118.717 2.858 . . . . 0.0 118.717 -174.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.491 ' HD3' HG23 ' A' ' 104' ' ' VAL . 95.9 Cg_endo -82.0 97.31 0.91 Allowed 'Trans proline' 0 N--CA 1.482 0.823 0 CA-C-N 122.584 1.959 . . . . 0.0 109.567 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 52.1 tttp -39.64 -47.77 2.02 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.313 1.445 . . . . 0.0 114.229 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -60.72 -39.33 88.19 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.108 1.521 . . . . 0.0 115.108 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 20.0 m -60.95 -44.97 96.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.564 1.146 . . . . 0.0 112.678 174.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 8.4 mp -54.44 -48.67 71.42 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.898 173.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' HD11 ' A' ' 113' ' ' ILE . 1.8 m -62.97 -45.76 90.92 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.72 0.771 . . . . 0.0 112.522 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 108' ' ' THR . 41.5 t0 -51.13 -49.88 59.95 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 112.247 -2.251 . . . . 0.0 110.372 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.677 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 31.9 m -58.51 -34.03 70.49 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.436 3.125 . . . . 0.0 119.436 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.613 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.258 0.0 OUTLIER -77.62 -51.73 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-O 123.438 1.59 . . . . 0.0 110.807 175.439 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' OE1' HG22 ' A' ' 110' ' ' THR . 46.1 mt-10 -59.41 -30.66 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 111.481 -2.599 . . . . 0.0 111.935 -172.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' A' ' 112' ' ' SER . 23.7 ttmm -42.69 -40.48 2.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.686 2.394 . . . . 0.0 113.962 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.565 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 54.2 p90 -115.85 -45.82 2.86 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.855 HD13 ' HD3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 67' ' ' LYS . 76.7 t . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 22.28 83.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 128.585 2.754 . . . . 0.0 115.789 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.558 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 3.1 m-20 81.26 -4.53 1.66 Allowed 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 110.402 -3.09 . . . . 0.0 115.57 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.56 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.5 t 50.51 -54.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 129.099 2.96 . . . . 0.0 114.059 -167.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 66.9 148.56 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.741 2.416 . . . . 0.0 112.858 177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.06 -42.6 63.28 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.754 1.222 . . . . 0.0 113.946 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -58.36 -59.46 5.31 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.999 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 p -85.41 -7.36 58.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' HG11 ' A' ' 35' ' ' VAL . 43.2 t-105 -45.12 -51.3 10.46 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.381 1.073 . . . . 0.0 113.662 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.802 ' HG2' HD12 ' A' ' 27' ' ' LEU . 37.0 mtmt -59.49 -33.49 71.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 44.3 mt-10 -82.57 -39.59 22.07 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 113.953 -1.476 . . . . 0.0 112.85 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' O ' ' HB2' ' A' ' 29' ' ' SER . 13.5 m-30 -74.93 -41.96 58.66 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.708 HG13 HG11 ' A' ' 33' ' ' VAL . 76.0 t -103.4 -56.32 5.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.289 -171.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.802 HD12 ' HG2' ' A' ' 23' ' ' LYS . 45.6 mt -79.87 -19.46 48.21 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 118.852 -1.139 . . . . 0.0 113.396 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 1.7 mt-10 -117.78 -5.4 11.09 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 119.046 2.98 . . . . 0.0 119.046 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.603 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 70.1 m -110.7 110.27 20.86 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.68 0.752 . . . . 0.0 110.373 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 78.08 -40.12 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 109.821 -3.354 . . . . 0.0 111.347 -174.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 93' ' ' ASN 0.445 20.4 t 99.17 -55.33 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 131.474 3.91 . . . . 0.0 111.988 174.289 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -68.65 124.27 11.36 Favored 'Trans proline' 0 C--N 1.351 0.667 0 N-CA-C 106.549 -2.135 . . . . 0.0 106.549 164.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.708 HG11 HG13 ' A' ' 26' ' ' VAL . 65.7 t -137.92 147.4 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.33 -170.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.527 ' HB2' HD12 ' A' ' 63' ' ' ILE . 32.4 ttm -113.5 133.17 55.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 112.437 -2.165 . . . . 0.0 110.531 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.583 HG23 ' HB2' ' A' ' 89' ' ' LEU . 1.7 m -138.4 128.66 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.84 ' HB3' HG12 ' A' ' 52' ' ' ILE . 10.9 p-10 -112.0 109.89 19.89 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.944 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -92.63 133.91 35.52 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.076 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.927 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.9 p-90 -136.96 159.14 42.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 113.931 -1.486 . . . . 0.0 110.943 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.47 137.58 29.33 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.445 -172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -62.23 -35.31 75.01 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.25 1.966 . . . . 0.0 113.486 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -66.48 -13.92 61.52 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 116.276 1.954 . . . . 0.0 116.276 174.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.3 t -91.63 17.89 8.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.198 1.399 . . . . 0.0 110.872 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.5 -109.17 0.64 Allowed Glycine 0 CA--C 1.545 1.94 0 C-N-CA 126.325 1.917 . . . . 0.0 111.979 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -84.3 48.69 2.54 Favored 'Trans proline' 0 N--CA 1.481 0.754 0 C-N-CA 122.16 1.907 . . . . 0.0 114.407 178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.927 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.1 OUTLIER -56.57 -23.19 38.68 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 177.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -53.26 -20.03 3.77 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 119.703 3.223 . . . . 0.0 119.703 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 50' ' ' PRO . 65.8 mt -53.09 -28.04 23.27 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.7 pp -59.24 -38.61 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.26 . . -54.91 -48.69 95.2 Favored Pre-proline 0 N--CA 1.484 1.263 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 47' ' ' LEU . 53.3 Cg_exo -59.16 -47.06 18.82 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.981 3.12 . . . . 0.0 111.405 173.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.9 t -58.47 -45.09 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.229 0.331 . . . . 0.0 110.949 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.84 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.41 -39.72 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.328 1.051 . . . . 0.0 112.126 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 29.9 m-20 -63.35 -33.61 75.91 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.081 0.943 . . . . 0.0 113.288 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.88 -40.67 60.8 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.478 -1.237 . . . . 0.0 113.877 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 37.2 mt -56.46 -31.33 63.89 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.412 0.685 . . . . 0.0 111.816 172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -59.02 -55.47 34.77 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.646 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -63.76 -38.52 91.41 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.987 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.78 -38.26 69.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.911 1.284 . . . . 0.0 113.265 -176.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' OH ' ' HB3' ' A' ' 55' ' ' LEU . 2.9 p90 -124.33 55.47 1.31 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.116 1.436 . . . . 0.0 112.031 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 m -45.06 119.13 1.89 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.443 -1.708 . . . . 0.0 115.108 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.33 59.1 1.05 Allowed Glycine 0 CA--C 1.542 1.74 0 CA-C-N 111.659 -2.518 . . . . 0.0 108.704 -172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.77 ' H ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -111.74 -118.75 0.3 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -167.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.688 ' H ' ' HG2' ' A' ' 62' ' ' LYS . 3.7 pt -123.86 148.16 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 1 C-N-CA 133.221 4.608 . . . . 0.0 107.606 -172.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -72.02 133.64 45.41 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.663 177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.9 t -104.27 125.83 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 122.595 1.188 . . . . 0.0 111.762 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CD1' HG22 ' A' ' 14' ' ' VAL . 86.1 m-85 -133.72 145.97 50.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 112.279 -2.237 . . . . 0.0 113.592 -176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.599 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -125.04 110.4 14.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD12 ' HB ' ' A' ' 17' ' ' VAL . 1.8 tp -102.3 125.11 48.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.079 -2.328 . . . . 0.0 111.375 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -77.31 94.41 4.17 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.653 HG21 HG12 ' A' ' 85' ' ' ILE . 6.1 t -53.94 -37.71 64.15 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -169.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.27 -27.4 63.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.24 -1.8 . . . . 0.0 114.138 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' OE1' ' HB3' ' A' ' 16' ' ' ASP . 5.4 tm-20 -74.31 -26.81 60.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 175.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -127.54 71.35 77.26 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 123.509 0.724 . . . . 0.0 112.715 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.48 -37.95 92.33 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.731 2.954 . . . . 0.0 112.467 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.61 -31.27 63.41 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 126.941 2.21 . . . . 0.0 113.38 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.403 HG23 ' CE2' ' A' ' 80' ' ' TYR . 27.2 mm -70.03 -51.64 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.46 0.704 . . . . 0.0 111.213 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -56.9 -35.14 68.64 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.808 174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.7 m -59.96 -62.13 2.1 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 122.055 0.931 . . . . 0.0 110.107 170.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -52.92 -37.06 60.41 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.699 2.0 . . . . 0.0 113.354 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CE2' HG23 ' A' ' 76' ' ' ILE . 31.6 m-85 -102.12 6.77 41.04 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.8 t30 42.26 59.85 2.51 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.193 1.797 . . . . 0.0 112.751 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 77' ' ' ALA . 1.1 pp -113.91 119.23 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 113.323 -1.762 . . . . 0.0 108.471 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.489 ' CZ ' ' H ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -118.34 -22.43 7.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 112.054 -2.339 . . . . 0.0 111.117 178.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.2 m -102.74 94.0 5.38 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.171 1.463 . . . . 0.0 111.75 -178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.653 HG12 HG21 ' A' ' 70' ' ' THR . 3.8 mp -93.22 138.44 23.14 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 111.784 -2.462 . . . . 0.0 107.54 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -69.24 134.33 28.09 Favored 'Cis proline' 0 N--CA 1.484 0.934 0 N-CA-C 117.481 2.069 . . . . 0.0 117.481 0.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -121.0 122.28 39.77 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.218 178.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 7.1 p -116.4 115.18 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.086 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 35' ' ' VAL . 6.2 mp -106.74 149.93 26.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 113.517 -1.674 . . . . 0.0 111.506 -176.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -130.38 118.85 21.84 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 112.929 -1.941 . . . . 0.0 107.418 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -106.92 144.55 33.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 110.247 -3.161 . . . . 0.0 111.046 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -105.24 -89.51 0.42 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.149 -1.841 . . . . 0.0 110.758 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.1 t30 -108.75 73.2 0.85 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.27 39.97 83.49 Favored Glycine 0 N--CA 1.479 1.542 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.205 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -157.6 126.89 5.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.623 0.725 . . . . 0.0 111.914 -170.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -84.5 125.19 32.16 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 112.547 -2.115 . . . . 0.0 109.18 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.84 -28.77 4.77 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.262 -2.245 . . . . 0.0 114.999 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.38 133.28 48.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.179 0.992 . . . . 0.0 109.053 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.7 m -146.29 122.18 10.64 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.559 1.787 . . . . 0.0 111.715 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.73 114.51 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.731 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.441 HG21 HH22 ' A' ' 83' ' ' ARG . 1.2 pp -98.64 114.83 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 112.583 -2.099 . . . . 0.0 114.096 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.39 -56.56 4.88 Favored Glycine 0 N--CA 1.482 1.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.893 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 100.66 0.09 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.002 1.321 . . . . 0.0 114.349 -176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.655 ' HA ' HD11 ' A' ' 109' ' ' LEU 0.305 12.3 p -115.5 80.18 7.75 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 171.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -110.82 20.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 121.716 1.611 . . . . 0.0 113.724 170.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 16.8 tptt 73.75 -55.74 0.66 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.49 2.316 . . . . 0.0 112.961 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 p -51.46 -53.68 34.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 5.1 m -58.78 -41.88 87.68 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.243 1.417 . . . . 0.0 113.706 177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 104' ' ' VAL . 6.1 mp -59.56 -46.92 87.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 112.515 -2.13 . . . . 0.0 109.38 175.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -63.31 -52.1 63.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.67 1.224 . . . . 0.0 111.101 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 108' ' ' THR . 12.8 t70 -42.88 -51.95 5.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 112.437 -2.165 . . . . 0.0 111.424 176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 96.6 p -67.12 -16.07 64.1 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 119.431 3.122 . . . . 0.0 119.431 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 63' ' ' ILE 0.31 0.0 OUTLIER -94.3 -52.76 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.968 0.793 . . . . 0.0 111.364 169.208 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -59.11 -25.5 63.88 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 112.113 -2.312 . . . . 0.0 115.607 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.309 23.7 ttmm -32.91 -43.31 0.09 Allowed 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 111.722 -2.49 . . . . 0.0 113.84 157.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' A' ' 113' ' ' ILE . 18.2 p90 -127.82 -47.99 1.38 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.222 1.809 . . . . 0.0 115.466 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 62' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 123.073 1.416 . . . . 0.0 108.473 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.329 0.585 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.87 74.19 10.53 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.578 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.291 1.4 p30 69.15 96.28 0.07 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 123.062 1.411 . . . . 0.0 114.588 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 66' ' ' TYR . 9.9 p -83.66 71.34 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.267 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.19 175.94 0.66 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 112.179 -2.282 . . . . 0.0 112.174 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.05 -41.63 62.46 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 111.169 -2.741 . . . . 0.0 113.248 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.5 p -55.66 -43.96 76.77 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 7.8 p -99.56 -21.75 15.76 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HH2' HG21 ' A' ' 35' ' ' VAL . 55.1 t-105 -36.96 -58.62 0.76 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.359 1.863 . . . . 0.0 114.257 -171.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 9.8 mttm -54.24 -35.04 62.04 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . 45.3 mt-10 -91.5 -52.5 4.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.017 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' SER . 0.5 OUTLIER -74.31 0.6 13.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 117.222 2.304 . . . . 0.0 117.222 -175.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 33' ' ' VAL . 75.9 t -133.22 -65.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.373 1.869 . . . . 0.0 107.009 175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 3.2 mm? -67.83 -34.46 76.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 24' ' ' GLU . 3.6 mp0 -117.98 59.01 0.8 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-O 123.0 1.381 . . . . 0.0 111.592 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -112.49 -138.36 0.38 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.315 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -58.86 -19.7 44.2 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.789 2.436 . . . . 0.0 111.473 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.501 53.4 t 98.13 -62.16 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 130.356 3.462 . . . . 0.0 111.113 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.533 ' HG3' ' NZ ' ' A' ' 92' ' ' LYS . 39.0 Cg_exo -71.84 116.97 4.92 Favored 'Trans proline' 0 N--CA 1.488 1.148 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 167.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 64' ' ' ALA . 23.6 t -137.04 152.82 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.772 -175.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.598 ' HE1' ' HE2' ' A' ' 90' ' ' PHE . 14.6 ptp -138.38 153.27 48.92 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 125.159 1.537 . . . . 0.0 114.385 171.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 9.3 m -141.02 136.27 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.266 1.426 . . . . 0.0 111.991 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.6 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.8 p30 -89.79 -44.99 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 120.862 3.653 . . . . 0.0 120.862 -176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 70.83 120.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 127.601 2.36 . . . . 0.0 115.337 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' A' ' 48' ' ' ILE . 5.4 p-90 -133.32 159.3 40.68 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.715 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -135.7 139.14 29.98 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.667 -173.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.94 -34.47 48.01 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.428 2.085 . . . . 0.0 114.202 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -67.34 -21.04 65.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 173.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 8.7 t -71.95 -24.18 61.57 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.744 1.218 . . . . 0.0 111.359 171.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.43 -157.62 14.86 Favored Glycine 0 CA--C 1.543 1.787 0 C-N-CA 126.684 2.087 . . . . 0.0 108.366 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -78.89 73.88 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 121.684 1.589 . . . . 0.0 108.885 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -81.29 24.41 0.55 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 -174.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -64.51 -23.27 67.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.944 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 mt -41.43 -37.8 1.12 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.827 2.051 . . . . 0.0 115.345 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.2 pp -67.64 -29.16 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.33 -46.45 99.81 Favored Pre-proline 0 N--CA 1.476 0.865 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.75 -47.7 22.22 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 124.61 3.54 . . . . 0.0 112.457 171.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -59.31 -47.11 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.6 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -63.49 -37.21 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 119.059 -0.496 . . . . 0.0 111.33 175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.79 -38.51 91.23 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.59 0.709 . . . . 0.0 111.408 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -67.46 -37.67 83.3 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.819 1.248 . . . . 0.0 113.998 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 95.2 mt -55.24 -22.56 18.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.49 -56.45 14.02 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.012 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -62.89 -37.06 85.42 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.453 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -52.17 -40.7 61.83 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.981 1.426 . . . . 0.0 112.098 179.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.725 ' HB2' ' HB2' ' A' ' 62' ' ' LYS . 2.8 m-85 -119.7 40.68 3.33 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 124.687 1.242 . . . . 0.0 112.143 176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t 65.84 -65.36 0.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 127.378 2.271 . . . . 0.0 113.256 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -169.5 51.5 0.21 Allowed Glycine 0 N--CA 1.476 1.326 0 C-N-CA 126.04 1.781 . . . . 0.0 111.045 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.75 ' HE3' ' HG ' ' A' ' 117' ' ' LEU . 11.2 mtpt -79.66 -33.52 41.16 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -128.9 147.38 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.791 0.805 . . . . 0.0 111.242 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.789 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -82.06 103.71 11.88 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.907 171.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.89 106.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 112.51 -2.132 . . . . 0.0 114.787 -171.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.756 ' HB3' HG11 ' A' ' 17' ' ' VAL . 30.5 m-85 -116.31 153.84 31.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 116.57 2.063 . . . . 0.0 116.57 -176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -143.86 128.0 17.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 111.575 -2.557 . . . . 0.0 111.459 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.52 150.0 52.31 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 174.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -78.13 96.09 5.08 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 110.534 -3.03 . . . . 0.0 104.46 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.428 HG21 HD11 ' A' ' 85' ' ' ILE . 6.8 t -50.64 -38.09 44.33 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.93 -21.94 64.18 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 111.759 -2.473 . . . . 0.0 114.567 176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.83 -24.68 35.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.221 0.534 . . . . 0.0 111.35 173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.97 66.09 76.83 Favored Pre-proline 0 N--CA 1.478 0.942 0 C-N-CA 123.546 0.738 . . . . 0.0 111.101 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.76 -35.33 89.49 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.334 2.69 . . . . 0.0 111.918 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.52 -35.07 60.82 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 126.636 2.065 . . . . 0.0 112.711 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -67.36 -56.4 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.078 0.551 . . . . 0.0 110.941 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HA ' HG23 ' A' ' 82' ' ' ILE . . . -52.36 -36.09 52.86 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.236 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 89.0 m -60.54 -60.4 3.87 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 0.0 111.23 171.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -54.57 -33.44 60.24 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.085 1.754 . . . . 0.0 113.605 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' HB2' HG22 ' A' ' 82' ' ' ILE . 38.4 m-85 -101.03 4.96 42.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.667 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER 50.02 37.72 14.83 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 123.598 1.666 . . . . 0.0 112.84 -177.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 77' ' ' ALA 0.351 0.0 OUTLIER -98.1 104.5 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 123.52 1.628 . . . . 0.0 109.475 177.8 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.667 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 85.6 mtt180 -100.29 -36.23 9.34 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 108.493 -3.958 . . . . 0.0 109.099 175.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 p -79.23 127.21 31.76 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.661 1.584 . . . . 0.0 112.898 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.3 mp -115.1 126.63 27.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 173.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 83.5 Cg_endo -91.4 152.75 21.34 Favored 'Cis proline' 0 CA--C 1.544 1.017 0 O-C-N 124.868 1.983 . . . . 0.0 113.891 -1.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 82' ' ' ILE . 89.0 m -138.22 111.75 8.15 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.818 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.2 p -95.22 117.07 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.619 -178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.786 HD22 HH11 ' A' ' 96' ' ' ARG . 4.8 mt -103.77 144.02 32.03 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.311 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' HE2' ' HE1' ' A' ' 34' ' ' MET . 37.7 m-85 -119.84 123.11 42.85 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.461 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' GLU . 91.8 m-85 -117.58 147.57 42.71 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 110.869 -2.878 . . . . 0.0 111.251 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.533 ' NZ ' ' HG3' ' A' ' 32' ' ' PRO . 57.0 tptt -129.15 -100.2 0.34 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 111.951 -2.386 . . . . 0.0 112.492 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -86.94 60.29 6.14 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.588 1.155 . . . . 0.0 112.741 -172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 59.08 38.63 93.29 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-N 113.336 -1.757 . . . . 0.0 110.127 -170.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 2.8 mt-10 -146.36 155.22 42.45 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.065 -169.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.786 HH11 HD22 ' A' ' 89' ' ' LEU . 33.4 ttp180 -111.1 124.11 51.52 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.458 -1.247 . . . . 0.0 107.669 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.453 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 19.4 mmmt -101.9 -39.97 7.12 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.857 -1.974 . . . . 0.0 111.501 -171.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 12.5 tp10 -144.62 148.77 34.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.718 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -143.31 108.46 4.98 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 126.023 2.077 . . . . 0.0 110.232 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.36 97.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.399 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.66 105.26 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 112.914 -1.948 . . . . 0.0 107.767 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.13 67.0 0.92 Allowed Glycine 0 CA--C 1.533 1.186 0 CA-C-N 113.709 -1.587 . . . . 0.0 111.075 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.75 76.61 3.39 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.513 1.149 . . . . 0.0 112.464 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.252 95.0 t -114.77 -55.84 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.719 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -77.58 105.43 2.03 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 CA-C-N 122.859 2.057 . . . . 0.0 108.691 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.2 tttt -39.22 -41.19 0.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.305 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p -58.16 -42.92 87.03 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.6 m -59.72 -41.13 90.14 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.485 1.136 . . . . 0.0 113.275 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 7.1 mp -56.3 -52.11 65.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.935 173.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.455 HG22 ' OE2' ' A' ' 114' ' ' GLU . 51.8 m -55.54 -53.57 54.73 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.16 1.384 . . . . 0.0 112.833 177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -44.95 -50.35 10.61 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 111.51 -2.586 . . . . 0.0 110.351 176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.9 m -64.99 -15.0 61.79 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.485 HG23 HD23 ' A' ' 117' ' ' LEU . 3.0 mp -90.01 -59.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' OE2' HG22 ' A' ' 110' ' ' THR . 53.7 mt-10 -57.14 -17.28 10.22 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 125.909 2.006 . . . . 0.0 115.025 -178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HE2' ' HB2' ' A' ' 98' ' ' GLU 0.274 21.7 ttpp -57.38 -48.54 78.78 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.13 2.172 . . . . 0.0 112.568 172.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.486 ' HD1' ' HE3' ' A' ' 115' ' ' LYS . 45.5 p90 -116.68 -41.61 3.05 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 114.629 -1.169 . . . . 0.0 114.154 -176.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.75 ' HG ' ' HE3' ' A' ' 62' ' ' LYS . 65.7 tp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 125.441 2.543 . . . . 0.0 105.532 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.8 p . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . 0.266 30.2 mm-40 61.21 -48.65 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -166.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -127.99 95.18 4.12 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.665 HG11 ' HB3' ' A' ' 66' ' ' TYR 0.257 8.0 p -106.58 123.99 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.764 177.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.427 ' HB3' ' OE1' ' A' ' 72' ' ' GLU . 13.0 p30 -127.34 -161.03 1.05 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 111.745 -2.48 . . . . 0.0 108.973 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.11 -42.71 95.31 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -70.41 -51.11 31.94 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 120.942 0.401 . . . . 0.0 111.225 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -67.82 -22.68 65.14 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.462 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 58.1 t-105 -54.57 -46.94 73.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.204 0.602 . . . . 0.0 111.961 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -69.45 -58.57 3.82 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.57 -28.04 68.21 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' ' HB2' ' A' ' 29' ' ' SER . 48.2 m-85 -105.4 -45.18 4.53 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 118.454 2.761 . . . . 0.0 118.454 177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG22 ' CD2' ' A' ' 66' ' ' TYR . 93.4 t -83.48 -51.3 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.0 mt -77.46 -25.16 50.27 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.946 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -124.58 87.26 2.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.191 0.995 . . . . 0.0 112.362 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 44.6 t -138.96 -151.33 0.37 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.244 176.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -70.5 -2.1 12.95 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 127.786 2.434 . . . . 0.0 114.091 177.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.523 76.6 t 102.74 -68.81 0.0 OUTLIER Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 129.918 3.287 . . . . 0.0 115.617 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 23.8 Cg_exo -69.53 110.01 2.4 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 CA-C-N 123.93 2.439 . . . . 0.0 108.596 176.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 38.0 t -119.32 144.46 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.211 -1.359 . . . . 0.0 111.77 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.41 ' HE1' ' HE1' ' A' ' 90' ' ' PHE . 54.9 ttm -123.26 141.7 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 113.514 -1.675 . . . . 0.0 109.412 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.8 p -133.36 137.94 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.041 -1.436 . . . . 0.0 112.2 174.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.881 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.7 p-10 -111.24 108.75 18.5 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.523 ' HB2' ' H ' ' A' ' 87' ' ' THR . 6.3 m-85 -73.32 107.41 5.61 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.628 172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -99.34 148.59 24.02 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.132 0.968 . . . . 0.0 108.951 -177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.85 143.97 34.74 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.037 -169.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.23 -38.17 88.16 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.826 1.684 . . . . 0.0 113.898 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -71.06 -12.55 61.58 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 117.454 2.391 . . . . 0.0 117.454 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 22.8 t -73.28 -21.03 60.69 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.713 1.205 . . . . 0.0 113.149 176.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.25 -140.4 15.21 Favored Glycine 0 CA--C 1.542 1.768 0 C-N-CA 124.265 0.936 . . . . 0.0 111.104 -175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.9 34.62 0.4 Allowed 'Trans proline' 0 CA--C 1.548 1.219 0 C-N-CA 123.495 2.797 . . . . 0.0 114.967 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.1 m -60.94 -23.48 65.32 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 tmmt? -69.09 -57.83 4.89 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.585 174.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -51.72 -33.33 34.0 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.533 1.933 . . . . 0.0 115.632 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 pt -105.42 -51.55 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . . . 33.81 55.41 1.57 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 124.244 1.018 . . . . 0.0 111.93 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.76 -67.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.659 2.239 . . . . 0.0 114.082 -161.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 HG13 ' HD3' ' A' ' 106' ' ' LYS . 74.3 t -48.94 -48.6 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 124.122 0.889 . . . . 0.0 112.289 177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.881 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -61.32 -48.59 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.416 1.487 . . . . 0.0 112.39 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 8.9 m-20 -63.65 -30.34 71.46 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.38 -41.94 55.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.212 -1.358 . . . . 0.0 113.931 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD22 ' OH ' ' A' ' 59' ' ' TYR . 81.0 mt -58.35 -26.39 63.08 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.17 97.28 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 113.782 -1.554 . . . . 0.0 113.582 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 pttt -91.23 -20.87 21.46 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 175.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 3.6 tt0 -58.24 -48.55 80.05 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 111.698 175.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.616 ' OH ' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.46 73.44 0.91 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.646 -2.354 . . . . 0.0 104.646 169.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -29.56 103.22 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 110.175 -3.193 . . . . 0.0 114.882 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.73 -7.26 66.28 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.468 -1.696 . . . . 0.0 116.267 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -52.39 -59.11 4.81 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 32' ' ' PRO . 2.2 pp -119.24 109.51 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 113.38 -1.736 . . . . 0.0 113.447 -174.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.93 107.55 2.27 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 112.786 -2.006 . . . . 0.0 109.557 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.13 120.6 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.665 ' HB3' HG11 ' A' ' 17' ' ' VAL . 79.7 m-85 -119.45 149.21 42.24 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.538 ' C ' HG12 ' A' ' 17' ' ' VAL . 5.9 mptt -113.79 94.88 5.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.221 1.008 . . . . 0.0 112.524 -174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.2 tm? -79.9 112.93 17.67 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.548 -176.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -74.9 87.05 2.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.52 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 85' ' ' ILE . 33.5 p -47.09 -42.81 19.57 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -65.22 -29.46 70.26 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.889 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' OE1' ' HB3' ' A' ' 18' ' ' ASN . 24.3 tt0 -86.84 -32.13 20.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.119 0.968 . . . . 0.0 111.167 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.86 72.02 68.81 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.19 -39.63 47.07 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.083 2.522 . . . . 0.0 110.122 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -55.7 -38.07 71.04 Favored Glycine 0 N--CA 1.479 1.517 0 C-N-CA 126.993 2.235 . . . . 0.0 114.491 178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.9 mm -68.07 -52.52 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.3 -36.38 63.64 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.789 175.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 90.4 m -61.22 -64.28 1.01 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.174 1.389 . . . . 0.0 110.205 171.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -52.76 -34.82 54.73 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.369 1.467 . . . . 0.0 114.183 -173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -94.61 0.36 55.09 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.734 HD21 ' NH2' ' A' ' 83' ' ' ARG . 31.7 t30 51.34 54.67 10.71 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 124.031 1.872 . . . . 0.0 112.152 176.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.664 HD13 HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -88.99 113.15 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 112.741 -2.027 . . . . 0.0 107.582 178.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.734 ' NH2' HD21 ' A' ' 81' ' ' ASN . 96.8 mtt180 -95.36 -8.17 36.45 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 110.726 -2.943 . . . . 0.0 114.707 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 t -161.51 136.53 7.39 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 125.727 1.892 . . . . 0.0 110.699 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.664 HG23 HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -120.08 142.34 33.28 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 112.459 -2.155 . . . . 0.0 110.722 -176.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -67.56 132.74 19.51 Favored 'Cis proline' 0 C--N 1.348 0.536 0 N-CA-C 116.063 1.524 . . . . 0.0 116.063 -1.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.523 ' H ' ' HB2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -108.91 125.7 52.29 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 111.73 -2.486 . . . . 0.0 106.884 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.766 HG11 HD22 ' A' ' 109' ' ' LEU . 8.4 p -114.4 108.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 113.264 -1.789 . . . . 0.0 109.094 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.77 152.04 23.03 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.176 -2.284 . . . . 0.0 111.312 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.518 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 16.2 m-85 -125.45 118.47 25.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 125.464 1.727 . . . . 0.0 107.143 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 95.7 m-85 -111.98 146.46 37.81 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 112.947 -1.933 . . . . 0.0 113.219 -178.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 20.3 pttm -101.58 -107.38 0.24 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 112.865 -1.971 . . . . 0.0 109.273 169.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 17.2 t30 -94.96 71.88 3.42 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.937 -1.102 . . . . 0.0 108.878 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.65 31.87 64.41 Favored Glycine 0 N--CA 1.481 1.695 0 CA-C-N 112.171 -2.286 . . . . 0.0 113.171 -172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -133.83 128.22 34.26 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.966 0.906 . . . . 0.0 108.737 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -83.07 121.46 27.07 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 123.317 1.532 . . . . 0.0 113.883 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 47.6 mtmt -85.57 -48.33 9.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 110.554 -3.021 . . . . 0.0 110.685 -174.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.738 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 2.3 tp10 -149.84 146.43 27.12 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.453 1.101 . . . . 0.0 109.175 -178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 69.0 m -137.93 112.45 8.78 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 125.985 2.053 . . . . 0.0 111.857 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.443 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -101.68 103.05 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 122.673 1.225 . . . . 0.0 110.027 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -80.46 119.54 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 111.183 -2.735 . . . . 0.0 113.366 179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.61 -53.68 4.84 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 114.12 -1.4 . . . . 0.0 114.955 173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.09 96.2 1.31 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.354 1.062 . . . . 0.0 113.455 -176.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' HA ' HD21 ' A' ' 109' ' ' LEU . 10.0 p -118.13 77.06 12.34 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.429 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -94.59 -117.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 0 N-CA-C 106.853 -2.018 . . . . 0.0 106.853 171.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 51' ' ' VAL . 14.8 tptt -129.94 -68.41 0.71 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.999 0.919 . . . . 0.0 113.171 177.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.4 p -51.92 -47.49 64.63 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.531 1.532 . . . . 0.0 114.996 -174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 m -55.09 -45.25 75.43 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.766 HD22 HG11 ' A' ' 88' ' ' VAL . 2.3 mt -67.63 -43.28 80.75 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.907 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.441 HG22 ' OE1' ' A' ' 114' ' ' GLU . 24.9 m -62.31 -50.93 69.68 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 123.32 1.533 . . . . 0.0 111.282 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -48.53 -47.85 38.87 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.573 176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -68.0 -12.19 60.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 118.146 2.647 . . . . 0.0 118.146 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.486 HG13 ' CE1' ' A' ' 59' ' ' TYR 0.293 0.0 OUTLIER -93.5 -50.29 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 CA-C-O 122.61 1.195 . . . . 0.0 111.025 170.172 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.441 ' OE1' HG22 ' A' ' 110' ' ' THR . 42.0 mt-10 -60.16 -23.37 63.89 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 111.814 -2.448 . . . . 0.0 113.106 -174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.296 19.2 ttmm -47.74 -40.34 20.25 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.315 2.246 . . . . 0.0 111.451 164.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.738 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 25.5 m-85 -89.12 -46.22 8.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.54 1.536 . . . . 0.0 112.549 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.479 1.006 0 O-C-N 124.603 1.189 . . . . 0.0 112.449 177.338 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.505 HG11 ' HB ' ' A' ' 17' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 62.79 -63.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.138 2.175 . . . . 0.0 111.56 -169.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -168.55 127.06 1.11 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.896 2.078 . . . . 0.0 108.032 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.304 14.8 p -99.33 134.31 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.9 0.857 . . . . 0.0 110.728 175.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -143.95 -166.02 2.25 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 109.821 -3.354 . . . . 0.0 108.322 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.09 -42.26 76.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -65.85 -51.14 61.41 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -74.35 -8.69 57.12 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' HH2' HG21 ' A' ' 35' ' ' VAL . 50.7 t-105 -55.12 -59.54 4.62 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.22 -51.57 51.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.3 -36.15 82.71 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -106.47 -40.37 5.6 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 119.019 2.97 . . . . 0.0 119.019 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.653 HG22 ' HD2' ' A' ' 66' ' ' TYR . 95.0 t -79.51 -39.78 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.142 0.902 . . . . 0.0 109.558 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.66 -20.83 38.78 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.255 3.0 mp0 -142.35 106.48 4.75 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 120.762 0.315 . . . . 0.0 111.556 172.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 31' ' ' VAL . 4.9 t -123.44 27.63 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 121.904 0.859 . . . . 0.0 108.916 162.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 71.19 -37.54 0.4 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.17 2.588 . . . . 0.0 111.816 -170.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' H ' ' C ' ' A' ' 29' ' ' SER . 34.2 m -104.5 155.45 37.33 Favored Pre-proline 0 C--O 1.248 0.996 0 C-N-CA 127.613 2.365 . . . . 0.0 109.994 -176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.568 ' HG3' ' HG3' ' A' ' 92' ' ' LYS . 76.7 Cg_exo -48.65 154.08 3.12 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 123.793 2.995 . . . . 0.0 109.375 170.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 26' ' ' VAL . 59.8 t -126.71 146.0 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-O 122.909 1.338 . . . . 0.0 111.991 -172.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.617 ' HE1' HD12 ' A' ' 113' ' ' ILE . 43.0 ttm -127.23 127.14 43.95 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 111.973 -2.376 . . . . 0.0 110.375 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 66' ' ' TYR . 5.9 m -124.08 115.23 44.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.914 ' HB3' HG13 ' A' ' 52' ' ' ILE . 9.2 p-10 -94.74 126.01 39.77 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.74 175.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CD2' HG21 ' A' ' 82' ' ' ILE . 1.7 m-30 -96.48 112.85 24.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.327 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.897 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 33.8 p-90 -103.26 164.49 11.6 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.7 -177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -130.75 140.31 38.28 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.696 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -55.11 -36.6 93.37 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 122.839 2.359 . . . . 0.0 113.985 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -67.39 -20.01 65.48 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.01 -0.41 56.58 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.644 0.778 . . . . 0.0 112.681 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.8 -101.55 0.05 OUTLIER Glycine 0 N--CA 1.487 2.043 0 C-N-CA 126.43 1.967 . . . . 0.0 114.736 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -60.2 -4.12 2.85 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 123.368 2.712 . . . . 0.0 117.437 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.897 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -36.22 -46.43 0.52 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.391 1.876 . . . . 0.0 114.947 176.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -51.69 -67.44 0.25 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.66 1.984 . . . . 0.0 112.654 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.0 mt -69.75 -34.75 74.25 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.298 21.2 pt -71.7 -45.15 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 23.45 58.08 0.32 Allowed Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 125.086 1.355 . . . . 0.0 113.204 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -52.48 -66.05 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.344 2.696 . . . . 0.0 115.372 -165.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 106' ' ' LYS . 94.6 t -55.78 -41.3 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.914 HG13 ' HB3' ' A' ' 36' ' ' ASP . 12.8 mm -63.12 -42.02 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 175.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 27.6 t70 -59.75 -35.09 73.89 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.443 174.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.94 -47.54 51.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.991 -1.459 . . . . 0.0 113.605 174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 42.3 mt -62.55 -20.05 64.29 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 175.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.0 -57.03 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.063 1.345 . . . . 0.0 110.752 173.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -69.68 -26.48 64.39 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 21.9 mt-10 -66.23 -53.32 38.52 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.921 1.388 . . . . 0.0 112.302 172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.934 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 48.3 m-85 -110.7 54.91 0.66 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.156 0.979 . . . . 0.0 112.947 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.8 m -54.42 101.0 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.416 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.84 -34.14 5.97 Favored Glycine 0 CA--C 1.545 1.928 0 CA-C-N 112.958 -1.928 . . . . 0.0 113.716 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 16.8 mmtt -63.13 -58.38 7.44 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.6 pp -117.16 124.61 73.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.309 -1.314 . . . . 0.0 114.296 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.5 93.22 3.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.193 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.28 112.85 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 112.279 -2.237 . . . . 0.0 112.094 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.653 ' HD2' HG22 ' A' ' 26' ' ' VAL . 17.0 m-30 -128.05 152.49 47.89 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.281 1.032 . . . . 0.0 111.896 -176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.57 119.46 34.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 122.609 1.195 . . . . 0.0 113.751 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 73' ' ' ALA . 0.6 OUTLIER -85.88 120.31 27.15 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 112.164 -2.289 . . . . 0.0 112.288 178.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.1 m120 -79.32 94.7 5.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 111.724 -2.489 . . . . 0.0 107.103 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.9 p -50.52 -40.55 51.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 113.825 -1.534 . . . . 0.0 114.614 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -64.5 -26.57 68.49 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.892 175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 69' ' ' ASN . 5.0 mt-10 -89.64 -14.62 34.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.521 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -127.94 75.16 78.56 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -85.54 35.36 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.96 2.44 . . . . 0.0 112.921 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.83 -51.44 0.05 OUTLIER Glycine 0 N--CA 1.482 1.71 0 C-N-CA 126.275 1.893 . . . . 0.0 110.112 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 68' ' ' LEU . 40.3 mm -56.5 -55.82 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 122.999 0.52 . . . . 0.0 112.084 173.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.18 61.27 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.036 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.5 m -60.09 -61.15 2.82 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.779 1.632 . . . . 0.0 110.468 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 80' ' ' TYR . 13.3 pt20 -66.01 -11.49 48.43 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -172.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 79' ' ' GLN . 21.1 m-85 -110.01 7.57 23.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.062 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.833 HD21 ' NH1' ' A' ' 83' ' ' ARG . 7.2 t30 48.49 51.92 14.54 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 125.085 2.374 . . . . 0.0 112.356 173.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.786 HD13 HD11 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -79.91 110.68 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 111.819 -2.446 . . . . 0.0 107.583 -177.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.833 ' NH1' HD21 ' A' ' 81' ' ' ASN . 27.0 mtm180 -124.32 -0.02 8.29 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 110.61 -2.996 . . . . 0.0 114.544 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 101' ' ' ILE . 40.5 t -112.91 -69.27 0.87 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.786 HD11 HD13 ' A' ' 82' ' ' ILE . 36.8 mm 69.12 112.9 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.04 1.736 . . . . 0.0 109.507 -172.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 91.4 Cg_endo -77.23 136.3 43.02 Favored 'Cis proline' 0 N--CA 1.482 0.838 0 O-C-N 123.49 1.258 . . . . 0.0 113.967 -1.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 101' ' ' ILE . 81.1 m -110.33 125.63 53.38 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.569 -1.65 . . . . 0.0 106.697 173.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 11.8 p -119.95 128.11 75.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.993 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mp -112.0 144.88 40.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 113.723 -1.581 . . . . 0.0 111.637 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.583 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 60.7 m-85 -114.62 115.01 26.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 112.26 -2.246 . . . . 0.0 108.332 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -116.6 143.1 46.04 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 110.846 -2.888 . . . . 0.0 108.764 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG3' ' HG3' ' A' ' 32' ' ' PRO . 35.0 ttpt -118.26 -88.97 0.6 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 113.452 -1.703 . . . . 0.0 111.441 170.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -89.97 49.73 1.76 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -174.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.15 42.73 99.88 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -170.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -150.71 128.24 11.47 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 6.5 ptt180 -93.45 117.36 29.99 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 125.235 1.585 . . . . 0.0 110.729 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -90.33 -56.62 3.14 Favored 'General case' 0 N--CA 1.476 0.86 1 CA-C-N 108.041 -4.163 . . . . 0.0 111.7 -169.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -141.54 144.47 34.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 111.444 -174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.9 p -129.79 108.37 10.12 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 122.742 1.258 . . . . 0.0 113.002 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.1 mm -94.09 92.67 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.062 175.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.664 ' HA ' HG23 ' A' ' 87' ' ' THR . 3.1 mp -53.66 -42.56 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 112.665 -2.061 . . . . 0.0 113.538 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.04 89.93 0.54 Allowed Glycine 0 N--CA 1.476 1.356 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -76.62 69.62 3.05 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 122.43 1.11 . . . . 0.0 112.989 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.276 35.2 t -116.0 -52.29 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 113.873 -1.512 . . . . 0.0 113.638 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.07 99.05 1.25 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 CA-C-N 121.99 1.747 . . . . 0.0 109.551 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.701 ' HG2' HG13 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -41.8 -45.6 3.65 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 112.965 -1.925 . . . . 0.0 113.349 -178.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.4 p -59.24 -40.01 84.6 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 77.1 m -60.78 -43.09 98.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.354 1.061 . . . . 0.0 113.844 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.499 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.8 mp -61.89 -42.47 99.11 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.582 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.492 HG23 ' OH ' ' A' ' 59' ' ' TYR . 32.9 m -62.42 -51.58 66.97 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 123.034 1.397 . . . . 0.0 111.111 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -48.84 -46.93 42.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 112.658 -2.065 . . . . 0.0 109.906 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.8 t -59.0 -27.08 65.08 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 117.575 2.435 . . . . 0.0 117.575 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HE1' ' A' ' 34' ' ' MET 0.271 0.0 OUTLIER -83.9 -56.1 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 123.989 0.806 . . . . 0.0 111.605 172.012 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 113' ' ' ILE . 45.2 mt-10 -61.07 -19.66 61.67 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 112.101 -2.318 . . . . 0.0 113.886 -169.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.259 23.8 ttmm -49.62 -55.5 13.42 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 127.376 2.27 . . . . 0.0 112.721 167.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.583 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.2 p90 -102.3 -42.12 6.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.224 -1.353 . . . . 0.0 113.564 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 62' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 125.465 2.555 . . . . 0.0 106.669 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.95 HG11 HG22 ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 122.099 0.952 . . . . 0.0 111.813 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -93.43 79.68 4.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 63.26 106.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 112.887 -1.96 . . . . 0.0 112.051 -177.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.95 HG22 HG11 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -72.87 134.2 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.849 177.208 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.669 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 23.0 p30 -138.2 -177.33 4.79 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 112.502 -2.135 . . . . 0.0 107.799 176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -51.19 -52.57 43.01 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -59.16 -49.76 76.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.132 0.573 . . . . 0.0 112.411 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 21.3 p -72.73 -27.78 62.25 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.559 ' CZ3' HG21 ' A' ' 35' ' ' VAL . 65.9 t-105 -49.4 -45.8 46.62 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.26 0.975 . . . . 0.0 111.666 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.17 -52.34 55.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 114.998 -1.001 . . . . 0.0 113.306 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.52 -31.17 66.77 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -96.07 -53.59 3.6 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 116.638 2.088 . . . . 0.0 116.638 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG13 HG11 ' A' ' 33' ' ' VAL . 96.6 t -79.29 -42.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.153 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' HA2' ' A' ' 94' ' ' GLY . 15.1 mt -87.89 -21.44 24.96 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -132.41 54.0 1.97 Allowed 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 2.9 t -94.02 -10.54 33.21 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 70.15 0.7 3.23 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 128.384 2.674 . . . . 0.0 112.386 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.4 m -130.57 156.0 80.34 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 128.636 2.774 . . . . 0.0 107.371 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -58.06 151.78 56.08 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.839 2.359 . . . . 0.0 108.303 169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 54.8 t -125.04 148.69 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.786 0.803 . . . . 0.0 112.419 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.71 ' HE1' HD12 ' A' ' 113' ' ' ILE . 34.4 ttm -125.38 132.05 52.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 112.356 -2.202 . . . . 0.0 107.534 171.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' CZ3' ' A' ' 22' ' ' TRP . 12.5 p -132.9 136.44 55.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.875 -1.057 . . . . 0.0 112.57 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.615 ' HB2' HG12 ' A' ' 52' ' ' ILE . 2.9 t0 -125.06 132.29 53.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.972 1.367 . . . . 0.0 111.772 172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -98.04 123.57 42.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 110.765 -2.925 . . . . 0.0 111.837 -175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.783 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 7.7 p-90 -126.76 159.83 32.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.196 -1.366 . . . . 0.0 110.102 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.443 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -134.89 130.4 19.56 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.008 -174.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -56.51 -28.13 72.26 Favored 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 122.807 2.338 . . . . 0.0 113.839 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -70.66 -26.2 63.34 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 14.1 p -88.24 54.76 3.17 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 124.274 1.988 . . . . 0.0 110.516 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 59.15 -125.34 39.37 Favored Glycine 0 N--CA 1.483 1.78 0 CA-C-N 111.77 -2.468 . . . . 0.0 109.833 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -68.4 -45.95 2.31 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.362 2.042 . . . . 0.0 113.421 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.783 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER 51.94 -29.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -174.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -48.14 -26.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.609 2.077 . . . . 0.0 116.609 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 mt -40.99 -32.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.887 2.075 . . . . 0.0 116.189 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 38' ' ' TRP . 2.5 pp -63.14 -31.65 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 174.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.85 99.74 Favored Pre-proline 0 N--CA 1.486 1.339 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -58.78 -46.4 23.58 Favored 'Trans proline' 0 N--CA 1.474 0.356 0 C-N-CA 124.43 3.42 . . . . 0.0 112.082 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 t -54.87 -50.04 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.299 0.64 . . . . 0.0 110.021 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.5 mp -58.43 -43.05 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.632 1.173 . . . . 0.0 112.832 175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -65.03 -31.65 72.98 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 176.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.28 -42.33 45.89 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.778 -1.101 . . . . 0.0 112.609 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.665 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 53.6 mt -54.73 -28.53 48.91 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 173.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 65' ' ' VAL . . . -55.83 -64.96 0.68 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.889 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -65.87 -25.27 67.11 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 34.8 tt0 -59.65 -31.22 69.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.866 1.266 . . . . 0.0 114.198 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.665 ' OH ' ' HB3' ' A' ' 55' ' ' LEU 0.297 0.7 OUTLIER -124.5 38.33 4.22 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 176.443 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.6 p 35.84 -88.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 119.553 3.168 . . . . 0.0 119.553 175.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.94 83.79 1.02 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB2' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -120.73 -106.37 0.37 Allowed 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -165.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 62' ' ' LYS . 1.9 pp -138.68 153.57 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 128.356 2.662 . . . . 0.0 112.27 -165.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.29 114.65 24.09 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.408 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 56' ' ' ALA . 6.1 m -78.44 110.57 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.201 1.801 . . . . 0.0 114.098 -176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 25.5 m-85 -124.6 145.94 49.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.139 0.971 . . . . 0.0 112.933 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.6 112.51 16.9 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 123.697 1.713 . . . . 0.0 114.761 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD22 ' O ' ' A' ' 17' ' ' VAL . 2.7 tm? -86.62 115.38 24.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 111.539 -2.573 . . . . 0.0 113.184 -175.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -79.71 99.54 7.47 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.394 170.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.8 p -51.91 -40.78 61.28 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -37.53 87.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.282 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -72.72 -19.52 61.38 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.203 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.64 71.05 81.27 Favored Pre-proline 0 N--CA 1.478 0.973 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.08 42.34 1.32 Allowed 'Trans proline' 0 CA--C 1.552 1.416 0 C-N-CA 122.972 2.448 . . . . 0.0 112.267 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.26 -42.99 0.06 OUTLIER Glycine 0 N--CA 1.478 1.458 0 C-N-CA 125.905 1.717 . . . . 0.0 109.861 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -64.53 -54.77 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.162 0.985 . . . . 0.0 111.302 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.39 -37.42 62.46 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.569 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -61.08 -61.9 2.24 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.631 1.972 . . . . 0.0 109.99 172.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -54.17 -31.98 54.21 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.025 -1.443 . . . . 0.0 113.631 -175.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -104.48 10.69 35.06 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.565 1.166 . . . . 0.0 112.778 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.644 HD21 ' NH2' ' A' ' 83' ' ' ARG 0.265 2.9 t30 33.62 55.66 0.53 Allowed 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 124.636 2.16 . . . . 0.0 113.624 175.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 82' ' ' ILE . 1.6 pp -82.72 110.75 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 110.162 -3.199 . . . . 0.0 109.456 -177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' HD21 ' A' ' 81' ' ' ASN . 36.7 mtt-85 -102.03 -17.37 16.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 110.032 -3.258 . . . . 0.0 115.515 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.7 m -139.08 106.54 5.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.199 -1.819 . . . . 0.0 112.185 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.7 mt -87.5 132.2 41.62 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 110.363 -3.108 . . . . 0.0 107.3 173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -74.52 148.69 92.46 Favored 'Cis proline' 0 N--CA 1.486 1.079 0 O-C-N 124.099 1.578 . . . . 0.0 114.954 2.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 m -127.86 132.52 49.38 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.046 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.687 HG11 HD22 ' A' ' 109' ' ' LEU . 9.3 p -120.43 126.16 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 124.574 1.171 . . . . 0.0 110.559 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -119.27 141.59 48.82 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.312 -1.313 . . . . 0.0 111.306 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HE2' HD13 ' A' ' 100' ' ' ILE . 10.2 m-85 -119.5 118.01 29.93 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.408 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 73.6 m-85 -111.52 146.98 36.33 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 109.324 -3.58 . . . . 0.0 109.604 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.741 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 42.1 tptt -105.72 64.12 0.69 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 167.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.17 86.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.029 -2.35 . . . . 0.0 110.761 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 78.53 -22.44 3.27 Favored Glycine 0 N--CA 1.484 1.871 0 CA-C-N 114.741 -1.118 . . . . 0.0 115.686 -175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -99.02 92.17 5.37 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -67.47 134.8 52.03 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 113.441 -1.708 . . . . 0.0 113.997 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.741 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 30.8 mttt -113.25 -51.55 2.81 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 112.058 -2.337 . . . . 0.0 113.482 -170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.694 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 9.2 tt0 -147.29 152.35 38.12 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.306 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.0 p -136.15 114.2 11.38 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.428 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.641 HD13 ' HE2' ' A' ' 90' ' ' PHE . 3.1 mp -109.14 104.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.025 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -80.22 137.08 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-N 111.847 -2.433 . . . . 0.0 109.054 171.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.39 48.18 6.96 Favored Glycine 0 CA--C 1.544 1.844 0 C-N-CA 124.169 0.89 . . . . 0.0 111.238 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.98 73.8 4.54 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.589 1.661 . . . . 0.0 114.819 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 73.3 t -105.7 -52.78 0.1 OUTLIER Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 113.366 -1.743 . . . . 0.0 114.196 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' O ' ' HG ' ' A' ' 109' ' ' LEU . 12.8 Cg_exo -72.04 107.54 2.26 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 CA-C-N 122.174 1.812 . . . . 0.0 109.652 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.81 -47.43 10.98 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.807 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -59.51 -45.78 90.73 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.525 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 71.0 m -59.88 -39.01 83.86 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 174.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.687 HD22 HG11 ' A' ' 88' ' ' VAL . 15.4 mt -64.36 -45.91 85.74 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.943 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 59' ' ' TYR . 3.8 m -57.34 -44.8 84.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 122.853 1.311 . . . . 0.0 112.689 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 108' ' ' THR . 21.9 t70 -54.26 -47.68 72.04 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 112.586 -2.097 . . . . 0.0 111.307 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -56.76 -32.69 65.84 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.71 HD12 ' HE1' ' A' ' 34' ' ' MET 0.257 0.0 OUTLIER -84.75 -49.63 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 123.505 0.503 . . . . 0.0 111.194 177.756 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.4 -19.09 64.38 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 113.277 -1.783 . . . . 0.0 114.069 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.286 19.2 ttmm -52.83 -41.97 64.73 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.338 2.255 . . . . 0.0 110.809 165.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.694 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 20.6 m-85 -87.44 -56.37 3.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.327 1.851 . . . . 0.0 111.528 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 125.272 2.463 . . . . 0.0 109.126 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.625 HG11 HG22 ' A' ' 17' ' ' VAL . 9.9 p . . . . . 0 CA--C 1.551 1.01 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 71.93 -55.4 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 124.918 1.386 . . . . 0.0 113.563 -166.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -156.29 108.57 2.56 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HB3' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.97 71.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 112.676 -2.056 . . . . 0.0 110.331 171.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 60.2 m-20 -72.4 170.36 14.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.69 -40.28 13.0 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 p -66.64 -62.31 1.52 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.032 1.333 . . . . 0.0 111.499 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -65.7 -18.28 65.22 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.395 2.369 . . . . 0.0 117.395 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -52.78 -52.68 55.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.78 0.832 . . . . 0.0 112.278 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 41.5 mttp -62.95 -31.65 72.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 27.5 mt-10 -82.61 -46.35 13.41 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.106 0.962 . . . . 0.0 112.967 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' HA ' ' HB3' ' A' ' 29' ' ' SER . 29.9 m-85 -87.69 -34.61 18.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 HG11 ' A' ' 17' ' ' VAL . 95.7 t -93.35 -55.8 5.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.268 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 2.6 mm? -76.48 -17.95 59.02 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 34.0 mt-10 -122.03 -27.15 4.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 119.634 3.198 . . . . 0.0 119.634 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 32.2 t -105.8 112.17 25.13 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 122.567 1.175 . . . . 0.0 110.051 -165.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 64' ' ' ALA . 7.2 tt0 48.68 45.47 21.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 110.832 -2.895 . . . . 0.0 111.474 -174.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.513 3.1 m -1.59 -53.2 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 120.738 3.607 . . . . 0.0 120.738 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HB2' HG22 ' A' ' 63' ' ' ILE . 28.6 Cg_endo -65.94 107.54 1.13 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 CA-C-N 122.85 2.054 . . . . 0.0 108.926 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.768 HG22 ' HB3' ' A' ' 64' ' ' ALA . 41.7 t -123.73 155.92 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-O 122.33 1.062 . . . . 0.0 113.54 -168.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.623 ' HE1' HG21 ' A' ' 113' ' ' ILE . 47.6 ttm -130.36 147.64 52.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.943 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 13.0 m -129.43 151.79 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 114.608 -1.178 . . . . 0.0 111.28 169.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.846 ' HB3' HG12 ' A' ' 52' ' ' ILE . 22.9 p-10 -95.93 -34.73 11.7 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 117.482 2.401 . . . . 0.0 117.482 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 40.89 132.19 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.75 2.42 . . . . 0.0 116.239 -165.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.885 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 5.1 p-90 -123.12 165.43 16.84 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.548 177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -119.87 136.18 24.72 Favored Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 39' ' ' ALA . 77.9 Cg_exo -56.14 -40.11 86.92 Favored 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 123.543 2.829 . . . . 0.0 110.623 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -64.1 -21.46 66.55 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.2 t -90.82 26.15 2.16 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 122.796 1.284 . . . . 0.0 109.855 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.06 -115.12 7.51 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.03 -26.61 4.27 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.41 2.073 . . . . 0.0 115.489 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.885 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER 44.99 15.92 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 -176.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -58.94 -11.01 2.85 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.258 2.688 . . . . 0.0 118.258 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.01 -22.91 6.36 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.582 HD12 ' HG3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -69.89 -36.07 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 124.131 0.972 . . . . 0.0 111.462 175.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.269 . . -49.43 -45.48 77.38 Favored Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 117.417 2.377 . . . . 0.0 117.417 -177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -57.62 -49.78 12.45 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.52 2.813 . . . . 0.0 112.081 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG13 ' HD3' ' A' ' 106' ' ' LYS . 97.3 t -51.86 -44.64 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.386 0.674 . . . . 0.0 110.93 176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.846 HG12 ' HB3' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -64.21 -43.1 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 176.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -62.06 -31.73 72.17 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.987 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -44.94 27.98 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.123 1.369 . . . . 0.0 114.683 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.663 HD12 HD12 ' A' ' 52' ' ' ILE . 86.2 mt -54.33 -22.62 12.55 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.382 1.052 . . . . 0.0 113.522 176.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.94 -61.61 2.33 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.339 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -75.94 -22.58 55.83 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -59.42 -39.51 83.73 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.303 1.441 . . . . 0.0 113.889 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.602 ' HE2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -121.56 39.01 3.96 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 122.199 1.0 . . . . 0.0 113.329 175.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.7 m -17.32 114.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.78 61.26 1.79 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 111.526 -2.579 . . . . 0.0 109.34 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD2' ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -122.96 -116.24 0.3 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 112.608 -1.796 . . . . 0.0 115.761 -164.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.627 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 2.2 pp -115.58 144.09 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.356 2.662 . . . . 0.0 110.89 -172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.768 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -76.96 88.67 3.51 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.848 1.309 . . . . 0.0 110.984 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG22 HG23 ' A' ' 52' ' ' ILE . 13.4 p -77.35 115.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 112.789 -2.005 . . . . 0.0 113.546 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -120.86 167.56 12.4 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -137.48 130.34 30.26 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 111.102 -2.772 . . . . 0.0 111.933 175.576 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.635 ' HB3' HG23 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -131.3 140.02 49.69 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 173.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.407 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 70.3 m-20 -74.46 105.65 5.7 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.96 171.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 p -54.16 -36.64 63.56 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -56.35 -37.41 69.99 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.122 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -88.84 -12.77 40.96 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.902 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -131.86 65.87 76.55 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.998 0.919 . . . . 0.0 111.741 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.15 -42.43 29.43 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.724 2.283 . . . . 0.0 114.163 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.36 -40.27 96.35 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 126.052 1.787 . . . . 0.0 112.307 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -62.85 -52.35 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.555 0.742 . . . . 0.0 110.915 174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.93 -39.98 69.43 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.32 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.4 m -60.48 -60.9 3.08 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.743 0.652 . . . . 0.0 110.416 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -55.39 -33.57 63.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.701 1.201 . . . . 0.0 113.995 -174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -98.6 8.92 44.32 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.696 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 15.8 t30 39.16 59.5 1.67 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 124.801 2.238 . . . . 0.0 112.909 175.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.684 HD13 HD11 ' A' ' 85' ' ' ILE . 1.2 pp -79.97 111.18 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 111.616 -2.538 . . . . 0.0 108.812 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.696 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 77.1 mtt180 -121.65 -22.18 5.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 110.228 -3.169 . . . . 0.0 114.36 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -109.28 -57.06 2.21 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -168.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.684 HD11 HD13 ' A' ' 82' ' ' ILE . 4.0 mp 69.67 131.19 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 126.042 1.737 . . . . 0.0 112.773 176.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.582 ' HG3' HD12 ' A' ' 48' ' ' ILE . 17.4 Cg_exo -75.99 124.93 10.89 Favored 'Cis proline' 0 N--CA 1.486 1.047 0 CA-C-O 122.003 0.751 . . . . 0.0 111.662 -0.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 101' ' ' ILE . 25.1 m -96.8 90.28 5.21 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.967 1.841 . . . . 0.0 109.095 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 4.2 t -97.01 102.94 14.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 110.647 -2.979 . . . . 0.0 109.658 -172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 96' ' ' ARG . 6.0 mp -101.27 143.61 31.13 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.797 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.532 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 11.2 m-85 -117.57 122.28 43.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 93.0 m-85 -111.89 139.35 47.44 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.015 -2.812 . . . . 0.0 115.36 -173.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 53.5 tptt -82.32 -80.89 0.16 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.023 -2.353 . . . . 0.0 110.661 175.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.8 68.88 0.69 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' ' 27' ' ' LEU . . . 53.26 24.22 21.21 Favored Glycine 0 N--CA 1.484 1.892 0 CA-C-N 112.606 -2.088 . . . . 0.0 113.832 -166.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -119.94 136.27 54.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.603 1.561 . . . . 0.0 111.45 -172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.514 ' HG3' ' CE1' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -75.5 121.5 22.44 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 -169.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 49.7 mtmt -98.26 -46.77 5.7 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 110.579 -3.009 . . . . 0.0 109.481 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.617 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 12.4 tt0 -152.22 140.42 20.36 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.79 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.6 m -124.38 103.85 8.44 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.204 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.39 99.58 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 87' ' ' THR . 2.3 tp -53.32 -36.71 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 117.165 2.283 . . . . 0.0 117.165 -175.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -161.17 94.71 0.13 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -150.7 122.46 8.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.834 0.826 . . . . 0.0 111.5 173.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.31 -20.12 0.15 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 111.878 -2.419 . . . . 0.0 117.097 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -70.42 123.28 9.74 Favored 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 122.114 1.791 . . . . 0.0 108.774 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HD3' HG13 ' A' ' 51' ' ' VAL . 3.2 tppt? -38.6 -58.45 1.04 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 110.828 -2.896 . . . . 0.0 113.989 176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.6 p -58.38 -39.88 80.82 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.279 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 49.1 m -60.94 -42.85 99.01 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.598 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.2 mt -65.44 -48.71 71.78 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.745 -2.025 . . . . 0.0 107.292 175.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.747 ' HA ' HD12 ' A' ' 113' ' ' ILE . 5.3 m -54.18 -46.25 72.33 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.647 176.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' THR . 37.6 t70 -53.42 -53.12 55.8 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.705 176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.1 m -64.02 -27.16 68.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.747 HD12 ' HA ' ' A' ' 110' ' ' THR 0.344 0.0 OUTLIER -91.59 -37.39 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -176.558 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 110' ' ' THR . 43.8 mt-10 -60.7 -29.23 69.2 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.329 21.2 ttmm -43.78 -40.25 4.26 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 128.312 2.645 . . . . 0.0 112.008 166.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.617 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 29.5 m-85 -93.94 -40.45 10.12 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.136 1.774 . . . . 0.0 112.295 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.411 HD23 HG12 ' A' ' 113' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 123.905 1.812 . . . . 0.0 111.009 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.734 HG11 ' HB ' ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 120.962 0.41 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -83.61 65.05 8.27 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 168.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 t0 58.89 116.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.391 -174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.734 ' HB ' HG11 ' A' ' 14' ' ' VAL 0.271 9.7 p -84.18 121.34 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.312 -177.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 21.8 t-20 -127.7 166.79 17.46 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 110.422 -3.081 . . . . 0.0 105.674 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' ILE . 2.3 m-20 -41.53 -43.67 2.75 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -68.9 -53.74 19.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.5 p -65.54 -30.97 71.78 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.659 ' HH2' HG11 ' A' ' 35' ' ' VAL . 54.8 t-105 -52.74 -51.15 61.7 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.809 1.243 . . . . 0.0 112.504 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HG2' HD12 ' A' ' 27' ' ' LEU . 66.1 mttm -66.89 -12.87 60.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -105.3 -66.95 0.94 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.16 174.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 28.2 m-85 -61.25 -29.41 69.82 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 117.987 2.588 . . . . 0.0 117.987 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' HG11 ' A' ' 33' ' ' VAL . 25.1 t -113.74 -44.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 O-C-N 125.243 1.589 . . . . 0.0 110.688 -174.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD22 ' HA2' ' A' ' 94' ' ' GLY . 34.3 mt -89.98 -26.7 20.22 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 23' ' ' LYS . 4.3 mm-40 -142.42 50.9 1.47 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 31' ' ' VAL . 19.1 m 178.54 153.28 0.35 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.142 0.977 . . . . 0.0 111.502 -174.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 67.66 -41.76 0.43 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 128.512 2.725 . . . . 0.0 114.564 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.513 59.5 t 88.12 -73.93 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 131.309 3.844 . . . . 0.0 112.414 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.14 112.41 2.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 CA-C-N 124.118 2.506 . . . . 0.0 107.799 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 HG11 ' HA ' ' A' ' 26' ' ' VAL . 41.7 t -130.96 136.66 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.89 -172.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.618 ' HE1' HD12 ' A' ' 113' ' ' ILE . 54.2 ttm -117.26 139.43 50.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 112.752 -2.022 . . . . 0.0 109.625 177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HH2' ' A' ' 22' ' ' TRP . 10.5 p -136.03 136.19 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 113.172 -1.831 . . . . 0.0 113.712 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.646 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.0 p30 -103.87 138.49 40.37 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 112.415 -2.175 . . . . 0.0 109.449 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 68' ' ' LEU . 31.0 m-85 -115.38 137.0 52.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.496 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.8 ' HB3' HD11 ' A' ' 48' ' ' ILE . 10.7 p-90 -141.45 161.11 38.71 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.906 1.379 . . . . 0.0 110.575 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' CB ' HG21 ' A' ' 85' ' ' ILE . . . -135.17 134.25 21.36 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 118.736 -0.65 . . . . 0.0 111.029 -174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.39 -42.08 69.51 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.527 2.151 . . . . 0.0 112.311 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -65.23 -14.86 61.67 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.26 -13.51 46.55 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.777 1.231 . . . . 0.0 112.386 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.72 -106.49 1.97 Allowed Glycine 0 N--CA 1.482 1.709 0 C-N-CA 124.699 1.143 . . . . 0.0 110.78 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.99 23.3 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.555 2.17 . . . . 0.0 117.389 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.673 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -48.8 -30.83 6.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -41.49 -30.16 0.19 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 118.391 2.737 . . . . 0.0 118.391 176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 pp -41.37 -34.83 0.57 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.8 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.4 pp -62.94 -35.25 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.332 . . -56.04 -53.22 65.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -60.92 -45.12 21.39 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.947 3.098 . . . . 0.0 111.376 172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.0 t -51.57 -50.55 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.252 0.621 . . . . 0.0 111.03 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -62.7 -42.42 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.337 1.055 . . . . 0.0 112.82 176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.92 -28.15 69.63 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -39.73 22.63 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.996 -1.456 . . . . 0.0 114.135 173.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 62.7 mt -52.89 -27.84 20.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 175.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.45 -54.61 33.83 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.981 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -64.13 -36.77 85.13 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.123 -1.853 . . . . 0.0 114.125 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -59.11 -43.32 91.9 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.768 1.627 . . . . 0.0 113.082 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.66 ' CZ ' HG13 ' A' ' 113' ' ' ILE 0.281 11.6 p90 -127.25 62.86 1.34 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.975 1.369 . . . . 0.0 112.859 173.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.0 m 29.66 61.33 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 109.965 -3.289 . . . . 0.0 119.28 171.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.82 33.14 49.09 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 114.042 -1.435 . . . . 0.0 115.408 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.613 ' HB3' HD13 ' A' ' 117' ' ' LEU . 73.1 mttt -60.37 -36.1 77.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 59' ' ' TYR . 1.8 pp -128.84 140.54 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.605 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.37 109.16 9.85 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.686 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.06 105.41 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.286 1.834 . . . . 0.0 115.569 -172.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.466 ' CE2' ' HB3' ' A' ' 25' ' ' PHE . 17.9 m-30 -117.93 157.49 26.62 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.721 1.248 . . . . 0.0 114.235 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.35 114.99 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 112.601 -2.091 . . . . 0.0 114.446 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.594 HD12 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -105.29 117.54 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 113.852 -1.522 . . . . 0.0 114.37 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -79.06 98.35 6.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.454 -2.157 . . . . 0.0 106.58 170.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.7 p -45.42 -43.54 11.39 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.27 -29.77 69.02 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 112.66 -2.064 . . . . 0.0 113.255 176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -91.08 -27.22 18.73 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.625 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -134.75 68.41 71.55 Favored Pre-proline 0 N--CA 1.484 1.265 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -63.31 -37.36 50.63 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 123.474 2.782 . . . . 0.0 112.157 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -57.47 -31.49 63.21 Favored Glycine 0 N--CA 1.482 1.725 0 C-N-CA 127.097 2.284 . . . . 0.0 114.08 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.458 HD11 ' HA ' ' A' ' 19' ' ' ASP . 36.2 mm -68.16 -47.31 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.251 0.548 . . . . 0.0 110.408 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 82' ' ' ILE . . . -58.01 -34.63 70.24 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.043 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 46.0 m -63.59 -62.76 1.45 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.887 0.742 . . . . 0.0 110.362 172.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -51.85 -33.84 38.06 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.089 1.756 . . . . 0.0 113.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -104.03 5.14 35.14 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 51.21 34.99 12.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 77' ' ' ALA 0.297 0.6 OUTLIER -92.52 98.32 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 113.782 -1.553 . . . . 0.0 107.568 -178.53 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -98.59 -28.6 13.49 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 108.487 -3.961 . . . . 0.0 110.282 174.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 p -85.27 94.11 8.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.287 -1.779 . . . . 0.0 110.609 -176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.658 HG22 ' SG ' ' A' ' 45' ' ' CYS . 4.8 mt -100.39 127.88 31.8 Favored Pre-proline 0 CA--C 1.551 0.996 0 O-C-N 120.139 -1.6 . . . . 0.0 109.037 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 30.9 Cg_endo -83.49 146.13 54.06 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 N-CA-C 116.619 1.738 . . . . 0.0 116.619 2.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 89' ' ' LEU . 28.8 m -133.69 134.97 43.73 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.669 1.187 . . . . 0.0 107.895 173.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 52' ' ' ILE . 58.4 t -117.29 124.19 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.85 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 HG22 ' A' ' 87' ' ' THR . 7.8 mp -109.88 151.21 27.33 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.279 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HE1' HG12 ' A' ' 100' ' ' ILE . 9.1 m-85 -129.46 116.89 19.66 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 123.133 1.445 . . . . 0.0 109.614 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -113.11 149.71 33.15 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 111.544 -2.571 . . . . 0.0 112.684 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.612 ' HB2' ' HD2' ' A' ' 97' ' ' LYS . 56.0 tttm -129.09 73.82 1.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 111.178 -2.737 . . . . 0.0 106.974 169.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG13 ' A' ' 31' ' ' VAL . 9.5 t30 56.88 80.27 0.16 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 111.203 -2.726 . . . . 0.0 110.932 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.481 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 63.81 11.46 43.53 Favored Glycine 0 N--CA 1.48 1.628 0 CA-C-N 113.475 -1.693 . . . . 0.0 115.95 -176.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 43.6 mt-10 -117.22 104.25 11.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -81.61 115.96 21.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 123.429 1.585 . . . . 0.0 110.279 -177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 92' ' ' LYS . 40.9 mtpt -86.27 -49.75 7.46 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 110.897 -2.865 . . . . 0.0 110.162 -174.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 156.63 42.51 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.833 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 p -146.82 125.18 12.3 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.065 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.419 HG12 ' HE1' ' A' ' 90' ' ' PHE . 24.0 mm -100.45 94.21 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 112.939 -1.937 . . . . 0.0 110.062 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.76 124.52 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.513 172.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.01 62.13 2.7 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -82.78 80.45 8.86 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.383 -1.408 . . . . 0.0 112.696 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -116.84 -47.23 0.05 OUTLIER Pre-proline 0 N--CA 1.483 1.195 0 CA-C-N 112.313 -2.221 . . . . 0.0 113.752 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.56 107.73 2.19 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 CA-C-N 122.462 1.915 . . . . 0.0 111.997 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 18.5 tttm -39.88 -47.44 2.16 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 111.942 -2.39 . . . . 0.0 114.379 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.9 p -62.64 -39.56 94.25 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.7 m -62.15 -39.89 94.13 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.353 1.061 . . . . 0.0 111.457 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 106' ' ' LYS . 5.1 mp -60.27 -39.54 87.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.753 -1.567 . . . . 0.0 111.856 172.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.6 m -71.21 -49.09 47.15 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.012 1.387 . . . . 0.0 111.904 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -44.26 -48.76 9.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.917 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 91.0 p -62.21 -27.94 69.33 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 117.43 2.382 . . . . 0.0 117.43 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.66 HG13 ' CZ ' ' A' ' 59' ' ' TYR 0.254 0.0 OUTLIER -88.96 -47.88 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 123.779 0.675 . . . . 0.0 110.855 173.478 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -77.37 17.35 0.5 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.016 -173.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.333 25.1 ttmm -81.43 -49.01 11.15 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 131.033 3.733 . . . . 0.0 108.678 166.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -102.77 -56.33 2.26 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.591 1.557 . . . . 0.0 113.555 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 62' ' ' LYS . 1.4 pp . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 125.244 2.45 . . . . 0.0 108.891 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.731 HG11 HG23 ' A' ' 17' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.32 -37.15 86.23 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.74 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 167.31 132.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 128.174 2.59 . . . . 0.0 109.211 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG21 ' HB3' ' A' ' 66' ' ' TYR . 21.7 t -100.99 125.94 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -128.2 -178.0 4.37 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.426 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 73' ' ' ALA . 1.9 m-20 -52.38 -53.12 49.09 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.99 -47.51 86.12 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.588 0.555 . . . . 0.0 111.049 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.02 -34.72 73.64 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -37.92 -45.62 0.88 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.172 1.389 . . . . 0.0 112.849 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.556 ' HG2' HD12 ' A' ' 27' ' ' LEU . 93.1 mttt -64.3 -64.88 0.77 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.287 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 24' ' ' GLU . 8.9 pt-20 -63.17 -30.8 71.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -91.39 -34.4 14.88 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.726 2.491 . . . . 0.0 117.726 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 33' ' ' VAL . 77.0 t -108.87 -61.42 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 124.4 1.063 . . . . 0.0 109.442 -176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 23' ' ' LYS . 38.0 mt -65.98 -30.93 71.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.606 -175.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.32 74.1 0.98 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.534 1.159 . . . . 0.0 110.517 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 t -124.79 -134.83 0.27 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.489 -1.232 . . . . 0.0 109.896 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.74 -13.7 62.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.31 2.244 . . . . 0.0 112.671 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . 0.466 93.0 t 95.11 -65.08 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 130.486 3.514 . . . . 0.0 111.042 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.595 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 18.5 Cg_exo -72.29 108.74 2.56 Favored 'Trans proline' 0 C--N 1.353 0.8 0 CA-C-N 123.845 2.409 . . . . 0.0 106.133 168.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 26' ' ' VAL . 87.4 t -122.85 139.49 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.253 -174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' HD12 ' A' ' 113' ' ' ILE . 56.8 ttm -120.48 143.56 48.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 113.305 -1.77 . . . . 0.0 108.924 177.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 14.6 p -140.81 140.25 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 113.932 -1.485 . . . . 0.0 112.785 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.716 ' HB3' HG12 ' A' ' 52' ' ' ILE . 4.7 p-10 -108.81 129.75 55.39 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.094 170.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -98.78 123.76 43.21 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.76 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 39.5 p-90 -115.55 159.36 21.35 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.914 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -126.35 142.78 43.88 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.499 -171.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -58.84 -33.99 98.82 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 122.449 2.099 . . . . 0.0 113.527 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.71 -10.31 57.81 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 16.5 t -95.48 26.03 4.12 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.831 1.3 . . . . 0.0 109.015 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 44.81 -120.7 3.88 Favored Glycine 0 CA--C 1.548 2.125 0 C-N-CA 126.62 2.057 . . . . 0.0 112.736 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.59 37.88 0.67 Allowed 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.58 2.853 . . . . 0.0 113.498 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.76 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.7 OUTLIER -46.37 -39.8 10.94 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.946 2.098 . . . . 0.0 116.191 -176.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -56.71 -47.69 79.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.101 1.76 . . . . 0.0 112.13 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.2 mt -91.98 22.72 4.11 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' CYS . 7.6 mt -114.07 -61.71 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.634 -1.621 . . . . 0.0 107.388 171.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 22.39 55.11 0.24 Allowed Pre-proline 0 N--CA 1.506 2.347 0 C-N-CA 126.353 1.861 . . . . 0.0 114.162 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.21 -65.06 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.45 0 C-N-CA 122.727 2.285 . . . . 0.0 114.88 -165.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.641 HG13 ' HG2' ' A' ' 106' ' ' LYS . 59.5 t -53.33 -42.0 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 124.088 0.867 . . . . 0.0 110.827 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.47 -45.03 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.654 0.782 . . . . 0.0 112.406 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -65.0 -26.43 68.28 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -76.59 -47.76 21.39 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.61 -1.177 . . . . 0.0 112.3 172.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 51' ' ' VAL . 63.9 mt -61.96 -23.92 66.68 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.88 -53.43 56.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.736 1.614 . . . . 0.0 111.631 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -82.65 -23.78 34.08 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.4 -41.26 98.75 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.907 0.755 . . . . 0.0 110.773 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.999 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 25.6 m-85 -112.54 66.48 0.64 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.89 1.329 . . . . 0.0 111.422 172.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.48 108.9 2.14 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.455 175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.61 -25.67 27.47 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-N 111.027 -2.806 . . . . 0.0 112.692 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.999 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -67.18 -61.69 1.8 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -115.68 129.75 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 122.636 1.207 . . . . 0.0 113.404 -175.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -87.01 100.9 12.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.583 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -76.81 121.98 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 -178.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.768 ' HB3' HG21 ' A' ' 17' ' ' VAL . 81.1 m-85 -128.1 158.19 38.68 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.138 -1.392 . . . . 0.0 114.39 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' H ' HG11 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -118.38 103.97 10.29 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.911 -177.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 17' ' ' VAL . 3.1 tm? -79.93 115.31 19.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.527 1.156 . . . . 0.0 111.595 177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.411 ' HA ' ' NE1' ' A' ' 38' ' ' TRP . 2.8 m120 -83.29 94.54 7.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 112.208 -2.269 . . . . 0.0 107.647 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 p -50.55 -41.57 54.23 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.338 -1.301 . . . . 0.0 114.454 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.87 -31.52 71.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.331 1.852 . . . . 0.0 112.915 175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -87.25 -17.28 32.92 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.604 1.162 . . . . 0.0 113.531 178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' HA ' ' OD2' ' A' ' 19' ' ' ASP . . . -132.09 70.77 80.37 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.14 38.42 0.76 Allowed 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.64 2.227 . . . . 0.0 112.73 175.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -142.17 -41.78 0.06 OUTLIER Glycine 0 N--CA 1.487 2.062 0 C-N-CA 127.495 2.474 . . . . 0.0 110.331 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -65.31 -47.95 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.65 74.84 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.917 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 8.7 m -59.28 -63.48 1.29 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.2 2.6 . . . . 0.0 110.584 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 78' ' ' THR . 31.1 tt0 -53.72 -26.83 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.639 1.976 . . . . 0.0 113.317 -175.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -106.77 12.57 28.94 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.491 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 6.6 t30 41.99 53.58 4.17 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 123.947 1.832 . . . . 0.0 113.383 176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.596 HG22 HG21 ' A' ' 87' ' ' THR 0.259 0.9 OUTLIER -84.11 118.3 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.34 -179.492 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 18.3 mtm180 -113.36 -11.75 13.11 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 109.244 -3.616 . . . . 0.0 114.654 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.3 t -152.02 141.18 21.32 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.757 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 39' ' ' ALA . 33.6 mm -113.09 138.69 22.39 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-N 111.777 -2.465 . . . . 0.0 106.634 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -77.34 135.63 40.04 Favored 'Cis proline' 0 N--CA 1.473 0.31 0 O-C-N 123.975 1.513 . . . . 0.0 112.85 -1.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.596 HG21 HG22 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -100.6 118.64 37.17 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.555 -1.202 . . . . 0.0 107.886 173.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 109' ' ' LEU . 8.0 p -109.25 117.57 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.654 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.04 152.73 33.0 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.591 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' HE1' ' HE1' ' A' ' 34' ' ' MET . 24.7 m-85 -129.9 122.64 29.01 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.955 1.41 . . . . 0.0 107.517 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.51 145.59 47.79 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 112.517 -2.129 . . . . 0.0 113.794 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.642 ' HG3' ' H ' ' A' ' 93' ' ' ASN . 22.5 pttm -100.8 -104.53 0.24 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.463 -2.153 . . . . 0.0 109.542 168.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 18.6 t30 -95.12 69.37 3.2 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 120.604 -1.31 . . . . 0.0 108.521 -175.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 61.38 26.52 66.38 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-N 112.856 -1.975 . . . . 0.0 113.114 -171.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -130.5 123.61 30.07 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 122.411 -0.464 . . . . 0.0 110.492 -170.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' H ' ' HG3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -76.25 125.28 28.88 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 125.22 1.575 . . . . 0.0 110.475 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 92' ' ' LYS . 48.1 mtmt -90.98 -44.1 9.54 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 108.51 -3.95 . . . . 0.0 109.387 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -155.98 149.06 24.38 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.284 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.9 m -149.27 130.94 14.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.624 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.15 117.88 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 124.529 1.143 . . . . 0.0 108.26 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -97.55 97.7 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.999 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.46 68.07 0.57 Allowed Glycine 0 CA--C 1.537 1.454 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB1' HD11 ' A' ' 109' ' ' LEU . . . -82.21 71.52 9.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.013 1.725 . . . . 0.0 113.741 -172.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 70.1 t -107.66 -45.94 0.11 Allowed Pre-proline 0 N--CA 1.487 1.409 0 CA-C-N 112.857 -1.974 . . . . 0.0 113.824 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.77 99.66 1.31 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 CA-C-N 122.132 1.797 . . . . 0.0 110.353 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.641 ' HG2' HG13 ' A' ' 51' ' ' VAL . 13.6 tmtt? -45.55 -49.14 14.14 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 112.644 -2.071 . . . . 0.0 113.975 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.0 p -62.33 -37.6 86.23 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.3 m -63.69 -36.69 84.68 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.135 0.969 . . . . 0.0 112.609 174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 88' ' ' VAL . 6.3 mt -70.57 -37.86 74.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.702 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.78 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.4 m -64.08 -52.46 59.18 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 123.041 1.401 . . . . 0.0 110.018 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -46.2 -44.48 16.14 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 112.564 -2.107 . . . . 0.0 110.686 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 73.3 m -65.44 -13.73 59.38 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.52 HD12 ' HE1' ' A' ' 34' ' ' MET 0.267 0.0 OUTLIER -99.83 -47.36 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.59 0.709 . . . . 0.0 111.38 165.839 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 21.0 mt-10 -73.57 17.37 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 112.059 -2.337 . . . . 0.0 116.077 -175.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.343 23.1 ttmm -84.3 -44.61 13.66 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 109.906 -3.315 . . . . 0.0 109.064 171.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 113' ' ' ILE . 8.3 p90 -110.57 -50.54 2.95 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.218 1.807 . . . . 0.0 113.275 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.598 HD13 ' HG2' ' A' ' 62' ' ' LYS . 3.4 pp . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 124.213 1.959 . . . . 0.0 109.687 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' HB ' ' HD1' ' A' ' 66' ' ' TYR . 48.7 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -97.62 118.21 33.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.984 169.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 67.73 72.89 0.32 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.905 1.682 . . . . 0.0 112.358 -169.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 21' ' ' SER . 2.9 t -57.93 -51.36 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 110.523 -3.035 . . . . 0.0 112.054 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 56.51 160.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.262 1.425 . . . . 0.0 113.051 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -48.41 -34.85 11.58 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.865 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 p -59.87 -57.05 14.56 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 125.451 1.719 . . . . 0.0 113.806 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD2' ' A' ' 25' ' ' PHE . 51.3 m -76.37 -23.5 54.14 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CH2' HG21 ' A' ' 35' ' ' VAL . 45.3 t-105 -47.07 -62.63 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -170.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HD12 ' A' ' 27' ' ' LEU . 98.6 mttt -64.91 -29.29 70.22 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.05 -26.9 16.57 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.756 ' O ' ' HB2' ' A' ' 29' ' ' SER . 62.6 m-85 -101.5 -39.39 7.55 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 116.536 2.05 . . . . 0.0 116.536 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -93.74 -44.09 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.721 HD22 ' HA2' ' A' ' 94' ' ' GLY . 18.5 mt -85.36 0.92 50.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.154 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -145.94 90.35 1.97 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 8.2 t -143.92 -145.02 0.16 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.678 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . 3.9 mt-10 -61.02 -5.58 1.47 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 129.091 2.957 . . . . 0.0 114.965 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.542 22.0 t 87.19 -72.24 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 128.992 2.917 . . . . 0.0 111.983 -174.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -71.41 108.03 2.28 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 N-CA-C 105.535 -2.525 . . . . 0.0 105.535 166.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 91' ' ' PHE . 48.6 t -117.86 138.91 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.422 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 37.5 ttm -123.49 133.65 54.0 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 112.055 -2.338 . . . . 0.0 111.627 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.522 HG21 ' CH2' ' A' ' 22' ' ' TRP . 8.6 p -134.35 135.11 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 113.109 -1.86 . . . . 0.0 112.678 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.687 ' HB3' HG12 ' A' ' 52' ' ' ILE . 5.5 p-10 -110.77 133.51 53.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.476 175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.498 ' HD2' HG22 ' A' ' 70' ' ' THR . 65.4 m-85 -111.84 137.75 49.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 112.8 -2.0 . . . . 0.0 110.378 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.813 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 3.6 p-90 -142.16 161.74 37.25 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 125.327 1.642 . . . . 0.0 111.071 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -136.2 129.61 17.97 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.296 -173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.03 -36.19 95.72 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.196 2.597 . . . . 0.0 115.183 178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -65.64 -25.49 67.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.5 t -79.69 20.81 0.56 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.12 1.368 . . . . 0.0 111.754 172.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 42.4 -110.6 0.26 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.092 1.806 . . . . 0.0 111.848 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.23 39.67 0.69 Allowed 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.127 2.551 . . . . 0.0 116.204 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -56.08 -30.49 62.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.04 -1.038 . . . . 0.0 113.392 174.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -51.1 -19.46 1.13 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.352 2.261 . . . . 0.0 116.012 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.2 -37.86 3.42 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 38' ' ' TRP . 1.1 pp -56.34 -33.37 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.321 . . -60.16 -49.69 89.65 Favored Pre-proline 0 N--CA 1.479 0.987 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -57.56 -44.96 37.21 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.823 3.016 . . . . 0.0 112.191 172.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG13 ' HG2' ' A' ' 106' ' ' LYS . 78.3 t -57.58 -50.61 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 123.676 0.61 . . . . 0.0 111.379 175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.687 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.6 mp -58.03 -40.57 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.407 0.683 . . . . 0.0 111.937 175.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -67.15 -27.71 67.53 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.64 -43.95 36.08 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.146 174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD22 ' OH ' ' A' ' 59' ' ' TYR . 54.8 mt -57.55 -26.38 61.34 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.78 -53.08 62.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.464 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -84.46 -20.01 32.43 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 2.3 mt-10 -59.14 -42.03 89.73 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.437 1.095 . . . . 0.0 112.675 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.591 ' OH ' HG23 ' A' ' 110' ' ' THR . 0.5 OUTLIER -113.57 33.3 5.23 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 123.287 1.518 . . . . 0.0 112.105 175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.9 p 33.96 71.98 0.09 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 112.656 -2.066 . . . . 0.0 114.688 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.23 -83.37 0.33 Allowed Glycine 0 N--CA 1.472 1.036 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.681 ' HE3' HD13 ' A' ' 117' ' ' LEU . 31.8 mmtt 33.98 -60.81 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 129.057 2.943 . . . . 0.0 118.546 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.462 HD12 ' O ' ' A' ' 63' ' ' ILE . 2.6 pp -119.06 124.35 73.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.184 -2.28 . . . . 0.0 114.629 -171.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.678 ' HB2' ' HB2' ' A' ' 30' ' ' GLU . . . -72.92 118.49 15.93 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 111.954 -2.384 . . . . 0.0 110.047 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.469 HG12 HG23 ' A' ' 52' ' ' ILE . 2.3 m -97.42 105.94 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 126.355 1.862 . . . . 0.0 115.474 -170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . 91.7 m-85 -119.09 150.36 40.12 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.127 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -147.92 131.93 17.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.796 177.22 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 HD12 ' HB3' ' A' ' 73' ' ' ALA . 2.4 pt? -136.65 149.74 48.13 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.025 -1.898 . . . . 0.0 114.993 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -73.97 114.05 11.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.137 172.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 37' ' ' PHE . 52.6 p -54.2 -44.63 71.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -69.3 -18.18 63.81 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.608 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -82.75 -27.38 31.11 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB3' HD12 ' A' ' 68' ' ' LEU . . . -123.14 78.08 51.95 Favored Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.4 35.49 0.57 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.222 3.281 . . . . 0.0 114.571 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -133.07 -41.94 0.17 Allowed Glycine 0 N--CA 1.479 1.553 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -67.81 -54.01 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.92 -42.86 49.13 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.606 0.762 . . . . 0.0 112.483 175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 16.2 m -54.79 -62.84 1.4 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 127.164 2.185 . . . . 0.0 110.948 172.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -53.75 -35.87 61.72 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.706 1.602 . . . . 0.0 112.586 -174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -98.05 3.34 49.33 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 49.73 40.39 19.96 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.435 1.494 . . . . 0.0 113.723 -178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.428 ' C ' HD12 ' A' ' 82' ' ' ILE 0.286 0.8 OUTLIER -92.94 97.58 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 123.432 1.587 . . . . 0.0 109.429 -178.657 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -105.09 -21.45 13.27 Favored 'General case' 0 C--N 1.313 -1.007 1 CA-C-N 108.276 -4.056 . . . . 0.0 112.702 176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.4 p -111.47 86.58 2.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 123.784 1.754 . . . . 0.0 111.662 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -93.45 136.22 24.48 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 111.596 -2.547 . . . . 0.0 109.546 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -70.06 136.03 37.4 Favored 'Cis proline' 0 N--CA 1.482 0.82 0 N-CA-C 117.154 1.944 . . . . 0.0 117.154 4.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -125.63 130.7 52.15 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.622 179.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -126.71 117.73 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.673 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.5 mt -106.64 155.89 19.18 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.269 -1.787 . . . . 0.0 111.76 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HD2' ' HB3' ' A' ' 98' ' ' GLU . 32.7 m-85 -132.35 112.87 12.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 111.868 -2.424 . . . . 0.0 110.476 -178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.636 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 84.9 m-85 -107.67 143.63 35.89 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 110.318 -3.128 . . . . 0.0 108.954 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.759 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . 41.7 tptt -111.13 64.05 0.61 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 167.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 10.4 t30 59.24 86.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 110.557 -3.019 . . . . 0.0 112.327 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.721 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 71.58 -1.93 25.95 Favored Glycine 0 N--CA 1.482 1.712 0 CA-C-N 113.407 -1.724 . . . . 0.0 115.573 -175.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 92' ' ' LYS . 50.1 mt-10 -114.46 93.8 4.5 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.161 0.984 . . . . 0.0 109.148 -175.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -83.85 98.57 9.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.884 -1.962 . . . . 0.0 111.815 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.759 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -97.04 -18.87 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 110.825 -2.898 . . . . 0.0 115.068 -177.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HB3' ' HD2' ' A' ' 90' ' ' PHE . 2.2 mm-40 -141.3 147.66 38.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 175.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 m -150.86 107.35 3.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 112.929 -1.941 . . . . 0.0 110.024 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . 0.265 1.4 mp -102.31 111.95 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 124.092 1.901 . . . . 0.0 110.717 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 87' ' ' THR . 1.1 mp -96.22 136.19 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 110.216 -3.175 . . . . 0.0 111.651 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.84 -32.41 0.74 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 126.658 2.075 . . . . 0.0 116.342 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.72 103.4 0.16 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 105' ' ' PRO 0.269 5.7 p -99.34 -20.94 0.21 Allowed Pre-proline 0 CA--C 1.569 1.688 0 N-CA-C 118.075 2.62 . . . . 0.0 118.075 170.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 28.9 Cg_endo -65.75 115.9 3.66 Favored 'Trans proline' 0 C--N 1.349 0.596 0 CA-C-N 123.596 2.32 . . . . 0.0 111.364 175.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.533 ' HG2' HG13 ' A' ' 51' ' ' VAL . 1.0 OUTLIER -34.64 -51.9 0.5 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 127.105 2.162 . . . . 0.0 114.547 -175.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -55.76 -42.88 76.12 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.519 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 27.9 m -62.09 -39.83 93.79 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.899 1.333 . . . . 0.0 113.843 175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 55' ' ' LEU . 4.7 mp -62.71 -39.43 94.0 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.191 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.591 HG23 ' OH ' ' A' ' 59' ' ' TYR . 19.8 m -64.02 -48.42 76.4 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 122.372 1.082 . . . . 0.0 111.181 173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 108' ' ' THR . 26.7 t70 -46.14 -47.15 17.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.367 174.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.428 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 49.3 m -58.53 -30.49 67.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 -177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.51 HG13 ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -84.31 -55.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-O 123.254 1.502 . . . . 0.0 111.238 175.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -56.43 -29.35 61.48 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-N 110.852 -2.885 . . . . 0.0 111.853 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HE3' ' HA ' ' A' ' 112' ' ' SER 0.285 36.6 ttmt -38.86 -46.31 1.27 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.771 1.628 . . . . 0.0 114.906 166.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -107.91 -49.83 3.15 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 116.047 1.869 . . . . 0.0 116.047 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.681 HD13 ' HE3' ' A' ' 62' ' ' LYS . 4.5 pp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 114.997 1.481 . . . . 0.0 114.997 -176.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.823 HG11 ' HB ' ' A' ' 17' ' ' VAL . 9.8 p . . . . . 0 C--O 1.238 0.472 0 CA-C-O 122.961 1.363 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -86.72 84.82 7.3 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 111.112 -2.767 . . . . 0.0 107.278 163.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.77 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 111.403 -2.635 . . . . 0.0 112.908 -177.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.823 ' HB ' HG11 ' A' ' 14' ' ' VAL . 7.7 p -83.73 133.9 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.942 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -133.12 -161.79 1.17 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 112.85 -1.977 . . . . 0.0 109.836 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -42.78 95.85 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -178.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.4 p -72.05 -51.93 19.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.793 0.683 . . . . 0.0 111.986 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -67.76 -21.86 65.25 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 69.6 t-105 -50.61 -52.42 39.53 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.035 0.534 . . . . 0.0 112.434 177.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -64.23 -46.21 84.82 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.72 -35.19 39.32 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' VAL . 7.2 m-30 -95.03 -32.54 13.09 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -177.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.629 HG13 HG11 ' A' ' 33' ' ' VAL . 55.5 t -91.75 -54.89 6.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.8 mt -85.83 -28.84 24.2 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -114.37 38.36 3.09 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.5 p -101.61 -21.24 14.75 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.464 170.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 68.4 -4.07 1.19 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.48 2.712 . . . . 0.0 114.979 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.646 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.1 m -94.02 145.48 29.9 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.946 1.699 . . . . 0.0 108.527 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -50.55 126.26 17.52 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 123.01 2.473 . . . . 0.0 109.369 177.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 31' ' ' VAL . 21.0 t -115.01 143.78 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 122.811 1.291 . . . . 0.0 113.135 -171.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 113' ' ' ILE . 51.7 ttm -125.9 133.53 51.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 111.545 -2.571 . . . . 0.0 109.104 174.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 8.0 p -136.63 127.38 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 3.8 p-10 -99.8 130.24 45.98 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.682 177.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -112.54 119.5 38.37 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 25.5 p-90 -119.65 160.56 22.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.861 175.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 85' ' ' ILE . . . -130.82 138.46 33.05 Favored Pre-proline 0 N--CA 1.48 1.028 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.06 -172.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HG3' ' HB2' ' A' ' 71' ' ' ASP . 36.4 Cg_endo -62.63 -35.54 69.42 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.615 2.21 . . . . 0.0 113.219 177.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -67.03 -13.63 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 174.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 15.7 t -87.28 0.04 56.0 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.129 1.372 . . . . 0.0 111.156 171.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.62 -127.0 30.85 Favored Glycine 0 CA--C 1.543 1.841 0 C-N-CA 126.054 1.788 . . . . 0.0 109.84 -178.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -76.11 79.9 2.81 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.592 1.528 . . . . 0.0 109.506 173.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 0.5 OUTLIER -79.44 68.87 5.57 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 113.43 -1.714 . . . . 0.0 111.792 -176.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -63.32 -84.15 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.864 -1.971 . . . . 0.0 111.327 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD22 ' H ' ' A' ' 47' ' ' LEU . 4.0 mm? 19.74 -86.73 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.582 2.353 . . . . 0.0 115.77 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.739 ' HB ' ' HB2' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -46.55 -58.22 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 125.512 1.525 . . . . 0.0 114.638 175.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.312 . . -54.88 -51.53 78.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -175.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -62.31 -42.02 30.76 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 124.338 3.358 . . . . 0.0 111.941 174.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG11 HD22 ' A' ' 109' ' ' LEU . 90.9 t -61.46 -43.8 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.656 0.598 . . . . 0.0 110.425 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.736 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.9 -34.69 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.519 0.728 . . . . 0.0 112.597 174.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 66.3 m-20 -66.01 -32.41 73.87 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 173.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -75.72 -43.24 47.97 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.239 173.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 33.6 mt -61.08 -19.83 61.89 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 172.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -66.79 -56.23 11.39 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 114.585 -1.188 . . . . 0.0 111.269 175.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -71.79 -29.06 64.06 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 174.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 9.7 mt-10 -64.56 -41.71 96.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.064 0.946 . . . . 0.0 111.782 173.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.825 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 73.2 m-85 -116.25 55.84 0.8 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.682 1.229 . . . . 0.0 111.999 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.09 103.85 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 112.694 -2.048 . . . . 0.0 110.322 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.42 8.85 60.83 Favored Glycine 0 CA--C 1.543 1.81 0 CA-C-N 113.26 -1.791 . . . . 0.0 113.465 -177.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.913 ' HB3' HD21 ' A' ' 117' ' ' LEU . 11.6 mptt -105.36 -65.99 1.01 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.947 1.091 . . . . 0.0 113.947 177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 65' ' ' VAL . 2.7 pp -114.55 138.12 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 33' ' ' VAL . . . -84.46 108.95 17.53 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 112.266 -2.243 . . . . 0.0 109.871 175.121 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -88.89 115.06 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 114.025 -1.443 . . . . 0.0 114.08 -175.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 63.3 m-85 -119.97 150.1 41.07 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 113.391 -1.731 . . . . 0.0 114.064 -177.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.472 ' C ' HG12 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -124.13 103.96 8.58 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.464 -172.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 73' ' ' ALA . 1.3 tm? -94.8 107.47 19.48 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.943 1.402 . . . . 0.0 112.745 -176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -73.24 100.64 3.17 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.219 -1.809 . . . . 0.0 107.35 167.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.4 p -51.52 -37.93 51.7 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 40' ' ' PRO . 23.3 t70 -61.59 -30.79 70.9 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.16 1.384 . . . . 0.0 112.687 174.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -89.33 -11.04 44.49 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.296 0.997 . . . . 0.0 113.625 177.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 68' ' ' LEU . . . -135.84 74.02 58.81 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 178.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -81.98 40.66 1.0 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.623 2.215 . . . . 0.0 112.261 176.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.3 -46.41 0.06 OUTLIER Glycine 0 N--CA 1.48 1.584 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.275 -178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.86 -59.29 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 113.803 -1.198 . . . . 0.0 111.48 173.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.01 -43.22 40.21 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.856 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 19.3 m -57.2 -61.87 2.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.273 2.229 . . . . 0.0 111.136 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -52.36 -43.55 64.71 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 125.16 1.537 . . . . 0.0 112.123 -175.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -88.75 -4.89 58.4 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 112.631 -2.077 . . . . 0.0 114.357 -176.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.464 HD21 ' CZ ' ' A' ' 83' ' ' ARG . 8.8 t-20 45.31 37.66 2.99 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.641 1.576 . . . . 0.0 113.851 -177.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -77.85 28.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.464 ' CZ ' HD21 ' A' ' 81' ' ' ASN . 69.7 mtm180 -52.54 -21.15 3.51 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -174.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.8 t -97.41 85.23 3.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 123.835 1.778 . . . . 0.0 109.014 175.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 39' ' ' ALA . 5.6 mt -92.08 135.4 27.18 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 108.856 -3.793 . . . . 0.0 106.771 177.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HB3' HG23 ' A' ' 48' ' ' ILE . 23.3 Cg_exo -62.15 128.5 5.74 Favored 'Cis proline' 0 N--CA 1.488 1.174 0 N-CA-C 116.748 1.788 . . . . 0.0 116.748 4.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.48 140.73 51.95 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.112 174.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 52' ' ' ILE . 12.7 p -138.02 129.92 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.823 172.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.24 143.87 41.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.51 -1.677 . . . . 0.0 112.396 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 85.4 m-85 -120.84 112.82 19.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.028 -1.896 . . . . 0.0 108.534 -175.426 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 89.6 m-85 -111.31 158.15 19.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 111.57 -2.559 . . . . 0.0 109.555 -178.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 97' ' ' LYS . 40.6 tptt -103.76 -94.01 0.33 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.046 171.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -113.98 72.9 0.8 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.561 1.545 . . . . 0.0 108.625 -179.112 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 57.67 38.86 89.82 Favored Glycine 0 CA--C 1.547 2.063 0 CA-C-N 113.092 -1.867 . . . . 0.0 113.919 -172.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -144.54 124.64 13.63 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -176.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -88.41 141.91 28.16 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.732 1.27 . . . . 0.0 110.887 -175.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' A' ' 92' ' ' LYS . 8.2 mmmm -115.95 -45.22 2.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 110.795 -2.911 . . . . 0.0 112.074 -172.329 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -145.03 143.14 30.31 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.376 0.671 . . . . 0.0 110.82 -173.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -130.94 104.9 7.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.326 1.06 . . . . 0.0 109.523 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 37.9 mm -94.1 94.14 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 113.831 -1.531 . . . . 0.0 109.72 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.39 134.25 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.035 -2.802 . . . . 0.0 107.716 172.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.4 43.35 38.21 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 124.541 1.151 . . . . 0.0 110.561 -176.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 109' ' ' LEU . . . -69.05 81.76 0.32 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 122.917 1.341 . . . . 0.0 112.805 -177.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.425 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 53.3 t -117.9 -47.48 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.313 0 CA-C-N 110.956 -2.838 . . . . 0.0 112.746 177.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' H ' ' A' ' 104' ' ' VAL . 89.1 Cg_endo -78.56 98.95 1.23 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 122.207 1.824 . . . . 0.0 111.993 -178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 51' ' ' VAL . 7.4 tmtm? -37.27 -44.57 0.6 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.863 2.465 . . . . 0.0 116.267 -176.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.3 p -64.41 -40.39 95.69 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 44.5 m -58.34 -40.85 83.28 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.906 0.882 . . . . 0.0 111.78 174.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 103' ' ' ALA . 5.3 mp -62.91 -36.46 83.46 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.773 175.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.4 ' O ' HG12 ' A' ' 113' ' ' ILE . 7.2 m -70.74 -48.06 56.44 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.302 1.048 . . . . 0.0 111.193 175.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' THR . 30.0 t70 -50.04 -41.53 47.74 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 112.983 -1.917 . . . . 0.0 110.587 173.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 33.8 m -60.3 -34.03 73.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.448 HD12 ' HE1' ' A' ' 34' ' ' MET 0.255 0.0 OUTLIER -76.45 -53.74 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.891 173.19 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -56.21 -31.57 63.61 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 112.528 -2.124 . . . . 0.0 112.688 -171.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.275 24.1 ttmm -39.98 -46.82 2.15 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.344 3.058 . . . . 0.0 113.332 169.08 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.419 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 55.0 p90 -116.98 -34.25 4.47 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.44 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.913 HD21 ' HB3' ' A' ' 62' ' ' LYS . 46.2 tp . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 126.914 3.245 . . . . 0.0 105.732 176.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.8 HG21 ' H ' ' A' ' 67' ' ' LYS . 8.1 p . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -127.56 53.44 1.75 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 111.254 -2.703 . . . . 0.0 107.446 164.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.54 ' H ' HG22 ' A' ' 14' ' ' VAL . 37.8 t0 65.87 105.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.529 -167.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.83 -59.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.631 -169.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 72' ' ' GLU . 89.6 m-20 55.96 -151.91 0.39 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.886 -173.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -78.47 -11.97 59.98 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 173.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -73.98 98.2 3.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.377 1.084 . . . . 0.0 110.564 -178.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p 64.71 19.56 11.86 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 111.404 -2.635 . . . . 0.0 115.986 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' A' ' 35' ' ' VAL . 29.8 t-105 -46.78 -45.39 19.87 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' HD13 ' A' ' 27' ' ' LEU . 61.7 mttp -72.62 0.92 9.28 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.09 -57.78 1.99 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.297 172.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.63 -37.15 17.44 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 112.754 -2.021 . . . . 0.0 114.956 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.697 ' HA ' HG11 ' A' ' 33' ' ' VAL . 38.8 t -118.75 -40.77 2.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 113.018 -1.901 . . . . 0.0 110.839 -175.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD13 ' HA ' ' A' ' 23' ' ' LYS . 9.7 mp -73.91 -39.88 63.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 118.685 -1.206 . . . . 0.0 114.068 179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.34 86.73 1.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 177.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.6 p -121.59 -88.69 0.62 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.174 -1.376 . . . . 0.0 111.798 176.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -87.94 -4.06 58.86 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.429 1.092 . . . . 0.0 112.367 174.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 33' ' ' VAL 0.451 20.1 t 83.01 -68.87 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 130.092 3.357 . . . . 0.0 112.075 -172.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -72.28 118.05 5.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 123.732 2.368 . . . . 0.0 106.51 169.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.697 HG11 ' HA ' ' A' ' 26' ' ' VAL . 36.7 t -128.11 141.95 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.829 -174.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.48 ' HG3' ' CE1' ' A' ' 90' ' ' PHE . 52.3 ttm -118.27 128.25 54.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.532 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG21 ' CH2' ' A' ' 22' ' ' TRP . 14.3 p -132.57 128.39 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.68 176.288 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.798 ' HB2' HD12 ' A' ' 48' ' ' ILE . 5.3 p-10 -99.57 142.32 31.21 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.494 -1.685 . . . . 0.0 112.48 172.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -121.04 120.6 35.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.231 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 3.6 p-90 -129.86 156.57 44.17 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.39 1.056 . . . . 0.0 111.49 177.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 42' ' ' CYS . . . -134.64 144.14 49.5 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.513 -175.001 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.92 -37.21 35.24 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 121.296 1.331 . . . . 0.0 113.193 177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CH2' HD13 ' A' ' 85' ' ' ILE . 12.7 p-90 -67.16 -8.56 32.08 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 173.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 85' ' ' ILE . 53.8 t -87.66 -13.61 42.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.804 1.242 . . . . 0.0 111.351 176.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.81 -139.17 14.35 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.164 1.364 . . . . 0.0 109.995 -178.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.24 43.86 1.57 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.78 2.32 . . . . 0.0 113.15 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.62 ' O ' HG12 ' A' ' 48' ' ' ILE . 96.8 m -65.26 -15.73 62.81 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -53.48 -27.63 26.25 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.6 -1.636 . . . . 0.0 112.841 174.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -42.41 -40.31 2.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.776 2.031 . . . . 0.0 114.389 173.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.798 HD12 ' HB2' ' A' ' 36' ' ' ASP . 28.2 pt -59.37 -32.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.256 . . -60.3 -47.31 96.89 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.38 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.96 -46.51 19.05 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.055 3.17 . . . . 0.0 111.369 169.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 106' ' ' LYS . 41.4 t -52.12 -49.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 123.139 0.575 . . . . 0.0 112.101 174.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.707 HG12 ' HB3' ' A' ' 36' ' ' ASP . 1.7 mp -64.15 -38.48 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 177.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -63.22 -39.97 96.15 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.292 1.044 . . . . 0.0 111.276 176.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.706 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 28.1 mt-10 -67.63 -39.84 84.64 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.965 177.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD22 ' OH ' ' A' ' 59' ' ' TYR . 93.7 mt -56.29 -26.31 51.55 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 175.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.58 88.36 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.539 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.706 ' HE2' ' HA ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -83.78 -23.08 31.64 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 174.133 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.5 -58.07 10.18 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 126.246 2.216 . . . . 0.0 107.214 177.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.794 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -107.09 76.94 1.12 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.816 1.293 . . . . 0.0 108.57 166.007 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.6 m -31.45 108.47 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.109 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.11 14.82 74.02 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 111.439 -2.619 . . . . 0.0 115.706 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -70.82 -45.8 63.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -177.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -132.72 136.39 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.076 -175.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.52 118.01 22.39 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.985 173.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 m -94.57 117.42 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 -170.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' A' ' 14' ' ' VAL . 98.1 m-85 -120.61 143.51 48.62 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 113.236 -1.802 . . . . 0.0 114.086 -176.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.8 ' H ' HG21 ' A' ' 14' ' ' VAL . 15.3 mmtt -120.52 119.61 33.44 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.367 -177.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -113.07 118.13 33.92 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.557 -1.656 . . . . 0.0 113.948 -177.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.62 97.31 7.16 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.073 -1.876 . . . . 0.0 106.432 171.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 p -48.96 -43.17 39.56 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -174.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.23 -28.79 67.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 114.246 -1.343 . . . . 0.0 113.38 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HB3' ' OD1' ' A' ' 18' ' ' ASN . 1.8 tt0 -75.41 -26.79 58.68 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.537 175.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.49 79.52 35.31 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 121.054 0.454 . . . . 0.0 112.213 176.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.37 -37.33 73.02 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.227 2.618 . . . . 0.0 111.644 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.36 88.32 Favored Glycine 0 CA--C 1.543 1.79 0 C-N-CA 126.502 2.001 . . . . 0.0 112.938 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.4 mm -66.74 -53.47 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.57 -38.74 60.52 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.352 175.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.512 ' HA ' HH22 ' A' ' 83' ' ' ARG . 53.5 m -61.75 -61.07 2.77 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.001 0.92 . . . . 0.0 110.882 174.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -53.03 -32.69 48.13 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 124.637 1.211 . . . . 0.0 114.22 -173.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -98.54 0.91 45.93 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.409 -1.723 . . . . 0.0 114.187 -178.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 50.75 43.46 28.07 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.551 1.167 . . . . 0.0 114.146 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.281 1.1 pp -96.51 106.73 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 123.722 1.725 . . . . 0.0 109.161 -177.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.512 HH22 ' HA ' ' A' ' 78' ' ' THR . 10.2 mmp_? -107.92 -28.68 9.46 Favored 'General case' 0 N--CA 1.481 1.086 1 CA-C-N 108.29 -4.05 . . . . 0.0 112.514 -178.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 p -111.85 94.92 5.19 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 124.318 2.008 . . . . 0.0 113.239 -178.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.582 HD13 ' CH2' ' A' ' 41' ' ' TRP . 3.8 mp -85.77 132.77 43.2 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 109.744 -3.389 . . . . 0.0 107.392 177.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.715 ' HB3' HD13 ' A' ' 48' ' ' ILE . 19.6 Cg_exo -73.78 144.48 81.14 Favored 'Cis proline' 0 N--CA 1.491 1.337 0 O-C-N 123.883 1.465 . . . . 0.0 113.773 3.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -130.95 129.46 42.18 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.211 -1.359 . . . . 0.0 110.764 176.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.42 HG11 HD11 ' A' ' 52' ' ' ILE . 7.2 m -115.69 127.44 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 O-C-N 124.003 0.814 . . . . 0.0 110.63 172.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.41 121.57 43.19 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 113.297 -1.774 . . . . 0.0 110.987 -178.124 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.579 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 18.2 m-30 -110.78 99.94 8.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 124.127 1.918 . . . . 0.0 111.842 -174.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 54.6 m-85 -86.71 155.1 20.5 Favored 'General case' 0 C--N 1.313 -1.008 1 CA-C-N 106.19 -5.004 . . . . 0.0 112.655 -178.367 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -161.78 99.55 1.12 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 109.029 -3.714 . . . . 0.0 103.994 169.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.413 ' O ' ' HG3' ' A' ' 95' ' ' GLU . 6.3 t30 59.6 68.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.918 1 CA-C-N 108.112 -4.131 . . . . 0.0 112.063 -179.982 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.58 41.6 9.54 Favored Glycine 0 N--CA 1.48 1.583 0 C-N-CA 126.078 1.799 . . . . 0.0 116.311 178.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' ASN . 31.1 mt-10 -113.98 -25.96 8.34 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -176.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . 0.352 0.0 OUTLIER 40.25 56.13 2.65 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 -174.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -37.65 65.58 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 110.453 -3.067 . . . . 0.0 114.012 -178.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -119.76 107.91 13.77 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 122.311 1.053 . . . . 0.0 113.179 175.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.7 m -117.51 101.74 8.62 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.025 -2.352 . . . . 0.0 109.247 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -98.35 94.51 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.387 -1.733 . . . . 0.0 109.853 -173.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 101' ' ' ILE . 1.8 pp -78.13 108.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 111.661 -2.518 . . . . 0.0 111.146 174.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.16 51.04 1.02 Allowed Glycine 0 N--CA 1.483 1.808 0 CA-C-N 113.102 -1.863 . . . . 0.0 109.132 -176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 77.79 7.16 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.621 -1.79 . . . . 0.0 113.459 -173.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.5 t -112.74 -48.23 0.06 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 113.593 -1.64 . . . . 0.0 114.426 177.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -79.2 111.73 2.94 Favored 'Trans proline' 0 C--N 1.349 0.604 0 CA-C-N 121.402 1.536 . . . . 0.0 111.556 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 51' ' ' VAL . 80.4 tttt -45.1 -48.53 12.01 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 111.821 -2.445 . . . . 0.0 111.586 177.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.3 p -55.56 -44.63 77.01 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.197 1.399 . . . . 0.0 114.594 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.6 m -63.29 -40.78 98.32 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 175.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.7 mt -63.25 -44.05 96.29 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 113.818 -1.537 . . . . 0.0 107.865 176.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.794 HG23 ' HE2' ' A' ' 59' ' ' TYR . 20.2 m -56.4 -57.03 14.03 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-O 122.175 0.988 . . . . 0.0 110.923 176.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -44.49 -48.51 10.1 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 112.994 -1.912 . . . . 0.0 111.253 177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.466 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 28.4 m -61.9 -26.71 68.32 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 118.995 2.961 . . . . 0.0 118.995 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 113' ' ' ILE 0.338 0.0 OUTLIER -80.93 -53.19 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.73 0.776 . . . . 0.0 109.995 173.691 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 117' ' ' LEU . 35.0 mt-10 -63.46 -15.68 58.43 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 111.81 -2.45 . . . . 0.0 113.438 -170.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 112' ' ' SER 0.251 24.7 ttmm -55.1 -46.52 75.54 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 129.68 3.192 . . . . 0.0 112.278 169.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.579 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 50.0 p90 -116.23 -40.41 3.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.266 1.026 . . . . 0.0 112.691 -178.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 114' ' ' GLU . 49.0 tp . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 125.079 2.371 . . . . 0.0 105.758 179.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' HB ' HG22 ' A' ' 17' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 tm0? -46.34 -45.39 17.58 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 111.845 -2.434 . . . . 0.0 114.174 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -138.66 85.19 2.07 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 113.606 -1.634 . . . . 0.0 112.337 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 14' ' ' VAL . 1.6 t -65.29 123.23 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 113.194 -1.821 . . . . 0.0 110.17 -178.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 5.3 p30 -111.58 170.72 7.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.489 179.467 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.08 -39.95 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 115.564 1.69 . . . . 0.0 115.564 -178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -50.22 39.5 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.796 ' HB2' ' HD2' ' A' ' 25' ' ' PHE . 58.9 p -66.27 -25.94 67.11 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HH2' HG11 ' A' ' 35' ' ' VAL . 55.8 t-105 -49.56 -50.09 43.71 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.835 0.854 . . . . 0.0 112.134 176.471 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 58.0 mttp -64.32 -58.36 6.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 178.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -64.96 -37.29 87.15 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.796 ' HD2' ' HB2' ' A' ' 21' ' ' SER . 48.2 m-85 -95.34 -18.54 20.69 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 119.21 3.041 . . . . 0.0 119.21 -177.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' HG11 ' A' ' 33' ' ' VAL . 93.4 t -113.07 -48.95 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 123.974 0.796 . . . . 0.0 110.03 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.621 ' HG ' ' HA3' ' A' ' 94' ' ' GLY . 9.9 mp -85.52 -20.58 29.44 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -177.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -128.86 63.53 1.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.685 1.231 . . . . 0.0 110.165 176.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.3 t -122.11 -166.26 1.38 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.287 -1.324 . . . . 0.0 112.033 -168.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 32' ' ' PRO . 9.8 pt-20 -66.15 -6.93 15.02 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 128.266 2.626 . . . . 0.0 114.056 177.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' A' ' 93' ' ' ASN 0.514 35.6 t 99.35 -69.86 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.527 3.531 . . . . 0.0 114.931 175.019 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 30' ' ' GLU . 93.5 Cg_endo -72.67 108.62 2.59 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 123.433 2.262 . . . . 0.0 109.379 175.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 66' ' ' TYR . 47.3 t -129.43 144.85 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.278 -173.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.3 ptp -139.7 161.46 37.48 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.734 1.271 . . . . 0.0 112.272 173.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.596 HG11 ' HH2' ' A' ' 22' ' ' TRP . 11.5 p -147.24 140.3 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 113.202 -1.817 . . . . 0.0 114.202 -176.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.617 ' HB2' HG12 ' A' ' 52' ' ' ILE . 35.9 t0 -112.45 130.36 56.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.082 174.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 70' ' ' THR . 54.1 m-85 -104.7 124.23 49.01 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.101 -1.863 . . . . 0.0 111.897 177.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 13.5 p-90 -129.52 152.67 48.8 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.466 175.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -119.01 127.45 26.51 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.415 -172.061 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 71' ' ' ASP . 38.5 Cg_exo -59.53 -26.65 82.74 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 O-C-N 123.786 1.414 . . . . 0.0 112.081 172.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . 0.268 8.4 p-90 -66.81 -25.74 66.6 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 26.8 p -98.42 45.55 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 123.185 1.469 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 44' ' ' PRO . . . 36.4 -113.18 0.16 Allowed Glycine 0 CA--C 1.549 2.189 0 CA-C-N 112.666 -2.061 . . . . 0.0 114.843 -178.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HA3' ' A' ' 43' ' ' GLY . 7.8 Cg_endo -80.14 38.71 0.76 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.596 2.864 . . . . 0.0 115.575 -176.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 1.3 m -56.43 -12.93 1.91 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 117.486 2.402 . . . . 0.0 117.486 176.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -49.63 -26.54 3.72 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 173.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -50.62 -31.43 16.03 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 175.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.91 -36.92 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.977 0.911 . . . . 0.0 111.725 176.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.255 . . -54.08 -42.9 95.81 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 117.157 2.28 . . . . 0.0 117.157 178.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 11.5 Cg_exo -50.04 -36.75 45.68 Favored 'Trans proline' 0 N--CA 1.481 0.743 0 C-N-CA 124.797 3.664 . . . . 0.0 115.498 171.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.1 t -60.85 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 123.532 0.52 . . . . 0.0 110.019 175.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.8 mp -65.97 -38.25 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.46 1.104 . . . . 0.0 111.819 177.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 50' ' ' PRO . 14.9 m-20 -57.08 -43.91 82.58 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 122.058 0.932 . . . . 0.0 112.095 174.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.71 -34.27 62.56 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.11 -1.859 . . . . 0.0 114.674 178.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.646 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 79.8 mt -53.85 -24.09 14.58 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 173.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 65' ' ' VAL . . . -65.01 -49.82 68.71 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.24 179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -77.25 -27.77 53.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 175.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -60.88 -31.86 71.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.174 0.99 . . . . 0.0 113.387 -178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.813 ' HD1' ' HB2' ' A' ' 62' ' ' LYS . 10.4 p90 -139.74 64.85 1.44 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.113 170.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m 3.62 79.2 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 109.313 -3.585 . . . . 0.0 117.871 178.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.18 35.82 50.67 Favored Glycine 0 N--CA 1.481 1.657 0 CA-C-N 112.692 -2.049 . . . . 0.0 116.657 178.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.813 ' HB2' ' HD1' ' A' ' 59' ' ' TYR . 69.4 mttt -61.32 -24.22 66.28 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 176.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD13 HG13 ' A' ' 65' ' ' VAL . 1.6 pp -141.97 166.01 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.188 2.195 . . . . 0.0 111.776 -176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.23 115.39 27.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.093 0.957 . . . . 0.0 110.112 173.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 63' ' ' ILE . 0.8 OUTLIER -90.35 106.06 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -175.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' VAL . 21.6 m-85 -113.32 161.36 17.34 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 113.408 -1.724 . . . . 0.0 112.784 179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -153.44 129.84 10.6 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.671 -1.604 . . . . 0.0 110.691 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 73' ' ' ALA . 1.3 pp -128.2 149.78 50.3 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 118.722 2.86 . . . . 0.0 118.722 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 72' ' ' GLU . 2.2 m-20 -78.5 107.85 11.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 110.731 -2.941 . . . . 0.0 104.114 172.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.587 HG21 HD11 ' A' ' 85' ' ' ILE . 75.4 p -51.71 -40.15 59.65 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -177.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB2' ' HG2' ' A' ' 40' ' ' PRO . 54.7 m-20 -74.14 -16.0 61.02 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 177.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HB3' ' HB2' ' A' ' 69' ' ' ASN . 3.9 tt0 -80.13 -32.76 38.95 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.421 0.688 . . . . 0.0 110.787 172.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -130.37 69.16 82.0 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.82 177.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -66.26 -38.45 20.88 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.548 2.165 . . . . 0.0 112.315 -175.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' GLN . . . -55.75 -40.03 78.7 Favored Glycine 0 N--CA 1.477 1.416 0 C-N-CA 126.89 2.185 . . . . 0.0 113.564 178.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.4 -54.2 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.806 0.842 . . . . 0.0 110.496 175.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.22 -36.68 71.2 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.885 -1.507 . . . . 0.0 113.215 174.689 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.2 m -59.44 -61.76 2.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.94 0.496 . . . . 0.0 109.933 174.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 75' ' ' GLY . 3.8 pt20 -62.94 -20.71 65.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -171.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -107.27 8.92 30.12 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.734 1.271 . . . . 0.0 113.718 175.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.489 HD22 ' NH1' ' A' ' 83' ' ' ARG . 15.2 m120 50.88 41.15 26.45 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.81 1.644 . . . . 0.0 114.479 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.296 0.1 OUTLIER -91.69 94.83 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 114.099 -1.409 . . . . 0.0 108.195 -178.537 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.489 ' NH1' HD22 ' A' ' 81' ' ' ASN . 52.4 mtt180 -98.48 -33.35 11.05 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 109.682 -3.417 . . . . 0.0 111.371 175.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 101' ' ' ILE . 4.8 p -82.93 131.1 35.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.553 -178.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.587 HD11 HG21 ' A' ' 70' ' ' THR . 48.3 mm -111.14 113.28 54.6 Favored Pre-proline 0 N--CA 1.475 0.796 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.712 172.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 43.5 Cg_endo -90.67 161.51 31.45 Favored 'Cis proline' 0 CA--C 1.54 0.775 0 O-C-N 125.364 2.244 . . . . 0.0 115.458 1.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.8 m -134.25 119.69 19.07 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.692 -2.049 . . . . 0.0 105.489 164.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.07 119.62 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.582 -179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 7.0 mp -109.26 146.68 33.86 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.63 -1.623 . . . . 0.0 111.829 -172.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HE2' HG12 ' A' ' 100' ' ' ILE . 25.9 m-85 -126.15 128.7 47.7 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 122.751 1.262 . . . . 0.0 109.474 -178.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -125.51 150.66 47.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.254 -2.248 . . . . 0.0 114.722 -173.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -117.75 77.52 1.15 Allowed 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 110.15 -3.205 . . . . 0.0 106.941 167.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' HB2' HG13 ' A' ' 31' ' ' VAL . 39.4 t30 63.21 70.7 0.53 Allowed 'General case' 0 N--CA 1.479 1.014 1 CA-C-N 107.851 -4.25 . . . . 0.0 110.699 -178.64 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . 63.07 7.65 18.55 Favored Glycine 0 CA--C 1.541 1.705 0 CA-C-N 112.872 -1.967 . . . . 0.0 116.622 -174.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -110.45 96.85 6.46 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 123.25 1.5 . . . . 0.0 108.596 -179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -51.21 111.27 0.54 Allowed 'General case' 0 C--N 1.312 -1.057 1 CA-C-N 108.145 -4.116 . . . . 0.0 114.445 -178.072 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.26 -26.77 15.28 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.731 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.51 ' HB2' ' OH ' ' A' ' 116' ' ' TYR . 3.2 tp10 -167.51 152.95 7.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.563 1.145 . . . . 0.0 112.232 178.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.525 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -140.73 127.76 20.74 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.563 1.164 . . . . 0.0 109.992 172.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.597 HG12 ' HE2' ' A' ' 90' ' ' PHE . 30.3 mm -98.27 99.4 8.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.256 -1.793 . . . . 0.0 110.634 177.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.428 HG23 ' OG ' ' A' ' 84' ' ' SER . 3.0 mt -82.84 122.99 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 111.257 -2.701 . . . . 0.0 109.302 177.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.54 -54.89 4.65 Favored Glycine 0 N--CA 1.484 1.867 0 C-N-CA 125.165 1.364 . . . . 0.0 115.492 173.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.548 ' O ' HD11 ' A' ' 109' ' ' LEU . . . -59.36 99.75 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -173.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 6.1 p -81.1 -25.84 0.42 Allowed Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 118.046 2.61 . . . . 0.0 118.046 173.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 104' ' ' VAL . 17.7 Cg_endo -57.87 122.97 12.65 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.041 2.494 . . . . 0.0 113.513 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -29.01 -57.25 0.14 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 110.264 -3.153 . . . . 0.0 114.295 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.6 p -52.87 -48.06 67.39 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.918 1.822 . . . . 0.0 115.918 -177.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.5 m -61.7 -43.15 99.41 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 177.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.548 HD11 ' O ' ' A' ' 103' ' ' ALA . 8.3 mp -59.35 -51.21 70.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 112.61 -2.086 . . . . 0.0 108.664 174.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -56.85 -54.0 51.41 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 123.44 1.59 . . . . 0.0 111.644 -179.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -46.29 -46.64 18.12 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 111.452 -2.613 . . . . 0.0 111.936 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.402 ' OG ' HD11 ' A' ' 100' ' ' ILE . 50.7 m -70.92 -5.71 32.86 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 117.439 2.385 . . . . 0.0 117.439 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.587 HG13 ' CZ ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -105.14 -48.93 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.276 168.275 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.91 -0.03 6.66 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -172.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 116' ' ' TYR 0.388 18.5 ttmm -69.67 -37.27 76.61 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 111.656 -2.52 . . . . 0.0 110.785 163.668 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.51 ' OH ' ' HB2' ' A' ' 98' ' ' GLU . 56.0 m-85 -94.23 -71.19 0.67 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 127.828 2.451 . . . . 0.0 110.628 -175.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.563 HD21 ' HB ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 124.786 2.231 . . . . 0.0 107.796 172.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.655 HG11 ' HB ' ' A' ' 17' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 66.11 -37.47 0.27 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.843 1.657 . . . . 0.0 115.092 -170.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -147.1 100.78 3.34 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.417 2.287 . . . . 0.0 111.794 171.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.655 ' HB ' HG11 ' A' ' 14' ' ' VAL . 8.0 p -85.97 55.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.806 1.765 . . . . 0.0 113.851 175.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -73.03 -172.02 0.98 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.007 -179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -47.99 -41.69 25.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -172.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -69.68 -50.28 45.36 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.797 0.808 . . . . 0.0 112.615 177.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 1.2 m -69.38 -33.41 73.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.465 178.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.415 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 68.9 t-105 -46.16 -47.91 17.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.981 0.912 . . . . 0.0 112.013 -176.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 27' ' ' LEU . 67.5 mttm -61.92 -68.25 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -58.79 -23.45 60.25 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -112.62 -18.61 12.33 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 119.41 3.115 . . . . 0.0 119.41 178.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' HA ' HG11 ' A' ' 33' ' ' VAL . 92.8 t -113.9 -43.95 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.628 0.371 . . . . 0.0 110.466 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' HA2' ' A' ' 94' ' ' GLY . 10.1 mt -88.71 -16.44 32.28 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.262 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.18 92.82 3.16 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 175.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -149.91 -152.69 0.45 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.001 -176.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.8 -5.54 9.21 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 129.372 3.069 . . . . 0.0 113.037 179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.652 ' HA ' ' HB2' ' A' ' 93' ' ' ASN 0.521 24.2 t 91.24 -74.43 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 130.048 3.339 . . . . 0.0 111.753 -177.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 16.5 Cg_exo -71.51 116.72 4.81 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 CA-C-N 124.593 2.676 . . . . 0.0 107.558 171.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 26' ' ' VAL . 93.6 t -120.69 142.69 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.111 -176.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.731 ' HE1' HD12 ' A' ' 113' ' ' ILE . 41.5 ttm -125.4 136.21 53.19 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 126.218 2.199 . . . . 0.0 108.933 176.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 7.1 p -136.2 130.82 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.825 -178.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.01 129.09 45.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.426 176.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' HD21 ' A' ' 68' ' ' LEU . 52.5 m-85 -105.26 122.97 47.04 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 113.732 -1.576 . . . . 0.0 112.216 178.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' HE3' ' HB2' ' A' ' 45' ' ' CYS . 7.8 p-90 -124.48 158.66 32.33 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.979 1.424 . . . . 0.0 111.557 177.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . . . -140.91 135.24 15.27 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.066 -174.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 50.7 Cg_exo -58.27 -34.75 98.91 Favored 'Trans proline' 0 N--CA 1.482 0.797 0 C-N-CA 123.984 3.122 . . . . 0.0 113.047 178.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -77.59 28.52 0.16 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 174.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 167.49 15.32 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.932 177.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.01 -81.41 0.96 Allowed Glycine 0 CA--C 1.55 2.239 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.026 170.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -82.38 88.28 1.3 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 121.705 1.603 . . . . 0.0 113.098 -179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.597 ' HB2' ' HE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -137.82 136.71 37.45 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.033 -178.109 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HB2' ' CD2' ' A' ' 38' ' ' TRP . 72.7 tttt 63.37 -56.16 0.19 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.965 2.106 . . . . 0.0 114.873 176.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 tp -80.24 52.34 1.56 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 123.28 1.515 . . . . 0.0 111.078 -179.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.453 HD12 ' H ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -158.32 -82.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 111.952 -2.385 . . . . 0.0 110.824 -176.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.453 ' H ' HD12 ' A' ' 48' ' ' ILE . . . 37.29 43.03 0.36 Allowed Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 126.087 1.755 . . . . 0.0 111.739 -174.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 48' ' ' ILE . 2.5 Cg_endo -62.09 -64.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.288 1.325 . . . . 0.0 112.467 -165.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 109' ' ' LEU . 17.6 t -55.64 -43.71 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.615 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -61.46 -45.39 98.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.129 1.371 . . . . 0.0 112.855 178.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 7.3 m-20 -64.09 -30.59 71.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.568 177.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -78.51 -41.74 31.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.992 174.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 58' ' ' GLU . 94.0 mt -60.74 -22.85 64.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.067 0.947 . . . . 0.0 112.31 174.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASP . . . -65.52 -51.92 56.42 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.52 173.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -75.87 -21.51 57.12 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 176.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 8.3 mt-10 -70.19 -40.44 74.64 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 124.508 1.13 . . . . 0.0 113.507 172.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 1.056 ' HB3' ' HB2' ' A' ' 62' ' ' LYS . 55.4 m-85 -125.41 58.9 1.28 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 124.698 2.19 . . . . 0.0 113.675 178.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.7 m -58.98 110.34 1.01 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 110.767 -2.924 . . . . 0.0 111.239 171.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.19 -36.46 3.97 Favored Glycine 0 N--CA 1.474 1.202 0 CA-C-N 112.81 -1.995 . . . . 0.0 111.012 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 1.056 ' HB2' ' HB3' ' A' ' 59' ' ' TYR . 6.6 mptt -56.73 -58.68 7.04 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.586 HG12 ' HE3' ' A' ' 34' ' ' MET . 2.8 pp -121.15 136.02 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 122.951 1.358 . . . . 0.0 113.075 -175.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.01 108.18 19.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.536 -2.574 . . . . 0.0 108.299 173.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -87.24 124.87 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 113.864 -1.516 . . . . 0.0 114.146 -177.012 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.464 ' HD1' ' HB ' ' A' ' 14' ' ' VAL . 59.2 m-85 -129.09 169.15 15.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.063 -179.028 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.22 136.02 18.4 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.488 174.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -127.05 153.3 46.13 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 173.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.57 96.6 8.12 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 109.765 -3.379 . . . . 0.0 105.834 175.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 66.3 p -51.72 -40.64 60.55 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.599 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 1.6 m-20 -63.68 -25.41 68.2 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 175.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -85.55 -22.41 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.385 176.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.71 75.02 80.25 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.63 0.772 . . . . 0.0 111.525 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -60.38 -36.51 86.78 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 123.613 2.875 . . . . 0.0 113.815 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 78' ' ' THR . . . -61.94 -39.67 97.85 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 127.73 2.586 . . . . 0.0 113.997 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.39 -49.08 80.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 122.513 -0.404 . . . . 0.0 110.591 177.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.05 -30.34 71.52 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.832 -1.076 . . . . 0.0 113.035 177.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 75' ' ' GLY . 56.0 m -62.8 -59.72 4.47 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.899 0.879 . . . . 0.0 110.211 170.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -57.25 -37.67 72.67 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.345 1.858 . . . . 0.0 112.621 -173.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -101.9 7.57 41.47 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 125.031 1.457 . . . . 0.0 114.076 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 45.38 55.32 6.61 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 pp -114.92 125.39 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.433 -176.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 -28.91 3.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 111.091 -2.777 . . . . 0.0 111.019 171.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 p -89.32 82.3 6.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 124.258 1.98 . . . . 0.0 114.993 -172.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.0 OUTLIER -76.09 132.7 73.28 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 110.679 -2.964 . . . . 0.0 108.661 175.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 6.6 Cg_exo -80.63 126.76 13.13 Favored 'Cis proline' 0 C--N 1.349 0.582 0 O-C-N 123.76 1.4 . . . . 0.0 114.631 -0.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -105.21 137.7 42.57 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG11 HD21 ' A' ' 109' ' ' LEU . 7.2 p -126.56 122.02 60.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 113.928 -1.487 . . . . 0.0 110.348 176.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HG ' ' HD2' ' A' ' 96' ' ' ARG . 7.8 mp -109.67 145.56 36.3 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.17 -176.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.452 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 27.7 m-85 -128.51 116.78 20.21 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 123.534 1.635 . . . . 0.0 110.069 -173.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 90.7 m-85 -117.8 156.71 27.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 110.078 -3.237 . . . . 0.0 111.475 -173.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -128.25 72.51 1.43 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.3 -2.682 . . . . 0.0 109.474 164.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.652 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 9.2 t30 60.7 83.07 0.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 108.978 -3.737 . . . . 0.0 111.289 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 73.55 -4.66 26.54 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 112.124 -2.307 . . . . 0.0 116.973 -176.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -108.03 94.29 4.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -171.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HD2' ' HG ' ' A' ' 89' ' ' LEU . 15.4 ttp180 -76.55 119.19 20.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.974 -1.921 . . . . 0.0 111.433 -177.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -108.1 -49.51 3.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 110.717 -2.947 . . . . 0.0 111.658 -173.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 147.0 49.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.719 -177.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 p -149.24 122.65 9.06 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.745 177.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.432 HG12 ' HE1' ' A' ' 90' ' ' PHE . 37.8 mm -104.02 99.26 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 113.157 -1.838 . . . . 0.0 107.525 178.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.669 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.7 OUTLIER -85.2 62.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 111.425 -2.625 . . . . 0.0 115.443 -175.899 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.83 163.04 11.04 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 112.291 -2.232 . . . . 0.0 109.663 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.98 75.1 10.02 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 124.444 2.069 . . . . 0.0 111.348 -178.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 96.7 t -89.14 143.55 31.29 Favored Pre-proline 0 CA--C 1.548 0.904 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.673 -176.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' VAL . 5.4 Cg_endo -51.02 156.68 4.64 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.757 2.971 . . . . 0.0 114.84 175.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -31.96 -58.61 0.29 Allowed 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 108.662 -3.881 . . . . 0.0 116.928 -173.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.7 p -50.82 -46.77 60.1 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 -174.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 50.2 m -60.91 -46.37 90.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 113' ' ' ILE . 6.2 mp -59.91 -40.0 87.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.119 -1.401 . . . . 0.0 112.044 175.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.585 HG22 ' OE1' ' A' ' 114' ' ' GLU . 6.7 m -68.85 -44.47 73.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.249 1.024 . . . . 0.0 111.988 -178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' THR . 47.9 t0 -52.57 -48.14 66.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 111.211 -2.722 . . . . 0.0 110.539 173.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.1 m -59.48 -25.86 64.78 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 117.753 2.501 . . . . 0.0 117.753 179.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.731 HD12 ' HE1' ' A' ' 34' ' ' MET 0.291 0.0 OUTLIER -85.32 -54.88 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-O 123.937 1.827 . . . . 0.0 112.623 172.739 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.585 ' OE1' HG22 ' A' ' 110' ' ' THR . 43.0 mt-10 -55.72 -30.22 60.81 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 110.96 -2.836 . . . . 0.0 112.669 -171.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.289 13.6 tppt? -28.86 -62.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 130.552 3.541 . . . . 0.0 113.392 164.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 28.6 p90 -103.82 -19.06 14.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.765 -173.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 114' ' ' GLU . 2.5 mm? . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.919 0.866 . . . . 0.0 111.301 166.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.544 0.712 0 CA-C-O 122.204 1.002 . . . . 0.0 113.3 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -85.5 64.05 8.42 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.539 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 49.4 46.08 23.42 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.67 -176.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 66' ' ' TYR . 4.9 t 39.46 -78.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 109.945 -3.298 . . . . 0.0 114.89 -172.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' H ' HD12 ' A' ' 68' ' ' LEU . 76.6 m-20 60.88 156.85 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.356 1.862 . . . . 0.0 112.534 -170.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -39.25 -33.45 0.14 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 175.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.7 p -63.1 -64.17 0.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.838 1.655 . . . . 0.0 111.703 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -72.32 -23.31 61.14 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.526 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.713 ' HZ3' HG21 ' A' ' 35' ' ' VAL . 70.5 t-105 -47.24 -51.53 18.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 27' ' ' LEU . 48.3 mttp -61.28 -67.18 0.43 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.597 179.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.75 -33.76 66.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 179.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -97.35 -35.26 10.76 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -176.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.74 HG13 HG11 ' A' ' 33' ' ' VAL . 93.2 t -100.57 -45.31 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.134 -1.394 . . . . 0.0 110.616 -174.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 23' ' ' LYS . 1.9 mm? -89.24 -35.39 16.21 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -132.48 47.14 2.55 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -170.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.8 t -105.89 -149.72 0.43 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 170.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -127.34 21.42 6.66 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 122.816 1.293 . . . . 0.0 109.386 175.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 33' ' ' VAL . 27.5 m -119.19 137.5 25.28 Favored Pre-proline 0 N--CA 1.473 0.692 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.583 -169.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.3 138.32 60.27 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 N-CA-C 103.665 -3.244 . . . . 0.0 103.665 164.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 HG13 ' A' ' 26' ' ' VAL . 70.3 t -121.85 144.16 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 122.144 0.973 . . . . 0.0 112.567 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.421 ' CE ' HD12 ' A' ' 113' ' ' ILE . 55.3 ttm -123.73 130.07 52.07 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 112.279 -2.237 . . . . 0.0 108.444 169.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.713 HG21 ' HZ3' ' A' ' 22' ' ' TRP . 13.5 p -126.17 133.06 69.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.822 173.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HB2' HG12 ' A' ' 52' ' ' ILE . 8.6 t70 -106.05 128.35 53.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 111.178 -2.737 . . . . 0.0 109.445 -178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 68' ' ' LEU . 31.1 m-85 -116.99 118.4 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 125.36 1.663 . . . . 0.0 111.918 177.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.651 ' HB2' ' HB3' ' A' ' 45' ' ' CYS . 9.5 p-90 -128.74 154.0 46.79 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.868 176.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -130.14 136.97 29.85 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.224 -176.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 71' ' ' ASP . 40.4 Cg_endo -59.03 -37.27 94.02 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 122.091 1.861 . . . . 0.0 113.801 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -67.16 -13.08 61.61 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 175.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 29.6 p -108.85 42.42 1.42 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.724 0.773 . . . . 0.0 111.137 170.1 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 10.0 -81.37 0.0 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 129.308 3.337 . . . . 0.0 116.882 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.99 -18.18 2.88 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.407 3.405 . . . . 0.0 117.404 177.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.651 ' HB3' ' HB2' ' A' ' 38' ' ' TRP . 14.0 m -42.92 -38.7 2.3 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -51.16 -34.77 32.78 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.997 1.319 . . . . 0.0 114.376 177.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 56.4 mt -60.15 -22.97 63.53 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 45' ' ' CYS . 12.9 pt -72.34 -23.16 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 176.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . 0.257 . . -62.13 -44.19 88.37 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 174.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.74 -46.39 29.96 Favored 'Trans proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.863 3.709 . . . . 0.0 111.826 169.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG13 ' HG3' ' A' ' 106' ' ' LYS . 13.0 t -53.71 -45.59 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.923 0.889 . . . . 0.0 111.87 173.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 36' ' ' ASP . 1.6 mp -66.0 -39.37 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.351 0.661 . . . . 0.0 112.248 175.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -59.66 -35.71 74.98 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.49 1.138 . . . . 0.0 112.637 175.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.45 -46.28 55.67 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.788 -1.551 . . . . 0.0 114.147 174.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.504 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 54.7 mt -52.64 -26.89 14.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.98 -56.59 20.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 110.566 175.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.74 -26.65 59.94 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -52.94 -51.6 60.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.848 0.859 . . . . 0.0 111.486 175.795 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.779 ' HE2' HG23 ' A' ' 110' ' ' THR . 0.7 OUTLIER -119.87 66.63 0.81 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.988 1.375 . . . . 0.0 110.73 171.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.4 t -12.74 102.91 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 1 CA-C-N 108.015 -4.175 . . . . 0.0 116.086 177.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.36 -9.55 13.8 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-N 112.797 -2.001 . . . . 0.0 116.317 174.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.636 ' HD2' ' HB2' ' A' ' 59' ' ' TYR . 69.0 mttt -49.39 -58.93 4.23 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -177.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.71 137.71 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 114.303 -1.317 . . . . 0.0 114.536 -179.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.63 105.07 11.59 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.397 -2.183 . . . . 0.0 109.46 174.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 52' ' ' ILE . 5.7 m -79.42 112.94 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 113.086 -1.87 . . . . 0.0 115.175 -176.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 33' ' ' VAL . 64.6 m-85 -117.16 142.32 47.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.704 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.33 112.62 15.26 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.103 -178.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 37' ' ' PHE . 13.5 tp -102.88 128.03 49.83 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 112.04 -2.345 . . . . 0.0 112.815 -176.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -79.23 89.67 4.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 103.387 -2.82 . . . . 0.0 103.387 170.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 38' ' ' TRP . 12.3 t -45.78 -43.73 13.36 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.146 -1.843 . . . . 0.0 115.293 -172.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 40' ' ' PRO . 7.5 m-20 -65.93 -27.4 68.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 112.358 -2.201 . . . . 0.0 114.026 175.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -78.22 -24.71 46.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.352 0.661 . . . . 0.0 111.448 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.12 78.03 59.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.763 175.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -57.62 -38.92 91.89 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.718 2.279 . . . . 0.0 112.374 -178.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.09 -44.03 94.91 Favored Glycine 0 N--CA 1.477 1.379 0 C-N-CA 126.364 1.935 . . . . 0.0 113.728 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.1 mm -66.3 -48.73 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 122.608 -0.348 . . . . 0.0 110.633 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.35 -41.54 69.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.446 175.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HH22 ' A' ' 83' ' ' ARG . 92.0 m -56.82 -63.09 1.32 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.277 1.031 . . . . 0.0 110.549 174.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -50.89 -44.86 59.91 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 114.351 -1.295 . . . . 0.0 113.807 -174.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -86.78 -6.84 58.7 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 113.582 -1.645 . . . . 0.0 114.591 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 46.57 44.09 13.04 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.085 1.421 . . . . 0.0 113.453 -178.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -83.67 41.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 112.999 -1.909 . . . . 0.0 115.681 -173.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.437 HH22 ' HA ' ' A' ' 78' ' ' THR . 31.9 mmt-85 -46.55 -25.85 0.77 Allowed 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 111.733 -2.485 . . . . 0.0 115.96 -176.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 t -105.68 76.17 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.861 1.315 . . . . 0.0 110.358 179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.0 mp -80.09 128.77 72.41 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -71.91 133.62 29.77 Favored 'Cis proline' 0 C--N 1.353 0.783 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 3.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.665 HG23 ' HA ' ' A' ' 101' ' ' ILE . 0.3 OUTLIER -128.38 141.71 51.34 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 112.826 -1.988 . . . . 0.0 109.521 179.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 103' ' ' ALA . 26.8 t -131.97 126.87 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.072 173.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.7 mp -110.95 146.31 36.84 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.588 1.18 . . . . 0.0 110.877 -178.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' HB3' ' OH ' ' A' ' 116' ' ' TYR . 39.4 m-85 -124.14 113.27 18.12 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.851 -174.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HB2' ' HB ' ' A' ' 33' ' ' VAL . 79.9 m-85 -114.32 148.93 36.79 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 109.719 -3.4 . . . . 0.0 110.556 -176.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -118.99 64.93 0.78 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.363 -2.199 . . . . 0.0 108.222 169.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 t30 59.52 84.57 0.11 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 108.924 -3.762 . . . . 0.0 111.26 -176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 67.82 3.72 29.86 Favored Glycine 0 N--CA 1.48 1.624 0 CA-C-N 112.689 -2.05 . . . . 0.0 116.078 -176.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' PHE . 62.5 mt-10 -107.73 106.67 17.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -177.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -87.08 117.64 25.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.195 -1.82 . . . . 0.0 110.062 -171.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.54 -60.47 1.56 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.528 -170.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -134.54 141.24 46.63 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.529 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.0 m -130.1 99.16 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.003 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.23 99.3 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.953 -179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' THR . 0.8 OUTLIER -66.37 -36.48 77.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 111.702 -2.499 . . . . 0.0 115.702 -178.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.93 77.92 0.25 Allowed Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.269 -1.533 . . . . 0.0 109.269 176.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -91.13 78.87 5.82 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.467 1.127 . . . . 0.0 113.365 -174.05 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.59 -46.84 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 CA-C-N 112.844 -1.98 . . . . 0.0 112.563 176.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -79.37 115.77 3.49 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 121.887 1.724 . . . . 0.0 109.629 175.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' HG13 ' A' ' 51' ' ' VAL . 78.8 tttt -48.91 -45.06 40.83 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 111.835 -2.439 . . . . 0.0 112.49 176.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 p -58.02 -46.79 84.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 28.3 m -53.96 -41.64 68.02 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.453 1.101 . . . . 0.0 113.45 175.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' O ' HD13 ' A' ' 113' ' ' ILE . 27.8 mt -63.41 -44.72 93.83 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.007 175.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.779 HG23 ' HE2' ' A' ' 59' ' ' TYR . 60.3 m -59.75 -51.07 71.35 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 123.11 1.433 . . . . 0.0 110.791 -179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' THR . 22.2 t0 -46.01 -50.32 15.08 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 111.667 -2.515 . . . . 0.0 110.025 174.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -61.94 -29.5 70.27 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 118.996 2.962 . . . . 0.0 118.996 179.322 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.543 ' H ' HD13 ' A' ' 113' ' ' ILE 0.324 0.0 OUTLIER -77.62 -54.99 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.671 172.422 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.446 ' HG3' HG12 ' A' ' 113' ' ' ILE . 47.4 mt-10 -65.0 -17.52 64.51 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 111.948 -2.387 . . . . 0.0 113.85 -170.254 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . 0.258 24.4 ttmm -45.43 -55.14 6.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.653 2.381 . . . . 0.0 111.622 164.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' OH ' ' HB3' ' A' ' 90' ' ' PHE . 52.1 p90 -107.72 -40.59 5.25 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.973 -1.012 . . . . 0.0 113.018 -178.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.461 ' HG ' ' HD3' ' A' ' 62' ' ' LYS . 31.9 tp . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 125.724 2.678 . . . . 0.0 106.385 -179.633 . . . . . . . . 1 1 . 1 stop_ save_